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ABSTRACT 
 
I-Jen Pan: Polychlorinated Biphenyls, Dichlorodiphenyldichloroethylene, and Infant 
Development and Growth: An Analysis of the PIN Babies Study 
(Under the direction of Julie L. Daniels, PhD) 
 
Polychlorinated biphenyls (PCBs) and dichlorodiphenyltrichloroethane (DDT) are 
persistent, bioaccumulative and toxic pollutants which were broadly used in the US until 
the 1970s. Common exposure to PCBs, DDT, and dichlorodiphenyldichloroethylene 
(DDE), the most stable metabolite of DDT, may influence children’s neurodevelopment 
and growth, but study results are not consistent. This dissertation reported the 
concentrations of PCBs, DDT and DDE in breast milk of lactating women in Central 
North Carolina in 2004-2006, and examined the associations between lactational 
exposure to PCBs, DDT and DDE and infant development and growth at 12 months using 
data from the Pregnancy, Infection and Nutrition Babies Study, 2004-2006. PCBs, DDT 
and DDE were measured in breast milk at the third month postpartum. Lactational 
exposure of these chemicals was estimated by the product of chemical concentrations and 
the duration of breast feeding. Infant development at 12 months was measured by the 
Mullen Scales of Early Learning (n=231) and the Short Form: Level I (infant) of the 
MacArthur-Bates Communicative Development Indices (CDI) (n=218). Serial infant 
growth measurements through the first 12 months of life were regularly recorded in each 
child’s growth card by pediatric practitioners (n=206). No consistent associations were 
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observed between lactational exposure to PCBs, DDT and DDE through the first 12 
months and the measures of infant development. However, DDE was associated with 
scoring below average on the gross motor scale of the Mullen among males only 
(adjusted OR=1.9, 95%CI=1.1, 3.3). Among infants breast fed for 6 months or longer 
there was no difference in weight and length through the first 6 months as the 
concentrations of PCBs, DDT and DDE increased. No difference was observed in weight 
and length at 12 months when comparing the accumulated lactational exposure through 
12 months after controlling for total duration of breast feeding. In the ranges of chemical 
concentrations studied here, combined with the beneficial effects of the long duration of 
breastfeeding in this study population, lactational exposure to PCBs, DDT and DDE did 
not appear to impair infant neurodevelopment at 12 months, and resulted in no negative 
influence on infant growth in the first 12 months. 
 
v
To my parents, my brother, and Jim 
 
 
vi
ACKNOWLEDGEMENT 
 
I would like to thank my dissertation committee, Drs. Julie L. Daniels, Barbara D. 
Goldman, Amy H. Herring, Walter J. Rogan, and Anna Maria Siega-Riz, for spending 
their time and effort to guide me through my dissertation. I thank the PIN Study staff, 
especially Kathryn Carrier, Diane Kaczor, and Jim Terry, for their assistance along the 
way, and thank the women who participated in the PIN studies. Without them, this study 
would not be possible. I acknowledge Dr. Andreas Sjödin and the Organic Analytic 
Toxicology Branch of the National Center for Environmental Health at the CDC for 
assays of PCBs, DDT and DDE. I appreciate the financial support provided by the 
Dissertation Completion Fellowship from the UNC Graduate School in my last year of 
the doctoral program. I also would like to extend my heartfelt thanks to Nancy L. Colvin 
and all of my friends, especially Ru-Shiun Liou and Sarah J. Nyante, for providing me 
much needed support and encouragement through my UNC life. At the end, I am 
profoundly grateful to my family and Jim. Their unconditional love and sustained support 
enabled me to complete this dissertation. 
 
vii
TABLE OF CONTENTS 
LIST OF TABLES ............................................................................................................. xi 
LIST OF FIGURES ......................................................................................................... xiii 
LIST OF ABBREVIATIONS .......................................................................................... xiv 
 
CHAPTER I. LITERATURE REVIEW ............................................................................. 1 
A. Introduction......................................................................................................... 1 
B. Systematic Review of Epidemiological Studies ................................................. 6 
B.1 Polychlorinated Biphenyls (PCBs) and Children's Neurodevelopment....... 7 
B.2 Dichlorodiphenyldichloroethylene (DDE) and Children's 
Neurodevelopment ......................................................................................11 
B.3 Polychlorinated Biphenyls (PCBs) and Children's Growth ....................... 13 
B.4 Dichlorodiphenyldichloroethylene (DDE) and Children's Growth............ 15 
C. Discussion ......................................................................................................... 16 
CHAPTER II. RESEARCH AIMS AND HYPOTHESIS ................................................ 40 
CHAPTER III. METHODS.............................................................................................. 43 
 
viii
A. Study Design Overview .................................................................................... 43 
B. Study Population............................................................................................... 44 
C. Data Collection ................................................................................................. 46 
C.1 Exposure Measurement .............................................................................. 47 
C.2 Outcome Ascertainment ............................................................................. 48 
C.2.1 Cognitive and Motor Development – by the Mullen Scales of 
Early Learning .......................................................................................... 49 
C.2.2 Language Comprehension and Production – by the Infant 
Short-form of the MacArthur Communicative Development Inventories 49 
C.2.3 Physical Growth – by the Babies’ Growth Card ............................. 51 
C.3 Other Covariates......................................................................................... 51 
D. Data Analyses.................................................................................................... 52 
D.1 Specific Aim 1 – Describe Distributions of PCBs, DDT and DDE in 
Contemporary Breast Milk and Their Correlations with Long-Chain 
Polyunsaturated Fatty Acids in a Subsample ............................................. 53 
D.2 Specific Aim 2 – Estimate the Associations Between PCBs, DDT and 
DDE in Breast Milk and Infant Development at 12 Months ..................... 53 
D.3 Specific Aim 3 – Estimate the Associations Between PCBs, DDT and 
DDE in Breast Milk and Infant Growth through the First 12 Months of 
Life. ............................................................................................................ 57 
D.4 Statistical Power......................................................................................... 58 
CHAPTER IV. RESULTS................................................................................................. 68 
 
ix
A. Manuscript 1: Organochlorine Compounds and Fatty Acids in Breast Milk 
in Central North Carolina 2004-2006 ............................................................... 68 
A.1 Introduction................................................................................................ 68 
A.2 Methods...................................................................................................... 69 
A.3 Results........................................................................................................ 74 
A.4 Discussion .................................................................................................. 78 
B. Manuscript 2: Lactational Exposure to Polychlorinated Biphenyls, 
Dichlorodiphenyltrichloroethane, and Dichlorodiphenyldichloroethylene 
and Infant Neurodevelopment: An Analysis of the Pregnancy, Infections, 
and Nutrition Babies Study ............................................................................... 93 
B.1 Introduction ................................................................................................ 93 
B.2 Methods...................................................................................................... 95 
B.3 Results ...................................................................................................... 102 
B.4 Discussion ................................................................................................ 105 
B.5 Acknowledgement .....................................................................................111 
C. Manuscript 3: Lactational Exposure to Polychlorinated Biphenyls, 
Dichlorodiphenyltrichloroethane, and Dichlorodiphenyldichloroethylene 
and Infant Growth: An Analysis of the Pregnancy, Infections, and Nutrition 
Babies Study ....................................................................................................117 
C.1 Introduction ...............................................................................................117 
C.2 Methods.....................................................................................................118 
C.3 Results ...................................................................................................... 125 
 
x
C.4 Discussion ................................................................................................ 127 
CHAPTER V. DISCUSSION ......................................................................................... 136 
A. Summary of Findings...................................................................................... 136 
B. Strengths and Limitations ............................................................................... 138 
B.1 Strengths................................................................................................... 138 
B.2 Limitations ............................................................................................... 140 
C. Conclusions..................................................................................................... 141 
REFERENCES ............................................................................................................... 143 
 
 
xi
LIST OF TABLES 
Table 1. Reviews of studies about the effects of polychlorinated biphenyls (PCBs) on 
children's neurodevelopment. ........................................................................................... 22 
Table 2. Neurodevelopment tests used in previous papers. .............................................. 29 
Table 3. Reviews of studies about the effects of dichlorodiphenyltrichloroethane 
(DDT) and dichlorodiphenyldichloroethylene (DDE) on children's neurodevelopment.
........................................................................................................................................... 32 
Table 4. Reviews of studies about the effects of polychlorinated biphenyls (PCBs) on 
children's growth............................................................................................................... 35 
Table 5. Reviews of studies about the effects of dichlorodiphenyltrichloroethane 
(DDT) and dichlorodiphenyldichloroethylene (DDE) on children's growth. ................... 38 
Table 6. Characteristics of the participant women in this study, in the PIN Postpartum 
Study and in the PIN 3 Cohort. ......................................................................................... 61 
Table 7. List of chemicals of interest measured in breast milk samples and the median 
of lipid adjusted limit of detection (LOD) (ng/g lipid). .................................................... 62 
Table 8. Lipid-adjusted chemical concentrations (ng/g lipid) in maternal breast milk at 
3 months postpartum (n=304)........................................................................................... 64 
Table 9. Linear correlation coefficients between the lipid-adjusted concentrations 
(ng/g lipid) of the most prevalent PCB congeners in maternal breast milk at 3 months 
postpartum......................................................................................................................... 66 
Table 10. Characteristics of participant women................................................................ 83 
Table 11. Lipid-adjusted chemical concentrations (ng/g lipid) in maternal breast milk 
at 3 months postpartum (n=304). ...................................................................................... 84 
Table 12. Linear correlation coefficients between the lipid-adjusted concentrations 
(ng/g lipid) of PCBs and organochlorine pesticides in maternal breast milk at 3 
months postpartum (n=304).............................................................................................. 85 
 
xii
Table 13. Polyunsaturated fatty acids relative concentrations (% of total fat) in 
maternal breast milk at 3 months postpartum (n=175). .................................................... 86 
Table 14. Linear correlation coefficients between the natural log of the concentrations 
of organochlorine compounds and polyunsaturated fatty acids in maternal breast milk 
at 3 months postpartum (n=175). ...................................................................................... 87 
Table 15. β coefficients and 95% confidence intervals of the factors of interest in 
multivariable linear regression models for the natural log of PCBs and organochlorine 
pesticides........................................................................................................................... 88 
Table 16. β coefficients and 95% confidence intervals of the factors of interest in 
multivariable linear regression models for ω-3 and ω-6 fatty acids. ................................ 91 
Table 17. Characteristics of participant mothers who provided breast milk at 3 months 
in the PIN Babies study and the mother-child pairs included in this study. ....................112 
Table 18. Adjusted mean difference in the scores of the Mullen Scales of Early 
Learning associated with a two-fold increase in lactational exposure metrics. ...............114 
Table 19. Adjusted odds ratio of being scored below average in the Mullen Scales of 
Early Learning for a two-fold increase in lactational exposure metrics. .........................115 
Table 20. Adjusted odds ratio for the infant Short Form of the MacArthur 
Communicative Development Inventories associated with a two-fold increase in 
lactational exposure metrics.............................................................................................116 
Table 21. Characteristics and chemical concentrations in breast milk of participant 
mothers who provided breast milk at 3 months in the PIN Babies study and 
characteristics and chemical concentrations of the mother-child pairs included in this 
study. ............................................................................................................................... 132 
Table 22. Fixed effect estimates of a 10 ng/g lipid increase in the concentrations of 
PCB153, PCBs, DDT and DDE in breast milk at 3 months postpartum on infant 
weight and length in the first 6 months........................................................................... 134 
Table 23. Mean difference in age- and gender-standardized weight and length 
(z-scores) at 12 months per 10 ng/g-month increase in lactational exposure metrics of 
PCB153, PCBs, DDT and DDE...................................................................................... 135 
 
xiii
LIST OF FIGURES 
Figure 1. Conceptual diagram of potential covariates of the association between PCBs, 
DDT and DDE in breast milk and infant development and growth. An arrow indicates 
the causal effect................................................................................................................. 63 
 
xiv
LIST OF ABBREVIATIONS 
AA   arachidonic acid 
ALA  alpha-linolenic acid 
AhR   aryl-hydrocarbon receptor 
BMI   body mass index 
BSID  Bayley Scales of Infant Development 
CDC  Centers for Disease Control and Prevention 
CDI   MacArthur-Bates Communicative Development Inventories 
CI   confidence interval 
CPP   Collaborative Perinatal Project 
DDE  dichlorodiphenyldichloroethylene 
DDT  dichlorodiphenyltrichloroethane 
DHA  docosahexaenoic acid 
EPA   eicosapentaenoic acid 
FA   fatty acid 
GC/IDHRMS gas chromatography/isotope dilution high-resolution mass spectrometry 
LA   linoleic acid 
LC-PUFAs long-chain polyunsaturated fatty acids 
LEM  Lactational Exposure Metric 
LOD  limit of detection 
MD   mean difference 
MDI  mental development index 
OC   organochlorine compounds 
 
xv
OR   odds ratio 
PBT   persistent bioaccumulative toxicants 
PCB   polychlorinated biphenyls 
PCDF  polychlorinated dibenzofurens 
PDI   psychomotor development index 
PIN   Pregnancy, Infection and Nutrition 
SD   standard deviation 
ω-3 FAs  omega-3 fatty acids 
ω-6 FAs  omega-6 fatty acids 
WHO  World Health Organization 
 
CHAPTER I. LITERATURE REVIEW 
 
A. Introduction 
 
Polychlorinated biphenyls (PCBs) and dichlorodiphenyltrichloroethane (DDT) are 
persistent organic pollutants which have been widely distributed in the environment and 
accumulated in the ecosystem. Research so far can not confirm the adverse effects on 
infant health from PCBs, DDT and DDE (the most stable metabolite of DDT) at the low 
background levels. Therefore, this study aims to evaluate the effects of lactational 
exposure to persistent organic pollutants on early growth and neurodevelopment 
measured at 12 months of life. 
 
PCBs are a mixture of synthetic organic compounds which do not exist naturally in 
the environment. These compounds are composed of chlorinated biphenyl rings. 
Theoretically, 209 isomers could be produced, which are different in the degree of 
chlorination and chlorinated positions. PCBs are hydrophobic, lipophilic, colorless to 
light yellow, nonflammable, and oily liquids or crystalline solids without smell or taste. 
Their viscosity, hydrophobility and stability increase as the number of chlorines increases. 
The half-lives of the congeners range from 1 day to 70 years 1. 
 
Because of their electrical insulating properties, mixtures of PCBs had been broadly 
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used as coolants and lubricants in electrical transformers, capacitors and hydraulic 
equipment, and also used as plasticizers in plastic and rubber products. The massive 
production of PCBs in industrial and commercial applications started in 1929. Following 
the widespread usage, their hazardous effects on ecosystem and humans were gradually 
observed, leading to the ban on manufacture in the U.S. in 1977 and the removal of the 
PCB-containing equipment by 2025 under the Stockholm Convention on Persistent 
Organic Pollutants. 
 
DDT was the first widespread organochlorine pesticide. DDT compounds are 
lipophilic, hydrophobic, and colorless crystals without smell or taste. The active 
ingredient of a mixture of DDT used for insecticides was p,p’-DDT, accounting for 
65-80%. The half-life of DDT is about 7 years, but dichlorodiphenyldichloroethylene 
(DDE), the DDT metabolite, persists longer 2. 
 
DDT was initially produced in 1945, and was broadly used as an insecticide in 
agriculture and mosquito control during the 1950s and 1960s. Like PCBs, DDT was also 
observed to be harmful to the ecosystem and human health. The most well-known 
example is the eggshell thinning effects on birds. Although DDT was banned in 1972 in 
the United States and has been listed as one of the persistent bioaccumulative toxicants 
(PBT) by the US Environmental Protection Agency, it is still used for malaria vector 
control in other developing countries because of its high cost-effectiveness on disease 
control 3,4. 
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Although both PCBs and DDT have been banned for decades, they can still be 
detected in the present environment and in the blood, urine and breast milk of the U.S. 
population 5-7. The potential sources of these two chemicals in the US now could be the 
leakage from contaminated waste sites, emissions from the pollutants built up in the 
environment, and continued use abroad. PCBs and DDT have also accumulated in the 
food chain resulting in human exposure mainly through diet, through eating contaminated 
meat, fish, and shellfish. After the ban on usage, occupational exposure to both chemicals 
and high-dose community spraying of DDT are not the main concerns in the US. For 
infants, they could be exposed to PCBs, DDT and DDE prenatally through placental 
transfer and postnatally from breast-feeding. 
 
Along with environmental pollutants, breast-fed infants obtain several essential 
nutrients from breast milk. Long-chain polyunsaturated fatty acids (LC-PUFAs) are one 
of them, which come from the maternal diet. LC-PUFAs are carboxylic acids with a long 
unbranched aliphatic tail consisting of two or more double bonds between carbons. 
LC-PUFAs have two families – omega-3 fatty acids (ω-3 FAs) and omega-6 fatty acids 
(ω-6 FAs). ω-3 FAs includes alpha-linolenic acid (18:3, ALA), eicosapentaenoic acid 
(20:5, EPA), and docosahexaenoic acid (22:6, DHA); ω-6 FAs includes linoleic acid (18:2, 
LA) and arachidonic acid (20:4, AA). Since ω-3 and ω-6 FAs may act either 
synergistically or antagonistically on health effects, the balance between ω-3 and ω-6 FAs, 
evaluated as a ratio, needs be considered. Some literature has shown evidence of the 
importance of LC-PUFAs to the fetal and neonatal brain development 8-10, but the results 
of human studies about LC-PUFAs contribution to the improvement of later infant 
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neurodevelopment and growth are not confirmed yet 11-19. 
 
The developing embryonic and fetal stage and the periods of rapid-growth in infancy 
and childhood are highly vulnerable to the effects of environmental pollutants. From cell 
multiplication, differentiation and migration to organogenesis and physical size change, 
the disruption of each process can cause irreparable damage and further influence the 
functioning of later life. The critical time windows of the vulnerability to various 
environmental exposures differ from organ to organ 20. For neurodevelopment, brain 
development starts at the embryonic stage and lasts through adolescence. In the first 
month of pregnancy, neurulation, which induces the neural plate and forms the neural 
tube, begins. Interruption during this period results in neural tube defects and 
malformations. The subsequent processes include proliferation, migration, differentiation, 
synaptogenesis, apoptosis and myelination, and these processes last from the embryonic 
stage through the postnatal period. The immature blood-brain barrier during embryonic, 
fetal and infant periods makes it easier for chemicals to enter the brain. Small, fat soluble 
molecules can easily enter the brain and possibly produce toxic effects. Since brain 
maturation is not simultaneous in all areas, chemical exposures at different time windows 
may cause adverse effects on different behavioral domains, such as cognitive, language, 
sensory, motor, emotional and social development domains 21,22. Neurotoxicants that are 
recognized so far include lead, methylmercury, arsenic, PCBs, pesticides (like DDT and 
chlorpyrifos) and so on 23. Maternal smoking, alcohol consumption and infections during 
pregnancy, fetal and infant nutrient absorption, and parenting and the home environment 
also influence children’s neurodevelopment along the way. 
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For physical development, the growth rate in the first year after birth is astonishingly 
rapid. The rate of infant weight-gain is 680 g per month in the first 5-6 months, and then 
weight triples by the end of the first year while body length increases by approximately 
50% over the first 12 months 24. Infant growth retardation can be due to intrauterine 
growth inhibition, childhood diseases, malnutrition, and disruption of hormone system 
caused by environmental exposures. Infant growth has been related to children’s 
cognition, pubertal development, adult obesity, chronic diseases, and workplace success 
25-32. 
 
Both PCBs and DDT have been suspected to have health effects on children’s 
neurodevelopment and growth. In vivo and in vitro studies have showed that PCBs may 
alter dopamine, estrogen and thyroid effects; animal and human studies have shown that 
prenatal and perinatal exposure to PCBs at environmental levels might influence 
cognition and behavior in infants and children 33-41. DDT and DDE are also suspected to 
have estrogenic, antiestrogenic and anti-androgenic properties which contribute to their 
adverse effects on reproduction and development 42-46. Although some epidemiological 
studies have focused on investigating the effects of PCBs, DDT and DDE on children’s 
neurodevelopment and growth, previous studies still have not reached any firm 
conclusions. In addition, only two studies discussed the joint effect of PCBs and 
LC-PUFAs on children’s visual function at 12 months and neuromotor function at 
preschool age 47,48, but both studies had small sample sizes and failed to find any 
associations. 
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Therefore, the goal of this dissertation is to describe the correlations between PCBs, 
DDT, DDE and LC-PUFAs in breast milk at the third month postpartum, and also to 
estimate the relationships between PCB, DDT and DDE postnatal exposure and infant 
development and physical growth in the first 12 months by using data from the PIN 
Babies Study. We hope to contribute to current knowledge of the effects of contemporary 
environmental exposures to PCBs, DDT and DDE on early human development. 
 
B. Systematic Review of Epidemiological Studies 
 
The literature search was done via PUBMED in January of 2007 by using keyword 
combinations of each one of the exposures and outcomes. Keywords for exposures were 
PCB, DDT, and DDE, and for outcomes, they were neurodevelopment, development, 
growth and anthropometry. Limitations were set as English language, human studies 
published from January 1st 1970 to December 31st 2006, involving children aged 0-18 
years. Additionally, references cited in the papers but not found in PUBMED search were 
also reviewed manually. For dose-response comparison purposes, this review excluded 
studies without direct measurements of chemical concentrations in biospecimens. Since 
we are interested in the effects on postnatal growth, the chemical effects on birth weight, 
gestational age, in utero growth, and any other growth measurements at birth are not 
considered in this review. 
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B.1 Polychlorinated Biphenyls (PCBs) and Children's Neurodevelopment 
 
Neurotoxicity of PCBs in humans was first observed in the Yusho mass poisoning 
accident in Japan in 1968, caused by ingestion of the rice oil contaminated with PCBs 
and polychlorinated dibenzofurens (PCDFs) 49. Later in 1978 and 1979, a similar accident 
also occurred in Taiwan, called the Yucheng accident, which affected around 2,000 
people 50. Several follow-up studies of the children born to exposed women in Taiwan 
have been conducted. The investigators matched Yucheng children to other children who 
were born to women who were not exposed in this accident by age, sex, neighborhood, 
maternal age, and socio-economic status. Children’s cognition, behavior and development 
were assessed by the Chinese Child Developmental Inventory, Bayley Scales for Infant 
Development, Stanford-Binet Test, Wechsler Intelligence Scale for Children-Revised, 
Raven’s Coloured and Standardized Progressive Matrices, and Rutter’s Child Behavior 
Scale A. The results showed that Yucheng children, compared to their matched controls, 
had poorer cognitive ability, delayed development and behavioral problems 51-57. 
Concentrations of PCBs in biological samples were not examined in all Yucheng children, 
but a subset study reported the median of mother’s serum PCBs levels at the end of 
pregnancy as 26.8 ng/ml 50, which is much higher than maternal concentrations during 
pregnancy in any subsequent cohort study in other countries. 
 
Since the concern of PCBs’ neurotoxic effects on children was raised by these two 
accidents, several cohort studies or secondary analyses were conducted in different 
countries to further investigate whether prenatal and postnatal exposures to 
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environmental levels of PCBs would impair children’s development. To the best of our 
knowledge, these studies included four cohort studies in the USA, one follow-up study of 
the monitoring program in Canada, and one cohort study each done in 5 additional 
countries - Germany, Netherlands, Denmark, Spain, and Japan (table 1). Although these 
studies covered the periods both before and after the ban and also covered infants through 
adolescents, no firm conclusion could be suggested. The study results are summarized 
below, and the tests used for assessing children’s neurodevelopment in these studies are 
listed in table 2. 
 
For newborns, in the North Carolina cohort the researchers found neonatal muscle 
tonicity and reflexes decreased as the concentrations of PCBs in breast milk at birth 
increased 58, while in the Oswego cohort, researchers observed that only the decrements 
in habituation scores and autonomic scores at 25-48 hours after birth were associated with 
highly chlorinated PCBs in cord blood 59. The Dutch study used the Prechtl Newborn 
Neurological Examination to assess neonatal neurological optimality. No association was 
found between cord blood PCBs concentrations and neurological optimality, but high 
exposure to planar PCBs in breast milk, collected in the 2-6 weeks after delivery, was 
associated with hypotonia but not with reflexes 60. 
 
For infants (1 to 24 months), prenatal PCBs exposure was found to be associated 
with deficits in motor development at 6 to 24 months in the North Carolina cohort 61,62 
but in the Dutch cohort it was only found at 3 months 63. In the Dutch cohort, they also 
found that postnatal PCBs exposure, after controlling the trichotomised lactational 
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periods, was associated with deficits in motor development at 7 months but not at 3 
months or 18 months. In contrast to these two studies, in the Collaborative Perinatal 
Project (CPP) cohort, the German cohort, the Spain cohort and the Hokkaido cohort, 
researchers did not find any similar associations of PCBs with infant motor development 
64-67. Infant mental development, assessed by the Bayley Scales of Infant Development 
(BSID), was not affected by PCBs exposure in most of the studies 61-64,66,67, except in the 
German cohort 65,68. A deficit in infant novelty preference, assessed by the Fagan Test of 
Infant Intelligence (FTII), was found in the Michigan cohort 69 and the Oswego cohort 70, 
but not in the German cohort 65. 
 
For preschool children aged 2-5 years, children’s cognition, assessed by the 
McCarthy Scales of Children’s Abilities (MSCA), was slightly associated with highly 
chlorinated PCBs when assessed at around 3 years in the Oswego cohort 71, but was not 
associated with PCBs in the North Carolina cohort when assessed at 3, 4 and 5 years 72. 
In the Oswego study, a potential interaction between PCBs exposure and the size of the 
splenium of the corpus callosum on children’s sustained attention was suggested 73. This 
may imply a plausible biomechanism of the relationship between PCBs and preschool 
children’s response inhibition. In the Michigan cohort, they found PCBs might be 
associated with the deficits in children’s cognition, memory, and visual information 
processing, but the results did not show constant patterns across bio-samples or across 
assessment methods 74,75. Associations between PCBs and the total score on the Kaufman 
Assessment Battery for Children (K-ABC) were found in two European studies, but in 
the Dutch cohort, it was suggested that this effect was caused by prenatal exposure 76 
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whereas in the German cohort it appeared to be related to postnatal exposure 68. No other 
studies observed any effects on children’s motor function 48,77. 
 
For children aged 6-12 years, in the Dutch cohort researchers found exposure to 
prenatal PCBs influenced children’s cognition and memory at 6.5 years, and these effects 
were modified by maternal age and maternal verbal intelligence quotient (IQ) 78. The 
Michigan studies also reported prenatal PCBs reduced children’s IQ, verbal capability 
and freedom from distractibility at 11 years 79. However, in the CPP cohort and the 
Denmark cohort, in contrast, researchers did not find any associations at 7 years 80,81. 
PCBs’ effects on children’s motor function were not observed in this period of life, except 
in the Dutch cohort, with a decrement in motor scores assessed by MSCA at 6.5 years 78. 
In addition, in the Dutch cohort, researchers also observed that prenatal PCBs influenced 
children’s play behavior 82, but no replications of this were reported by others. 
 
Environmental levels of PCBs seem to have adverse effects on children’s motor 
functioning in neonatal and infant stages, and the adverse effects on children’s cognition 
and neurobehaviors might persist longer to school age. However, no consistent results 
were reported across previous studies. It is still not clear whether the observed effects by 
PCBs should be attributed to prenatal exposure via the transplacental route or to postnatal 
exposure via breast-feeding. From animal studies and in vitro studies, PCBs have been 
observed to have high binding affinity for the aryl-hydrocarbon receptor (AhR), have 
influence on thyroid hormone homeostasis, and cause alterations of dopamine and 
estrogen levels, which may be the potential mechanisms responsible for the neurotoxicity 
 
11
observed in exposed humans. PCBs are fat soluble molecules which can easily enter the 
brain and possibly produce toxic effects. 
 
B.2 Dichlorodiphenyldichloroethylene (DDE) and Children's Neurodevelopment 
 
DDT insecticidal function is to prolong neuronal repolarization in mosquitoes and 
other insects, but its metabolite, DDE, has less toxicity. Both DDT and DDE persist for a 
long time and are bioaccumulated in the ecosystem. In animal studies, DDT exposure 
during the period of the brain growth spurt can cause cholinergic disturbance and 
neurobehavioral alteration in adult life 83. The neurological toxic effects of DDT and 
DDE on humans, except by acute poisoning of DDT, are still unclear. To our knowledge, 
only three studies in the United States, one in Denmark, and one in Spain have 
investigated the potential adverse effects of DDT or DDE on children’s 
neurodevelopment (table 3). Among the studies in the United States, the California study 
is the only study in which p,p’-DDT could be detected in 100% of maternal blood 
samples, and o,p’-DDT could be detected in 95.8% when DDT can not be detected in 
most of the general population around the same time periods 5,84. Findings of the studies 
have been inconsistent. 
 
For newborns, assessed by Brazelton Neonatal Behaioral Assessment Scale, the 
North Carolina study observed a gradual upward association between p,p’- DDE and 
hyporeflexia 58, whereas the Oswego study found no association. It might be because the 
Oswego cohort was prenatally exposed to lower DDE concentration than the North 
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Carolina cohort. 
 
For infants (1 to 24 months), the North Carolina study did not find any associations, 
and the only significantly positive association found between DDE and Bayley Mental 
Development Index (MDI) at 6 months of age might be a chance finding 61,62. In the 
California study of Mexican farm-workers' children, DDE was only observed to be 
associated with a decrement of Bayley Psychomotor Development Index (PDI) at 6 
months, but not associated with either PDI at 12 and 24 months or MDI at 6, 12, 24 
months 85. In the Oswego cohort, results also suggested that prenatal DDE exposure was 
not associated with infant novelty preference 70. However, in the Spain cohort of 92 
mother-child pairs, cord blood DDE levels was associated with the decrements in MDI, 
PDI, and infant’s social, performance, and locomotor scores, assessed by Griffiths Mental 
Development Scales, at the age of 13 months. The California study, which is the only 
study that assessed the effects of DDT on infants, found p,p’-DDT and o,p’-DDT were 
negatively associated with infant’s MDI at 12 and 24 months of age, but only p,p’-DDT 
was negatively associated with infant’s PDI at aged 6 and 12 months. 
 
For preschool children aged 2-5 years, none of the studies found associations 
between prenatal DDE exposure and children’s neurodevelopment 72,73,86, but in the Spain 
study, they observed prenatal p,p’-DDT exposure to be associated with the deficits in 
children’s cognition on memory and verbal functions 86. For 7-year-olds, no clear 
association was observed 73,81. One ecologic study using the data from 11 countries and 
14 federal states of Germany suggested an inverse relationship between DDT 
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concentrations in breast milk and the general mental capacity of 15-year-old children 87, 
but further studies are still needed to rule out the possibility of ecological fallacy. 
 
In summary, the effects of prenatal DDE exposure on children’s neurodevelopment 
might be slight, but not confirmed. So far there are too few studies to make any 
conclusions about the relationships between prenatal DDT exposure and children’s 
neurodevelopment. The effects of postnatal exposure from breast-feeding can not be 
determined, since no previous studies have directly assessed it. 
 
B.3 Polychlorinated Biphenyls (PCBs) and Children's Growth 
 
In the Yucho accident in Japan and the Yucheng accident in Taiwan, the studies 
reported that the growth of children was suppressed after being exposed to PCBs, but 
after several years on average they returned to normal 51,88,89. PCBs acting as endocrine 
disruptors may be the plausible mechanism for the alteration in children’s growth. Five 
cohorts in the United States, one cohort each in Germany, in the Netherlands, and in 
Denmark have investigated the association between maternal exposure to environmental 
PCBs levels and children’s growth retardation (table 4). However, the results contradict 
each other. 
 
Children prenatally exposed to higher PCBs levels were reported to be shorter from 
birth to 3 months of age in the formula-fed group in the Dutch cohort 90, and were also 
reported to be shorter at 18 months of age in the Faroe Islands cohort study 91. Conversely, 
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the California study reported that higher prenatal PCBs exposure was associated with 
greater growth in height among 5-year-old girls 92. None of the others found any 
differences in children’s height caused by prenatal PCBs exposure. 
 
As for body weight, the negative association with prenatal PCBs exposure was 
observed among girls only in the small subset of the CPP cohort in New York 93, and also 
in the Michigan polybrominated biphenyl (PBB) incident cohort 94. This negative 
association was found without gender differentiation among children aged 18 months in 
the Faroe Islands cohort 91 and among 4-year-old children in the Michigan fish 
consumption cohort 95. In the Dutch cohort, they reported that the growth rate estimated 
by weight change was negatively related to prenatal PCBs exposure, but this association 
was only observed in the formula-fed group from birth to 3 months 90. Conversely, the 
positive association between prenatal PCBs exposure and growth in weight was found in 
children during 0-5 years in the North Carolina study when the analysis was restricted to 
white girls only 96. None of the others reported any differences in children’s weight 
caused by prenatal PCB exposure. 
 
In summary, gender differentiation on the effects of prenatal PCBs exposure on 
children’s growth was found in several studies, although the potential biomechanisms are 
still not clear. Because of inconsistent results, no conclusive suggestion can be made 
about in which age period growth is vulnerable to prenatal PCBs exposure. In addition, 
previous papers investigating the effects of postnatal PCBs exposure via breast-feeding 
are too scarce, so further research is still needed. 
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B.4 Dichlorodiphenyldichloroethylene (DDE) and Children's Growth 
 
DDT and DDE, suspected as endocrine disruptors, have been found to have 
estrogenic and antiandrogenic properties (11, 61-63). Because children’s growth depends 
on hormonal regulation, the prenatal and postnatal exposures to DDT and DDE may 
adversely affect children’s physical development. There were only three cohort studies in 
the United States and one cohort study in Germany evaluating the relationships between 
prenatal or postnatal DDT or DDE exposure and children’s growth (table 5). Most of the 
studies did not observe any associations between prenatal DDT or DDE exposure and 
children’s growth in height or weight. However, the CPP cohort found a negative 
association between p,p’-DDE and children’s height at 1, 4, and 7 years 97. This negative 
association was also found in the German study, but only among girls 98. Contrarily, 
positive association was found between prenatal p,p’-DDE and boys’ height and weight at 
age of 0-5 years in the North Carolina study 96. Among these studies, only in the German 
cohort did researchers use the concentrations detected in children’s blood at 8 years to 
index perinatal exposure, which may induce exposure misclassification. 
 
In summary, gender differentiation of the effects of DDE on children’s growth was 
observed in two studies, but the results were not consistent. Only two studies have 
investigated the effects of prenatal DDT exposure, but neither found any associations. 
Although previous studies suggested that no adverse effects on children’s growth were 
caused by prenatal DDT or DDE exposure, we are still far from any conclusions, because 
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there are so few studies and they have diverse study characteristics and inconsistent 
findings. Postnatal exposure was only evaluated in the North Carolina study by the 
multiplication of maternal concentration in blood and duration of breast-feeding, but no 
association was found. 
 
C. Discussion 
 
There are several differences among studies which could explain the discordant 
results observed in different studies. First, the exposure assessments differed among 
studies. Previously, researchers used three different ways to estimate children’s prenatal 
exposure: 1) the concentration detected in maternal blood obtained at the third trimester 
of the index pregnancy, 2) the concentration detected in the cord blood, and 3) the 
estimated concentration calculated from the concentration in maternal breast milk 
collected at delivery. In the German cohort, the correlation between PCBs in cord blood 
and milk was 0.57 68. In the Dutch cohort, the correlations between PCBs in maternal 
blood and milk were 0.70-0.79, while the correlations between maternal blood and cord 
blood were 0.52-0.74 99. In the North Carolina study, the correlation of PCBs 
concentration between maternal serum at birth and milk at birth was 0.64, while the 
correlation of DDE concentrations was 0.82 100. However, the correlation between the 
concentrations of PCBs in cord blood and breast milk in the Oswego cohort was low 
(r=0.15) 59. Overall, if the correlations between these three biospecimens, maternal blood 
at pregnancy, cord blood, and breast milk at birth, were high, all could be good surrogates 
for prenatal exposure, but if the correlations are merely low to medium, certain amounts 
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of exposure misclassification would be induced and influence the study results. 
 
As for postnatal exposures, the total amount of PCBs or DDE consumed by infants 
through breast-feeding is influenced by the duration of lactation. The Faroe Island study 
and the Michigan study used the multiplication of total PCBs concentration in maternal 
milk and duration of breast-feeding to estimate the levels of postnatal exposure, while the 
German study treated lactational period as a covariate in the statistical models. It is more 
accurate to use both lactational period and the concentrations in breast milk to indicate 
postnatal exposure, because this estimate would be more highly correlated with infant’s 
PCB plasma concentration 101. It is hard to distinguish postnatal effects from prenatal 
effects, especially when the breast milk samples were collected at the time close to the 
delivery to make postnatal concentrations highly correlated with prenatal concentrations. 
The findings from the Rogan et al. paper suggested a decline in concentrations as an 
increase in the length of lactation 100, whereas the Hooper paper suggested that the 
concentration was not substantially reduced in the first 3 months of breast feeding 102. 
Breast milk is also an excellent source of nutrition and provides several potential benefits 
to the infant’s immunologic system, growth and neurodevelopment 103,104, so the 
comparisons between the formula group, which generally was assumed to have no 
chemical exposure, and the breast-feeding group may mask the potential adverse effects 
of environmental exposures in breast milk. 
 
The other differences in exposure assessments that could contribute to the different 
findings in PCBs effects are different laboratory analyses, and different summary 
 
18
estimates of total PCBs concentrations. In the earlier papers, investigators could only use 
packed column gas chromatography to detect the concentrations of total PCBs, while 
later investigators could use the capillary column gas chromatography method to detect 
the concentrations of specific congeners. The new laboratory analysis is better at 
quantification of the lower environmental concentrations because of their lower detection 
limits and higher sensitivity, and it also has the capability to detect each specific congener 
concentration. However, different studies may not use the same method to compose the 
summary estimate of total PCBs concentrations. One may choose to include all detectable 
congeners, whereas another may choose several peak levels of PCB congeners to estimate 
the total amounts, so the differing total PCBs concentrations in previous studies do not 
allow for direct comparisons. Besides, some findings in the previous studies were 
observed only when their analyses were restricted to some specific grouping, such as 
highly chlorinated PCBs or dioxin-like PCBs or coplanar PCBs. Using the gross 
concentration instead of specific target chemical concentrations may introduce noise into 
the exposure estimation. 
 
Secondly, different study population characteristics, like population size, racial 
composition, the distribution of children’s gender, parental education and economic status, 
may also contribute to different findings across studies. In addition, different mixtures of 
environmental exposures across studies would also influence the associations of interest 
in PCBs or DDE. For example, the Faroe Island population consumed large amounts of 
seafood. The Michigan cohort and the Oswego cohort consumed more freshwater fish. 
Parts of the Dutch cohort lived in a highly industrialized city. The California Mexican 
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farm-workers cohort was exposed to more agricultural pesticides. The mixtures of 
environmental chemicals could be methyl mercury and PCBs, dioxin and PCBs, PCDF 
and PCBs, or DDT/DDE and PCB. For fish eaters, they also obtained more fish protein 
and ω-3 fatty acids, which has been reported to be beneficial for fetal growth 105-108. If 
these chemicals act synergistically or antagonisticly on infant growth or 
neurodevelopment, the association observed for either one of chemicals may be biased if 
other chemicals are not considered in the statistical analyses. 
 
Thirdly, differences in outcome measurements may partially explain the differences 
in findings. For neurodevelopment, studies used different scales to test children’s 
cognition, motor function and/or neurobehaviors. The different scales did not allow for 
direct comparisons among results, because different scales may measure different brain 
functions, may have different sensitivities and differing ability to predict children’s future 
neurodevelopment and capacity. The neurodevelopment measurements could be either 
quantitative or qualitative. Different examination age, testing protocols or administrative 
efforts used for the same measurements may also cause the differences in the results. For 
infant physical growth, few studies were able to use serial measurements instead of 
measuring at only one time point to investigate the differences in children’s growth rates. 
Since development is a continuous process, it would be better to have serial growth 
measurements and employ statistical regression models of repeated measurements. 
 
Fourthly, inadequate confounding controls may attenuate the effect estimates of 
interest or decrease the precision of effect estimates. Home observation for measurement 
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of the environment characteristics, parental intelligence, socioeconomics status, and 
parental nursing have been linked to children’s development, but if the distribution of 
these factors is not differentiated between exposure groups or not related to chemical 
concentrations, then it is redundant to control these factors. On the other hand, several 
reproductive factors, such as parity, lactational periods, number of children nursed, and 
maternal age, have been observed to be associated with chemical concentrations, and if 
these reproductive factors are also associated with children’s development and/or growth, 
then these factors should be controlled for the statistical models. Still residual 
confounding effects could bias the results in either direction. 
 
Several methodological challenges could be identified from previous studies. Firstly, 
the accuracy of exposure measurement is crucial. Secondly, when prenatal exposure is 
highly correlated with postnatal exposure, it is difficult to assess the critical windows for 
adverse effects of environmental chemicals on children’s development and growth. 
Thirdly, there is not just one single chemical existing per time in the environment. If the 
chemicals of interest are highly correlated and have mixed effects on the outcome of 
interest, collinearity will be an issue when all chemicals are involved in one traditional 
regression model. Fourthly, low environmental exposure levels tend to have minor effects, 
which require larger study populations or a wider range of chemical concentrations to 
obtain sufficient statistical power to detect the effects. Fifthly, the simple neurobehavioral 
tests would have limited ability to detect subtle physiological deficits of the brain and 
nervous system which might be identified with more sensitive clinical assessments. 
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This dissertation will be focused on investigating the associations between postnatal 
exposure to PCBs, DDT and/or DDE through breast-feeding and infant development and 
growth through the first twelve months. This dissertation also will estimate whether the 
associations between lactational exposure to PCBs, DDT and DDE and infant 
development would be modified by the concentrations of LC-PUFAs in breast milk. The 
postnatal exposures will be directly estimated by the duration of lactation and the 
concentrations detected in breast milk collected at the third month postpartum by gas 
chromatography/isotope dilution high-resolution mass spectrometry. Neurodevelopment 
at age 12 months is measured by the Mullen Scales and the MacArthur Communicative 
Development Inventories Short Form. These two measures are able to assess different 
aspects of infant neurodevelopment, and the administration is relatively easy and feasible 
for assessing children at 12 months. Repeated growth measurements in height and weight 
through the first 12 months of life are recorded on the child’s growth card by the pediatric 
practitioners, so each infant’s growth pattern can be more accurately estimated. The 
sample size of breast-feeding mother-child pairs is larger than in most of the previous 
studies. All pre-, peri- and post-natal covariates were collected prospectively by 
questionnaires in PIN studies, so potential confounders could be appropriately controlled. 
However, this dissertation has limitations on distinguishing the effects of postnatal 
exposure from the effects caused by prenatal exposure. We also will have difficulties in 
controlling the effects of other environmental exposures. Nonetheless, this dissertation’s 
results will contribute to our knowledge about the effects of lactational exposure to low 
background levels of PCBs, DDT and DDE on early human development. 
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Table 1. Reviews of studies about the effects of polychlorinated biphenyls (PCBs) 
on children's neurodevelopment. * 
Study Size# Biospecimen PCBs Conc † Age Test ‡ Result § 
USA       
CPP Cohort (1959-1965) 
Daniels 
2003 64 
1207 Maternal 
blood at 3rd 
triemester 
Median=2.7 
(95%CI=1.8, 
3.7) (µg/l, wet 
weight) 
 
8 mo BSID  – 
Gray 
2005 80 
894 Maternal 
blood at 3rd 
triemester 
Median=2.85, 
95th=6.75 (µg/l, 
wet weight) 
 
7 yr WISC 
WRAT 
 – 
       
North Carolina Cohort (1978-1982) 
Rogan 
1986 58 
(912) Milk at birth Median=1.74, 
95th=3.64 
(ppm) 
 
<1 mo BNBAS Muscle tonicity ↓ 
Reflex ↓ 
 
Gladen 
1988 61 
(802) Milk at birth (similar to 
Rogan 1986) 
6 mo
12 mo
BSID PDI at 6 mo ↓ 
PDI at 12 mo ↓ 
 
Rogan 
1991 62 
(676) Milk at birth (similar to 
Rogan 1986) 
18 mo
24 mo
BSID PDI at 18 mo ↓ 
PDI at 24 mo ↓ 
 
Gladen 
1991 72 
(645) Milk at birth (similar to 
Rogan 1986) 
3 yr 
4 yr 
5 yr 
 
MSCA 
English, math 
grades 
 – 
       
Michigan Cohort (1980-1981) 
Jacobson 
1985 69 
81 
(67) 
Cord blood 
Breast milk 
within 2 
months 
Cord serum 
(ng/ml): 
range: 0.2-7.9 
Breast milk: 
(unmentioned)
 
7 mo FTII Prenatal PCBs: 
recognition memory 
↓ 
preference for 
novelty ↓ 
Postnatal PCBs: 
 – 
 
Jacobson 
1990 95 
146 
(87) 
Cord blood 
Breast milk 
within 2 
months 
Cord serum 
(ng/ml): 
mean=2.5, 
SD=2.0, range: 
0-12.3 
Breast milk 
(ng/ml): 
mean=835.9, 
SD=388.4, 
range: 
185.7-2600, 
 
4 yr Activity rating 
from 
EASI+BSID 
Prenatal PCBs: 
 – 
Postnatal PCBs: 
activity ↓ 
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Jacobson 
1990 74 
146 
(120) 
Cord blood 
Breast milk 
within 2 
months 
Cord serum 
(ng/ml): 
mean=2.5, 
SD=2.0 
Breast milk 
(ng/ml): 
mean=835.9, 
SD=388.4 
 
4 yr MSCA Prenatal PCBs: 
verbal ↓ 
quantitative ↓ 
Postnatal PCBs: 
memory ↓ 
Jacobson 
1992 75 
143 
(118) 
Cord blood 
Breast milk 
within 2 
months 
Cord serum 
(ng/ml): 
mean=2.5, 
SD=2.0 
Breast milk 
(ng/ml): 
mean=833, 
SD=389.5 
 
4 yr SMT 
MFFT 
CPT 
Prenatal PCBs: 
# of errors on the 
Sternberg memory 
task ↑ 
Postnatal PCBs: 
RT on the visual 
discrimination task ↑
 
Jacobson 
1996 79 
Jacobson 
2002 109 
139 
(124) 
Cord blood 
 
Cord serum 
(ng/ml): 
mean=3, SD=2
11 yr WISC-R 
WRAT 
WRMT-R 
Prenatal PCBs: 
IQ ↓ 
verbal ↓ 
verbal 
comprehension ↓ 
freedom from 
distractibility ↓ 
word comprehension 
↓ 
reading 
comprehension ↓ 
(effects modified by 
maternal intellectual 
input) 
 
       
Oswego Cohort (1991-1994) 
Stewart 
2000 59 
293 Cord blood 25th=0.17, 
50th=0.52, 
75th=1.11 (ng/g 
wet) 
birth BNBAS Highly chlorinated 
PCB: 
(at 25-48 hr after 
birth) 
Habituation scores ↓
autonomic scores ↓
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Darvill 
2000 70 
230 
(86) 
Cord blood 
Breast milk 
b/w 1-3 
months 
Cord serum 
(ng/g wet): 
25th=0.17, 
50th=0.52, 
75th=1.11 
Breast milk 
(n=86) (ng/g 
lipid): 25th=87, 
50th=153, 
75th=249 
 
6 mo
12 mo
FTII Prenatal total PCBs:
FTII scores at 6 mo ↓
FTII scores at 12 mo 
↓ 
Prenatal highly 
chlorinated PCBs: 
FTII scores at 6 
mo – 
FTII scores at 12 mo 
↓ 
Postnatal total 
PCBs: 
 – 
 
Stewart 
2003 71 
212 
(86) 
Cord blood 
Breast milk 
b/w 1-3 
months 
(similar to 
Darvill 2000) 
38 mo
54 mo
MSCA Prenatal highly 
chlorinated PCBs: 
GCI at 38 mo ↓ 
GCI at 54 mo – 
 
Stewart 
2003 73 
189 
(86) 
Cord blood 
Breast milk 
b/w 1-3 
months 
 
(similar to 
Darvill 2000) 
4.5 yr
7.8 yr
CPT 
MRI (n=60) 
Prenatal highly 
chlorinated PCBs: 
# of errors of 
commission ↑ 
(modified by the size 
of the splenium of 
the corpus callosum)
 
       
Canada       
Nunavik Monitoring Program(1993-1996) 
Despres 
2005 48 
110 Cord blood Geometric 
mean=330.3, 
SD=267.6, 
range: 
99.5-1725.7 
(µg/kg) 
4-6 yr ATNA  – 
       
Germany       
Dusseldorf cohort (1993-1995) 
Winneke 
1998 65 
171 
(131) 
Cord blood 
Breast milk 
within 1 
month  
Cord serum 
(ng/g fat): 
mean=218, 
SD=100.2 
Breast milk 
(n=131) (ng/g 
fat): 
mean=426.5, 
SD=184.4 
 
7 mo BSID 
FTII 
Prenatal PCBs: 
 – 
Postnatal PCBs: 
MDI ↓ 
PDI – 
Fagan – 
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Walkowiak 
2001 68 
171 
(126) 
Cord blood 
Breast milk 
within 1 
month  
 
Cord serum 
(n=141) 
(ng/ml): 
median=0.39, 
5th=0.11, 
95th=0.83 
Breast milk 
(n=126) (ng/g 
lipids): 
median=404, 
5th=173, 
95th=679 
 
7 mo
18 mo
30 mo
42 mo
BSID 
K-ABC 
Prenatal PCBs: 
 – 
Postnatal PCBs: 
MDI at 7-30 mo ↓ 
MDI at 30 mo ↓ 
PDI at 7-30 mo ↓ 
K-ABC at 42 mo ↓ 
       
Netherlands      
Dutch cohort (1990-1992) 
Huisman 
1995 60 
418 
(209) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal serum
(n=415) (µg/l): 
median=2.04, 
5th=1.00, 
95th=3.81 
Cord serum 
(n=373) (µg/l): 
median=0.38, 
5th=0.18, 
95th=0.86 
Breast milk 
PCB169 (µg/kg 
fat): 
median=79.53, 
5th=42.35, 
95th=143.70 
 
<1 mo Prechtl Prenatal PCBs: 
 – 
Postnatal planar 
PCBs: 
Tonicity ↓ 
Reflex – 
neurological 
optimality ↓ 
Huisman 
1995 110 
418 
(209) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
Maternal 
serum: 
(same as 
Huisman 1995)
Cord serum: 
(same as 
Huisman 1995)
Breast milk (ng 
TEQ/kg milk 
fat): 
median=33, 
5th=17, 
95th=61 
 
18 mo THNE Prenatal PCBs: 
Neurological 
optimality ↓ 
Postnatal PCBs: 
 – 
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Koopman- 
Esseboom 
1996 63 
207 
(105) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal serum 
(ng/g plasma): 
mean=2.2, 
SD=1.0 
Cord serum 
(ng/g): 
mean=0.5, 
SD=0.3 
Brest milk (pg 
TEQ/g fat): 
mean=66.6, 
SD=24.2 
 
3 mo
7 mo
18 mo
BSID Maternal PCBs: 
PDI at 3 mo ↓ 
PDI at 7 mo – 
PDI at 18 mo – 
Breast milk PCBs: 
PDI at 3 mo – 
PDI at 7 mo ↓ 
PDI at 18 mo – 
Lanting 
1998 77 
418 
(209) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
(same as 
Huisman 1995)
42 mo THNE  – 
Patandin 
1999 76 
373 
(195) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal 
serum: (same 
as Huisman 
1995) 
Cord serum: 
(same as 
Huisman 1995)
Breast milk 
(n=193) (µg/kg 
fat): 
median=405, 
5th=205, 
95th=723 
 
42 mo K-ABC 
RDLS 
Maternal PCBs: 
K-ABC score ↓ 
Breast milk PCBs: 
 – 
Vreugdenhil 
2002 78 
376 
(194) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal serum 
(µg/l): 
median=2.04, 
range: 
0.59-7.35 
Cord serum 
(µg/l): 
median=0.38, 
range: 
0.08-2.08 
Breast milk 
(n=194) (µg/kg 
fat): 
median=403.66
, range: 
158.35-1226.38
 
6.5 yr MSCA Maternal PCBs: 
GCI ↓ (modified by 
maternal age and 
VIQ) 
Memory ↓ (modified 
by maternal age and 
VIQ) 
Motor ↓ (modified by 
VIQ and HOME) 
Breast milk PCBs: 
 – 
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Vreugdenhil 
2002 82 
160 
(85) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal serum 
(µg/l): 
median=2.06, 
range: 
0.73-5.08 
Cord serum 
(µg/l): 
median=0.42, 
range: 
0.08-1.99 
Breast milk 
(µg/kg fat): 
median=390, 
range: 174-805
 
7.5 yr PSAI Maternal PCBs: 
masculinized play 
behavior in boys ↓ 
Cord serum PCBs: 
masculinized play 
behavior in boys ↓ 
masculinized play 
behavior in girls ↑ 
Breast PCBs: 
 – 
 
       
Denmark       
Faroe Islands Cohort (1986-1987) 
Grandjean 
2001 81 
435 Cord tissue median=1.02, 
interquartile 
range: 
0.53-1.71, 
max=65.2 (µg/g 
lipid) 
 
7 yr NES2 
WISC-R 
BVMG 
CVLT 
BNT 
Neurophysiologi
cal and sensory 
test 
 
Wet-weight PCBs: 
Boston naming test ↓
RT in NES2 ↑ 
Lipid adjusted PCBs:
 – 
       
Spain       
Spain cohort (1997-1999) 
Ribas-Fito 
2003 66 
92 Cord blood <LOD - ? 13 mo BSID 
GMDS 
 – 
       
Japan       
Hokkaido cohort (2002-2004) 
Nakajima 
2006 67 
134 Maternal 
blood at 3rd 
triemester 
 
Geometric 
mean=11770.9, 
range: 
3311.1-37267.2 
(pg/g lipid) 
 
6 mo BSID-II  – 
* Abbreviation used in this table: CPP, the Collaborative Perinatal Project; CI, confidence interval; 
SD, standard deviation; hr, hours; mo, months; yr, years; b/w, between; PDI, psychomotor 
development index; MDI, mental development index; #, numbers; RT, reaction time; IQ, 
intelligence quotient; GCI, General Cognitive Index; VIQ, verbal intelligence quotient; HOME, 
Home Observation for Measurement of the Environment. 
† PCBs concentrations listed in this table may not be directly comparable, because different 
studies used different congeners to compose the total PCBs concentrations. Different studies 
also used different biospecimens to estimate the PCBs concentrations. In addition, sensitivities, 
detection limits, equipments, and recovery methods of laboratory analyses were different.  
‡ ATNA, Ameiel-Tison and Gosselin Examination; BNBAS, Brazeltom Neonatal Behavioral 
Assessment Scale; BNT, Boston Naming Test; BSID(-II), Bayley scales of Infant Development 
(-second version); BVMG, Bender Visual Motor Gestalt Test; CPT, Continuous Performance 
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Testing; CVLT, California Verbal Learning Test; FTII, Fagan Test of Infant Intelligence; EASI, 
Emotionality, Activity, Sociability and Impulsivity Temperament Survey; GMDS, Griffiths Mental 
Development Scales; NES2, Neurobehavioral Evaluation System; MFFT, Matching Familiar 
Figures Test; MRI, magnetic resonance imaging; MSCA, McCarthy Scales of Children’s Abilities; 
K-ABC, Kaufman Assessment Battery for Children; Prechtl, Prechtl Newborn Neurological 
Examination; PSAI, Pre-school Activities Inventory; RDLS, Reynell Development Language 
Scales; SMT, Sternberg Memory Test; THNE, Touwen/Hempel Neurologic Examination; 
WISC(-R), Wechsler Intelligence Scale for Children (-Revised); WRAT, Wide Range of 
Achievement Test; WRMT-R, Woodcock Reading Mastery Test-Revised. 
§ – indicates no association. ↑ indicates positive association with the increments of PCBs 
concentrations. ↓ indicates negative association with the increments of PCBs concentrations. 
# Numbers in the parentheses represent the numbers of breast milk samples in each study. 
 
 
29
Table 2. Neurodevelopment tests used in previous papers. 
Test Abbrev Age* Assessment 
Neonatal Tests    
Brazelton Neonatal Behavioral 
Assessment Scale 
BNBAS <3 d Habituation 
Orientation 
Motor performance 
Range of state 
Regulation of state 
Autonomic regulation 
Reflexes 
 
Prechtl Newborn Neurological 
Examination 
 
Prechtl 10-21 d Neurodevelopment 
    
Children’s Tests – Mental    
Bayley Scales of Infant 
Development 
 
BSID 
BSID-II 
2-30 mo 
1-42 mo 
Mental development index (MDI) – 
cognition, language and social 
development 
 
Fagan Test of Infant Intelligence 
 
FTII 3-12 mo Novelty preference 
Griffiths Mental Development 
Scales 
GMDS 0-8 yr Locomotor scale 
Personal-social scale 
Hearing and language scale 
Eye-hand coordination scale 
Performance scale 
 
Reynell Developmental Language  
Scales 
RDLS 1.5-6 yr Language ability 
General mental ability 
 
Kaufman Assessment Battery for 
Children 
K-ABC 2.5-12.5 yr Short term memory 
Visual processing 
Learning ability 
Planning ability 
Crystallized ability 
 
McCarthy Scales of Children’s 
Abilities 
MSCA 2.5-8.5 yr Verbal scale - language 
comprehension and use 
Quantitative scale - mathematical 
ability 
Perceptual-performance scale - ability 
to conceptualize and reason without 
words 
Memory scale - short-term recall of 
words, numbers, pictures, and tonal 
sequences 
Motor scale - gross and fine motor 
coordination 
General cognitive scale - overall 
intellectual functioning 
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Wechsler Intelligence Scale for 
Children 
WISC 6-16 yr Verbal IQ 
Verbal comprehension factor 
Freedom from distractibility factor 
Performance (nonverbal) IQ 
Perceptual organization (nonverbal) 
factor 
Processing speed factor 
Full scale IQ 
 
Wide Range Achievement Test WRAT 5-11 yr 
>12 yr 
 
Learning ability – reading, spelling, 
arithmetic 
 
Woodcock Reading Mastery 
Test-Revised 
WRMT-R >5 yr Word comprehension 
Passage comprehension 
Reading comprehension 
 
Boston Naming Test BNT  Learning ability 
 
California Verbal Learning Test CVLT  Verbal memory ability 
 
Sternberg Memory Test SMT  Short-term memory search 
 
Matching Familiar Figures Test MFFT  Visual discrimination 
 
    
Children’s Tests – Motor    
Bayley Scales of Infant 
Development 
 
BSID 
BSID-II 
2-30 mo 
1-42 mo 
Psychomotor development index 
(PDI) - fine and gross motor 
development 
 
Amiel-Tison and Gosselin 
Examination 
ATNA 0-6 yr Head circumference and growth 
Craniofacial examination of the cranial 
nerves 
Motor development 
Passive muscle tone 
Motor activity 
Deep tendon and cutaneous reflexes
Primitive reflexes 
Postural reactions 
Qualitative abnormalities in gross 
motor function and acquired 
deformities 
 
McCarthy Scales of Children’s 
Abilities 
MSCA 2.5-8.5 yr Motor scale - gross and fine motor 
coordination 
 
Bender Visual Motor Gestalt Test BVMG >3 yr Visual-motor maturity 
 
Touwen/Hempel Neurologic 
Examination 
THNE  Motor functions – grasping, sitting, 
crawling, standing, and walking 
 
    
Children Tests – 
Neurobehavioral 
   
Continuous Performance Testing CPT >4 yr Sustained attention 
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Emotionality, Activity, Sociability, 
and Impulsivity Temperament 
Survey 
EASI 3-18 Tendency to emotionality, activity, 
sociability, and impulsivity 
 
Neurobehavioral Evaluation 
System 
NES2  Reaction time 
Hand-eye coordination 
Continuous performance 
 
Pre-school Activities Inventory PSAI  Gender role behavior 
 
* d, days; mo, months; yr, years. 
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Table 3. Reviews of studies about the effects of dichlorodiphenyltrichloroethane 
(DDT) and dichlorodiphenyldichloroethylene (DDE) on children's 
neurodevelopment. * 
Study Size** Biospecimen DDT/DDE Conc † Age Test ‡ Result § 
USA       
North Carolina Cohort (1978-1982) 
Rogan 
1986 58 
(912) Milk at birth DDE: 
Median=2.51 
ppm, 95th=7.59 
(ppm) 
 
<1 mo BNBAS DDE: 
Reflex ↓ 
 
Gladen 
1988 61 
(802) Milk at birth (similar to Rogan 
1986) 
6 mo 
12 mo
BSID DDE: 
MDI at 6 mo ↑ 
MDI at 12 mo – 
 
Rogan 
1991 62 
(676) Milk at birth (similar to Rogan 
1986) 
18 mo
24 mo
BSID DDE: 
 – 
 
Gladen 
1991 72 
(645) Milk at birth (similar to Rogan 
1986) 
3 yr 
4 yr 
5 yr 
 
MSCA 
English, 
math grades
DDE: 
 – 
       
Oswego Cohort (1991-1994) 
Stewart 
2000 59 
293 Cord blood DDE: 
25th=0.06, 
50th=0.10, 
75th=0.18 (ng/g 
wet) 
 
Birth BNBAS DDE: 
 – 
Darvill 
2000 70 
230 
(86) 
Cord blood 
Breast milk 
b/w 1-3 
months 
 
Not mentioned 
 
6 mo 
12 mo
FTII DDE: 
 – 
 
Stewart 
2003 73 
189 
(86) 
Cord blood 
Breast milk 
b/w 1-3 
months 
 
Not mentioned 4.5 yr 
7.8 yr 
CPT 
MRI (n=60) 
DDE: 
 – 
       
California – CHAMACOS study (1999-2000) 
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Eskenazi 
2006 85 
330 Maternal 
blood at 3rd 
trimester or 
delivery 
p,p'-DDT: 
range: 
1.55-33174, 
geometric mean 
(95%CI)=22.0 
(18.4-26.4) (ng/g 
of lipid) 
o,p'-DDT:  
range: 
0.07-1878.1 
geometric mean 
(95%CI)=1.8 
(1.5-2.1) (ng/g of 
lipid) 
p,p'-DDE: 
range: 
48.80-159303.3, 
geometric mean 
(95%CI) = 1436.9 
(1257.4-1642.1) 
(ng/g of lipid). 
6 mo 
12 mo
24 mo
BSID p,p'-DDT: 
MDI at 6 mo – 
MDI at 12, 24 mo ↓ 
PDI at 6, 12 mo ↓ 
PDI at 24 mo – 
o,p'-DDT: 
MDI at 6 mo – 
MDI at 12, 24 mo ↓ 
PDI at 6, 12, 24 mo –
p,p'-DDE: 
MDI at 6, 12, 24 
mo – 
PDI at 6 mo ↓ 
PDI at 12, 24 mo – 
 
       
Denmark       
Faroe Islands Cohort (1986-1987) 
Grandjean 
2001 81 
435 Cord tissue p,p'-DDE: 
median=0.713 
(µg/g lipid) 
 
7 yr NES2 
WISC-R 
BVMG 
CVLT 
BNT 
Neurophysio
logical and 
sensory test
 
Collinear with total 
PCBs (data not 
shown) 
       
Spain       
Spain cohort (1997-1999) 
Ribas-Fito 
2003 66 
92 Cord blood p,p'-DDE: 
<LOD - ? 
13 mo BSID 
GMDS 
MDI ↓ 
PDI ↓ 
Social ↓ 
Performance ↓ 
Hearing & 
language – 
Locomotor ↓ 
Eye-hand 
coordination – 
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Ribas-Fito 
2006 86 
475# Cord blood p,p'-DDT: 
[Ribera d'Ebre] 
50th=0.05, 
max=1.87 (ng/ml)
[Menorca] 
50th=0.08, 
max=2.28 (ng/ml)
p,p'-DDE: 
[Ribera d'Ebre] 
50th=0.86, 
Max=7.11 (ng/ml) 
[Menorca] 
50th=1.03, 
Max=19.54 
(ng/ml) 
 
4 yr MSCA (also 
regrouped 
as verbal 
memory, 
working 
memory, 
memory 
span or 
short-term 
memory, 
and 
executive 
function by 
authors) 
p,p'-DDT: 
GCI ↓ 
Memory ↓ 
Verbal ↓ 
Executive function ↓
Memory span ↓ 
Verbal memory ↓ 
p,p'-DDE: 
 – 
* Abbreviation used in this table: CI, confidence interval; mo, months; yr, years; PDI, psychomotor 
development index; MDI, mental development index; GCI, General Cognitive Index; CHAMACOS, 
the Center for the Health Assessment of Mothers and Children of Salinas. 
† DDT or DDE concentrations listed in this table may not be directly comparable, because different 
studies used different biospecimens to estimate the concentrations. In addition, sensitivities, 
detection limits, equipments, and recovery methods of laboratory analyses might be different. 
‡ BNBAS, Brazeltom Neonatal Behavioral Assessment Scale; BNT, Boston Naming Test; BSID, 
Bayley scales of Infant Development; BVMG, Bender Visual Motor Gestalt Test; CPT, Continuous 
Performance Testing; CVLT, California Verbal Learning Test; FTII, Fagan Test of Infant 
Intelligence; GMDS, Griffiths Mental Development Scales; NES2, Neurobehavioral Evaluation 
System; MRI, magnetic resonance imaging; MSCA, McCarthy Scales of Children’s Abilities; 
WISC-R, Wechsler Intelligence Scale for Children-Revised. 
§ – indicates no association. ↑ indicates positive association with the increments of DDT or DDE 
concentrations. ↓ indicates negative association with the increments of DDT or DDE 
concentrations. 
# This study included two cohorts, Ribera d’Ebre cohort (n=70) and Menorca cohort (n=405). 
** Numbers in the parentheses represent the numbers of breast milk samples in each study. 
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Table 4. Reviews of studies about the effects of polychlorinated biphenyls (PCBs) 
on children's growth. * 
Study Size# Biospecimen PCBs Conc † Age Outcome  Result ‡ 
USA       
CPP Cohort (1959-1965) 
Ribas-Fito 
2006 97 
1712 Maternal 
blood at 3rd 
trimester 
Median=2.7, 
interquartile 
range: 1.8-3.7 
(µg/l, wet 
weight) 
 
1 yr 
4 yr 
7 yr 
Height 
Weight 
 – 
Lamb 
2006 93 
150 Maternal 
blood at 3rd 
trimester 
25th=6.8, 
75th=10.4, 
mean=9.2, 
SD=3.5 (µg/l)
 
Birth 
1 yr 
4 yr 
7 yr 
17 yr 
Height 
Weight 
Ortho-substituted 
PCBs: 
Height ↑↓ 
Weight ↓ (through 17 
yrs, girls only) 
 
       
California – CHDS cohort (1964-1967) 
Hertz-Picciotto 
2005 92 
399 Maternal 
blood at 2nd 
or 3rd 
trimester 
Median=616, 
5th=378, 
95th=1115 
(ng/g lipids) 
 
Birth 
5 yr 
Height 
Sitting height
Weight 
Head 
circumferenc
e 
Bi-acromial 
distance 
Bi-iliac 
distance 
Chest depth
Chest 
breadth 
 
Height at 5 yr ↑ (girls 
only) 
Sitting height at 5 yr 
↑ (girls only) 
       
Michigan – PBB incident cohort (1976-1979) 
Blanck 
2002 94 
206 Maternal 
blood at 
enrollment 
 
Median=5, 
range: ND-78 
(ppb) 
5-24 yr 
(mean
=15.2 
yr) 
Height 
Weight 
Height – 
Weight adjusted for 
height and age ↓ 
(girls only) 
 
       
North Carolina Cohort (1978-1982) 
Rogan 
1987 111 
(802) Milk at birth (similar to 
Rogan 1986)
 
0-1 yr
 
Weight gain  – 
Gladen 
2000 96 
(594) Milk at birth Median=1.7, 
range: 0.5-5.5 
(ppm) 
0-5 yr Height 
Weight 
Stage of 
pubertal 
development
Weight adjusted for 
height ↑ (white girls 
only) 
       
 
36
Michigan Cohort (1980-1981) 
Jacobson 
1990 95 
146 
(87) 
Cord blood 
Breast milk 
within 2 
months 
Cord serum: 
mean=2.5, 
SD=2.0, 
range: 0-12.3 
(ng/ml) 
Breast milk: 
mean=835.9, 
SD=388.4, 
range: 
185.7-2600 
(ng/ml) 
4 yr Height 
Weight 
Head 
circumferenc
e 
Prenatal PCBs: 
Weight ↓ 
Height – 
Head 
circumference – 
Postnatal PCBs: 
 – 
 
       
Germany       
Hesse cohort (1994-1997) 
Karmaus 
2002 98 
343 Child’s blood 
at 8 years old
Not 
mentioned 
Birth 
1-48 
mo 
8 yr 
9 yr 
10 yr 
 
Height 
Weight 
 – 
       
Netherlands       
Dutch cohort (1990-1992) 
Patandin 
1998 90 
207 
(105) 
Maternal 
blood at last 
month of 
pregnancy 
Cord blood 
Breast milk in 
the 2-6 weeks
 
Maternal 
serum: 
Median=2.04, 
range: 
0.59-7.35 
(µg/l) 
Cord serum: 
Median=0.40, 
range: 
0.08-2.08 
(µg/l) 
Breast milk 
(n=105): 
Median=391.
5, range: 
173.7-1226.4 
(µg/kg fat) 
 
10 d 
3 mo 
7 mo 
18 mo
42 mo
 
Length 
Weight 
Head 
circumferenc
e 
 
Prenatal PCBs: 
(b/w birth-3 mo, in 
formula-fed group 
only) 
Growth rate (weight 
change) ↓ 
Length ↓ 
Head circumference 
↓ 
Postnatal PCBs: 
 – 
       
Denmark       
Faroe Islands Cohort (1994-1995) 
Grandjean 
2003 91 
(182) Breast milk in 
the first 2 
weeks 
 
Geometric 
mean=1.52, 
range: 
0.07-18.5 
(µg/g lipid) 
 
18 mo
42 mo
Standing 
height 
Weight 
 
Height at 18 mo ↓ 
Weight at 18 mo ↓ 
Height at 42 mo – 
Weight at 42 mo – 
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* Abbreviation used in this table: CPP, the Collaborative Perinatal Project; CHDS, the Child Health 
and Development Study; SD, standard deviation; d, days; mo, months; yr, years; b/w, between; 
PBB, polybrominated biphenyl. 
† PCBs concentrations listed in this table may not be directly comparable, because different 
studies used different congeners to compose the total PCBs concentrations. Different studies 
also used different biospecimens to estimate the PCBs concentrations. In addition, sensitivities, 
detection limits, equipments, and recovery methods of laboratory analyses were different.  
‡ – indicates no association. ↑ indicates positive association with the increments of PCBs 
concentrations. ↓ indicates negative association with the increments of PCBs concentrations. ↑↓ 
indicates inconsistent associations. 
# Numbers in the parentheses represent the numbers of breast milk samples in each study. 
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Table 5. Reviews of studies about the effects of dichlorodiphenyltrichloroethane 
(DDT) and dichlorodiphenyldichloroethylene (DDE) on children's growth. * 
Study Size# Biospecimen DDT/DDE Conc † Age Test Result ‡ 
USA       
CPP Cohort (1959-1965) 
Gladen 
2004 112 
304 Maternal 
blood at 3rd 
triemester 
p,p'-DDT: 
Median=1.9, 
range: ND-12.7 
(µg/g lipid) 
o,p'-DDT: 
Median=0.14, 
range: ND-1.33 
(µg/g lipid) 
p,p'-DDE: 
Median=5.7, 
range: 1-25 (µg/g 
lipid) 
 
Puberty Height 
BMI 
Ratio of 
sitting 
height to 
height 
Triceps 
skinfold 
thickness 
Ratio of 
subscapula
r to the sum 
of triceps 
and 
subcapular 
skinfold 
thickness 
Skeletal 
age 
 
 – 
(male African 
Americans only) 
Ribas-Fito 
2006 97 
1712 Maternal 
blood at 3rd 
triemester 
p,p'-DDE: 
Median=24.4, 
interquartile 
range: 17.0-36.2 
(µg/l) 
 
1 yr 
4 yr 
7 yr 
Height 
Weight 
p,p’-DDT: 
 – 
p,p’-DDE: 
Height ↓ 
 
Lamb 
2006 93 
150 Maternal 
blood at 3rd 
triemester 
Not mentioned Birth 
1 yr 
4 yr 
7 yr 
17 yr 
 
Height 
Weight 
 – 
       
California – CHDS cohort (1964-1967) 
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Jusko 
2006 113 
399 Maternal 
blood at 2nd 
or 3rd 
trimester 
p,p'-DDT: 
Mean=1.93, 
SD=1.25, 
25th=1.11, 
75th=2.30 (µg/g 
lipid) 
o,p'-DDT: 
Mean=0.27, 
SD=0.22, 
25th=0.12, 
75th=0.35 (µg/g 
lipid) 
p,p'-DDE: 
Mean=6.85, 
SD=4.80, 
25th=3.90, 
75th=8.56 (µg/g 
lipid) 
 
Birth 
5 yr 
Height 
Sitting 
height 
Weight 
Head 
circumfere
nce 
Bi-acromial 
distance 
Bi-iliac 
distance 
Chest 
depth 
Chest 
breadth 
 
 – 
       
North Carolina Cohort (1978-1982) 
Rogan 
1987 111 
(802) Milk at birth (similar to Rogan 
1986) 
 
0-1yr 
 
Weight 
gain 
 – 
Gladen 
2000 96 
(594) Milk at birth p,p’-DDE: 
Median=2.4, 
range: 0.3-23.8 
(ppm) 
 
0-5 yr Height 
Weight 
Stage of 
pubertal 
developme
nt 
 
Height ↑ (boys only)
Weight adjusted for 
height ↑ (boys only)
 
       
Germany       
Hesse cohort (1994-1997) 
Karmaus 
2002 98 
343 Child’s blood 
at 8 years old 
p,p’-DDE: 
0.04-4.02 (µg/l) 
 
Birth 
1-48 mo
8 yr 
9 yr 
10 yr 
 
Height 
Weight 
Height ↓ (girls only) 
* Abbreviation used in this table: CPP, the Collaborative Perinatal Project; SD, standard deviation; 
mo, months; yr, years. 
† DDT or DDE concentrations listed in this table may not be directly comparable, because different 
studies used different biospecimens to estimate the concentrations. In addition, sensitivities, 
detection limits, equipments, and recovery methods of laboratory analyses might be different. 
‡ – indicates no association. ↑ indicates positive association with the increments of DDT or DDE 
concentrations. ↓ indicates negative association with the increments of DDT or DDE 
concentrations. 
# Numbers in the parentheses represent the numbers of breast milk samples in each study. 
CHAPTER II. RESEARCH AIMS AND HYPOTHESIS 
 
Polychlorinated biphenyls (PCBs) and dichlorodiphenyltrichloroethane (DDT) are 
persistent, bioaccumulative and toxic halogenated compounds, which were broadly used 
in the United States until the 1970s when they were banned because of their adverse 
effects on human health and the ecosystem. Although both chemicals have not been used 
for decades, PCBs and dichlorodiphenyl dichloroethylene (DDE), a metabolite of DDT, 
can still be detected in the environment and in the blood, urine and breast milk of the U.S. 
population 5-7. Due to the lipophilic property of PCBs, DDT and DDE, infants could be 
exposed to these chemicals prenatally through placental transfer or postnatally through 
breast-feeding. 
 
Some epidemiological studies have shown that PCBs and DDE may influence 
children’s neurodevelopment and growth, but the findings remain inconclusive. In vivo 
and in vitro studies have shown that PCBs may alter synaptic transmission and dopamine, 
estrogen and thyroid effects 114-121; animal and human studies have shown that prenatal 
and perinatal exposure to PCBs at background levels may influence cognition and 
behavior in infants and children 33-41. DDT has estrogenic properties, while DDE has 
antiandrogenic properties 42,44,45. In an animal study, DDT exposure during the brain 
growth spurt period caused cholinergic disturbance and neurobehavioral change in adult 
life 83. 
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Since few of the previous studies were focused on the effects of infant lactational 
exposure and most of the previous studies were conducted during 1980s and 1990s, this 
dissertation proposes a secondary data analysis of the PIN Babies Study in 2004-2006 to 
investigate whether lactational exposures to low background levels of PCBs, DDT and 
DDE affect infant development and physical growth in the first 12 months of life. The 
specific aims are to: 
 
1. Describe distributions of PCBs, DDT and DDE in breast milk and their 
correlations with long-chain polyunsaturated fatty acids in the same subsamples.  
 
2. Estimate the associations between the concentrations of PCBs, DDT and DDE in 
breast milk and infant communicative development at 12 months, measured by 
the MacArthur-Bates Communicative Development Indices (CDI). The 
alternative hypothesis for this study aim is that PCBs, DDT and DDE are 
separately associated with infant CDI scores at 12 months. 
 
3. Estimate the associations between the concentrations of PCBs, DDT and DDE in 
breast milk and infant physical, cognitive, and communicative development at 
12 months, measured by the Mullen Scales of Early Learning (Mullen). The 
alternative hypothesis for this study aim is that PCBs, DDT and DDE are 
separately associated with infant Mullen scores at 12 months. 
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4. Estimate the associations between the concentrations of PCBs, DDT and DDE in 
breast milk and serial infant growth measurements through the first 12 months. 
The alternative hypothesis for this study aim is that PCBs, DDT and DDE are 
separately associated with infant weight and length through the first 12 months. 
 
From sub-analyses, we will also be able to 1) assess the degree of effect measure 
modification by infant gender, and LC-PUFAs concentration in breast milk, 2) examine 
which pre-, peri-, and post-natal variables, such as fish consumption, maternal parity, and 
maternal body weight, could predict PCBs, DDT and DDE concentrations in breast milk 
at 3 months. 
 
The study population was the children of the PIN Postpartum Study participants, 
who were recruited for participation in the PIN Babies Study. For this study, samples of 
breast milk were collected from breast-feeding mothers at 3 months postpartum in order 
to determine the concentration of PCBs, DDT and DDE in breast milk. The Mullen Scale 
and MacArthur-Bates CDI were used to assess the children’s development at 12 months 
postpartum. Infant weight and height were recorded regularly on the child’s growth card, 
which was filled out by medical care providers. The expected size of the study population 
for having both exposure and outcome measurements is approximately 219 mother-child 
pairs. We hypothesize that in the PIN Babies Study, PCBs and DDE levels in breast milk 
will have minor associations with the deficits on infant’s cognition and also with the 
delay in infant’s growth of the first 12 months.
CHAPTER III. METHODS 
 
A. Study Design Overview 
 
The Pregnancy, Infection and Nutrition (PIN) Study is a cohort study of pregnancy.  
Pregnant women were recruited before 20 gestational weeks from prenatal care clinics at 
the University of North Carolina (UNC) Hospitals from January 2001 to June 2005. The 
women who participated in the PIN were followed up to their delivery. During pregnancy, 
they completed two research clinic visits at less than 20 gestational weeks and during 
24-29 gestational weeks, and completed two telephone interviews during 17-22 
gestational weeks and during 27-30 gestational weeks. After delivery, women also 
completed one brief questionnaire while in the hospital, and were asked to continue study 
participation as part of the PIN Postpartum Study. 
 
In the PIN Postpartum Study, participant women were interviewed in their homes 
around the third and the twelfth months postpartum; at the same time, they were asked 
whether they were willing to have their child participate in PIN Babies Study. Data 
collection was completed during home visits for women who consented. Each mother 
completed a computer assisted interview about her health and lifestyle and that of her 
child. In addition, the child’s development was assessed using the Mullen Scales of Early 
Learning. Self-administered MacArthur-Bates Communicative Development Inventories 
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(CDI) and a child’s growth card were left for mothers to return later. A sample of breast 
milk was collected from breast-feeding mothers at the third month postpartum and stored 
at -80°C. 
 
Overall, the PIN Study, the PIN Postpartum Study, the PIN Babies Study collected 
data about prenatal and postpartum maternal and infant information on basic 
characteristics, diet, physical activity, psychosocial status, infant feeding habits, etc. The 
informed consent forms were signed at each study stage, and the participants were 
compensated for participation to aid retention. The Institutional Review Board of 
University of North Carolina at Chapel Hill has approved all the study protocols of the 
PIN studies. Details of these studies are available at the website: 
http://www.cpc.unc.edu/projects/pin/. 
 
B. Study Population 
 
A total of 2006 women were recruited in the PIN Study from the prenatal care 
clinics at the University of North Carolina (UNC) Hospitals between January 2001 and 
June 2005 (participation rate: 64%), of whom 1942 women’s delivery information was 
available. In this PIN cohort, 69% of the women are white, 22% are African American, 
and 9% are other races. Approximately 80% of the women were between 20-34 years of 
age, 6% were less than 20 years and 16% were 35 or over. Most women were married 
(71%), and about half of them had education levels at 16 years and more. Thirty percent 
of the women self-reported smoking during the pregnancy. For this large cohort, 14.6% 
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had preterm births (n=284) and 9.9% had a low birth weight baby (n=192). 
 
About 65% of PIN Study participants gave consent for the PIN Postpartum Study. 
The women having singleton births without major birth defects were further asked to 
have their children participate in the PIN Babies study at 3 months postpartum and 12 
moths postpartum. The end of data collection of PIN Postpartum Study and PIN Babies 
Study was in December 2006. There were 589 infants participated in the PIN Babies 
Study, 496 (84%) participated at the 3 months, and 502 (85%) participated at the 12 
months. Over two-thirds of the subjects, 69% (n=409) participated in both the 3- and 
12-month time periods. Of the 331 women still breast feeding at 3 months, 306 (92%) 
were willing to provide a breast milk sample (304 were usable). The comparison of 
characteristics among the PIN Studies showed that a higher percentage of white women 
participated in the PIN Postpartum and provided breast milk in the PIN Babies Study than 
participated in the original PIN Study. Participant women who were still breast feeding at 
3 months and willing to provide breast milk were older and had higher education levels 
compared to the PIN sample (table 6). 
 
For the purpose of dissertation, to investigate the association between the levels of 
PCBs and DDE in breast milk and infant development and growth, the study population 
will be a subset of mother-child pairs in the PIN Babies study – singleton births without 
major birth defects with the mother breastfeeding and providing a valid breast milk 
sample at the third month postpartum. The expected size is approximately 219 
mother-child pairs. 
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C. Data Collection 
 
In the PIN Postpartum Study, the participant women were called beforehand to 
schedule a home visit interview around the third and twelfth months postpartum. A milk 
collection kit and a growth card were mailed to the mother before the scheduled visit and 
collected at the home visit. A confirmation call was made in a few days before the visit to 
ensure that both the mother and the child were generally healthy and comfortable with the 
visit. 
 
A two-person research team was sent out for the home visit at the appointed time. 
The team had standardized training on conducting the computer-assisted interview and 
administering the Mullen Scales of Early Learning. At the home visit, the research staff 
explained the research goals and interview steps to the mother, and obtained signed 
consent. One interviewer, then interviewed the mother, asking questions about her health 
status, diet, psychosocial status, physical activity, and infant health and feeding, while the 
other person observed and interacted with the infant to score the Mullen Scales. After the 
12-month visit interview, the child’s growth card was collected, and the self-administered 
short-form version of the MacArthur-Bates Communicative Development Indices (CDI) 
was left for mothers to return by mail. The completion time of the whole 12-month home 
visit was around 2 hours. 
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C.1 Exposure Measurement 
 
Participant women who breastfed their child at 3 or 12 months postpartum were 
asked to provide a breast milk sample for measuring the concentrations of chemicals in 
the breast milk. A milk collection kit, containing three 1.5ml tubes, a plastic pipette, and 
the instructions, was sent before the scheduled visit. At around 10 in the morning of the 
scheduled visit day, participants followed the instructions to use the pump to empty both 
breasts, gently mix the milk and use the plastic pipette to transfer the milk into 3 tubes. 
These milk samples were frozen in the refrigerator until the interviewers came, and the 
samples were transported on ice back to the -80°C storage freezers in the Carolina 
Population Center. 
 
Breast milk samples were analyzed for nine dioxin-like PCBs, twenty-seven 
nondioxin-like PCBs, p,p’-DDT, o,p’-DDT, and p,p’-DDE (table 7) according to the 
existing methodology at the Organic Analytic Toxicology Branch of the National Center 
for Environmental Health at CDC under the supervision of Dr. Andreas Sjödin 122. The 
measurement of selected chemicals in breast milk samples was performed using gas 
chromatography/isotope dilution high-resolution mass spectrometry (GC/IDHRMS) 
using a MAT95 instrument (ThermoFinnigan MAT; Bremen, Germany). All milk samples 
were pasteurized prior to analysis to eliminate risk of pathogen exposure to the 
experimenter. Breast milk (1g) was added to cartridges containing Hydromarix (1g) 
(Varian Inc, Walnut Creek, CA). To the specimens were then added 13C-labeled internal 
standards. The specimens were then dried using pressurized nitrogen and the milk lipids 
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eluted with dichloromethane (10mL), using the Rapid Trace Solid-phase Extraction 
Workstation (Caliper Life Sciences; Hopkinton, MA) for automation. The lipid 
concentration was gravimetrically determined by an analytical balance AX105 Delta 
Range (Mettler Toledo; Columbus, OH) with an accuracy of ±10-4 g. The lipid extracts 
were then purified on a two layered column containing silica (top layer) and 
silica/sulfuric acid (bottom layer), using the Solid-phase Extraction Workstation for 
automation. The specimens were then evaporated to 10uL and fortified with recovery 
standards. Each analysis batch contained sixteen unknowns, two method blanks and two 
quality control (QC) specimens. The specimens were then analyzed by GC-IDHRMS 
together with a 6-point calibration curve spanning the concentration range of 0.2-2000 
µg/l. The between-assay coefficient of variation (CV) is normally less than 10%. The 
medians of limits of detection (LODs) are given in the table 7. 
 
C.2 Outcome Ascertainment 
 
The outcomes of interest are infant early development and growth in the first 12 
months of life, which is a period of dramatic change in babies’ cognitive development 
and physical growth. A baby learns to recognize sounds, focus vision, produce sounds, 
and interact with others by using cries, chuckles, gestures, and babbling. At the end of the 
first year, an infant’s weight is triple and body length is increased by a half. PIN Babies 
study chose the Mullen Scales of Early Learning (the Mullen) and the infant short-form 
version of the MacArthur Communicative Development Inventories (CDIs) to detect the 
variation of cognition, motor skills, and language developments among the one-year-old 
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infants. In addition, the study collected babies’ growth measurements from routine 
clinical checkups in the first year as a means to measure each infant’s growth trajectory. 
 
C.2.1 Cognitive and Motor Development – by the Mullen Scales of Early Learning 
 
The Mullen Scales of Early Learning (the Mullen) were administered at the 
12-month postpartum home visit by trained testers. This instrument was designed for 
evaluating children aged from birth to 68 months old on five dimensions of 
development – visual reception, fine motor, receptive language, expressive language, and 
gross motor. The Mullen can provide scores of verbal and nonverbal skills separately 
along with an overall index of developmental ability. Some of the evaluations using the 
Mullen involved the mother’s assistance and her observation from daily care. The overall 
administration time for evaluating a 12-month-old infant is about 30 minutes. The Mullen 
has fair reliability and moderate correlations with other developmental scales 123. It has 
been used in several autistic spectrum disorders studies 124-126. 
 
C.2.2 Language Comprehension and Production – by the Infant Short-form of the 
MacArthur Communicative Development Inventories 
 
Infant language comprehension and production at 12 months postpartum were 
measured by the MacArthur Communicative Development Inventories (CDIs). The CDIs 
are parent-report instruments for evaluating children’s early language development 
(http://www.sci.sdsu.edu/cdi/cdiwelcome.htm). There are two forms – one for infants 
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aged 8-18 months and the other for toddlers aged 16-30 months 127. Compared to two 
other traditional means, language sampling and structured testing, CDIs are less 
labor-intensive, have better cost-efficiency, are easier in larger studies, and have greater 
feasibility for assessing the children younger than two-and-a-half years old 127. However, 
since the forms are completed by parents, it is limited to literate parents. In the PIN 
cohort, only 8% of participant women had education level less than 12 years and all could 
read, so this limitation won’t influence the validity of our outcome measurement. 
 
To shorten the self-administration time for the mother to increase the response rate, 
we used the short-form version of the infant form for infants aged between 8 and 18 
months, which is an 89-word inventory for vocabulary comprehension and production 
instead of 396-word full form 128. At the 12-month postpartum home visit, the 
interviewers left this self-administrative short-form for participant mothers to fill out and 
return by mail. The short-form checklist contains two columns, one labeled as 
“Understands” and the other labeled as “Understands and Says”. These two choices are 
exclusive. If a baby can understand the word on the list but can’t say it, the mother should 
check “Understands”. If a baby can both understand and say the word, the mother should 
check “Understands and Says” rather than “Understands”. The overall correlation 
between the short-form and the original long-form is very high (r=0.97), but an action 
and gesture scale is not included in the short-form because of inability to reliably simplify 
it in the brief format 128,129. Meadows et al paper has showed that mothers can 
consistently report their infants’ communicative acts, which suggests the certain 
reliability of parent-report instrument 130. The infant short-version of CDIs can not be 
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used for identifying children at risk for later clinical language deficits, but the correlation 
between the early infant form and later toddler form provide the evidence for the 
instrument’s predictive validity for language development 127. 
 
C.2.3 Physical Growth – by the Babies’ Growth Card 
 
Mothers were provided with the babies’ growth card and were asked to take the card 
to the child’s 12-month well-child medical visit. This card, filled out by medical care 
providers, recorded infant weight and length at each previous routine clinical baby visit. 
The suggested time for visits are at 2, 4, 6, 9, and 12 months of age, but the frequency 
and times of visits may vary among infants by their health status. This growth card was 
then collected at the 12-month postpartum home interview. 
 
C.3 Other Covariates 
 
We’re also interested in knowing the correlation between PCBs, DDT, DDE and 
LC-PUFAs in breast milk. Fatty acid extraction and assessment was performed by the 
Collaborative Studies Clinical Laboratory at the University of Minnesota Medical Center, 
Fairview (Minneapolis, MN). Fatty acids were extracted from 0.5 ml of breast milk 
mixed with 0.5 ml of 0.9% saline. 0.1 mg of 17:0 standard (diheptadecanoyl 
phosphatidylchloine) was added to monitor efficacy of extraction. The extraction process 
was conducted by a Hewlett Packard 5890 gas chromatograph equipped with a HP6890A 
autosampler as previously described 131. Nine LC-PUFAs in breast milk were identified: 
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five ω-3 FAs – 18:3 (ALA), 20:3, 20:5 (EPA), 22:5 (docosapentaneoic acid), and 22:6 
(DHA); four ω-6 FAs - 18:2 (LA), 18:3 (gamma-LA), 20:3 (dihomo-gamma-LA), and 
20:4 (AA). 
 
Other covariates of interest are potential confounders and risk factors (figure 1). 
Potential confounders are the factors which are associated with both lactational PCBs, 
DDT and DDE and infant development or growth, but which should not be an effect of 
either exposure or outcome. These factors are race/ethnicity, maternal age, socioeconomic 
status, duration of breastfeeding, parity and additionally maternal BMI for the 
investigation of infant growth. Risk factors are the factors related to outcome, but not 
apparently associated with exposure. These include maternal smoking, alcohol 
consumption and drug use during pregnancy, infant gender, and infant age. For infant 
growth association, maternal diabetes, paternal weight and height, and in utero growth 
retardation are additionally included. All these data are collected through interviews, 
self-adminitered questionnaires and the prenatal medical records in PIN, PIN Postpartum, 
and PIN Babies studies. 
 
D. Data Analyses 
 
The data from the PIN, PIN Postpartum, and PIN Babies studies will be merged 
using subject identification numbers by the programmer at the Carolina Population Center. 
Data will be further checked and cleaned for plausible range and consistency across 
studies. The conflicts among different sub-files may indicate the errors of data linkage or 
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key-in. Before the analyses for specific aims, frequency distribution or descriptive 
statistics of each variable of interest will be assessed to detect potential outliers and 
missing data. Unrealistic answers or numbers for each variable will be flagged for 
verification. 
 
D.1 Specific Aim 1 – Describe Distributions of PCBs, DDT and DDE in 
Contemporary Breast Milk and Their Correlations with Long-Chain 
Polyunsaturated Fatty Acids in a Subsample 
 
Descriptive analyses of the concentrations of PCBs, DDT, DDE, and LC-PUFAs will 
be done via univariate analyses. The minimum, maximum, median, mean, standard error, 
number of missing, skewness and graphical distribution of each chemical will be 
described. The correlations between PCBs, DDT and DDE and LC-PUFAs will be 
assessed in the sub-sample of PIN Babies Study participants who have observations of 
both environmental pollutants and LC-PUFAs in breast milk. The sample size is 
approximately 175 participant mothers. The demographic distribution of mothers with 
LC-PUFAs data and mothers without LC-PUFAs data will be compared. 
 
D.2 Specific Aim 2 – Estimate the Associations Between PCBs, DDT and DDE in 
Breast Milk and Infant Development at 12 Months 
 
Initial exploratory analyses for the concentrations of PCBs, DDT and DDE in breast 
milk, developmental scores of the Mullen and the CDI, and the potential confounders will 
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be done via univariate analyses. For continuous variables, the minimum, maximum, 
median, mean, standard error, number of missing, skewness and graphical distribution 
will be described; for categorical variables, sample size, frequency and number of 
missing will be given. Categories with sparse data will be combined to reduce numbers of 
strata to increase sample size of the stratum, if the effect estimates are homogeneous 
across strata. Mother-child pairs with unverifiable erroneous numbers or missing 
variables will be excluded from the data analyses, if the number of missing is less than 
10% and not related to their exposure or outcome status, i.e. under the assumption of 
missing at random (MAR). 
 
Concentrations of PCBs, DDT and DDE are the main exposures of interest. Nine 
dioxin-like PCBs, twenty-seven nondioxin-like PCBs, p,p’-DDT, o,p’-DDT, and 
p,p’-DDE were measured in maternal breast milk at 3 months postpartum (table 8). From 
linear correlation coefficients between the most prevalent PCB congeners, which are 
detectable in more than 90% of samples, we find that tri-ortho-substituted PCBs are not 
highly correlated with mono-ortho-substituted PCBs (r<0.6) and some of the 
di-ortho-substituted congeners are not highly correlated with some of the 
mono-ortho-substituted congeners either (table 9). Therefore, we may need to treat each 
PCB congener as an exposure variable in separate models to explore the potential 
difference of the effects. We will also group PCB congeners based on the degree of 
ortho-substitution in 3 groups – mono-ortho-substituted PCBs, di-ortho-substituted PCBs 
and tri-ortho-substituted PCBs, and also use the sum of total PCB congeners to provide 
one composite exposure value (ΣPCBs). For the samples measured as under the limits of 
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detection (LOD), three manipulations are used: 1) <LOD is imputed as 0; 2) <LOD is 
imputed as 2/LOD ; and 3) <LOD is imputed as 2/)(LODmedian . Since there is no 
standard method to calculate ΣPCBs, we decided that only the PCB congeners which 
have less than 30% of the samples with concentrations under LOD, will be counted in 
ΣPCBs in order to reduce the exposure misclassification resulting from data imputation. 
To treat exposure as a continuous variable, natural-log transformation may be needed 
because of the right-skewness of the distribution. Since the exposure-response trend may 
not be strictly monotonic, we will further use quartiles of the individual chemical 
distribution of this study cohort to categorize the study population. The multiplication of 
concentrations of chemicals in breast milk and the duration of mostly breast-feeding will 
be calculated to represent the accumulated lactational exposure under the assumptions 
that the amount of milk fat is similar among mothers and infants consumed the same 
amount of milk daily. 
 
The Mullen will provide scores of five dimensions of development, visual reception, 
fine motor, receptive language, expressive language, and gross motor, along with a 
composite score of early learning. Standard T scores for each scale, with mean=50 and 
standard deviation (SD)=10, and standardized composite score, with mean=100 and 
SD=15, will be provided based on the US normative sample. Standard scores will be used 
when continuous outcomes are of interest, and the percentile ranking and descriptive 
categories will be used to provide proper categorization of the study population when the 
risk association is of interest. The lowest 15th percentile or 1 SD below age-adjusted mean 
will be used as a cut point for low scores. 
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The short form of the CDI at 12 months provides the scores of infant’s language 
comprehension and production. Raw scores can further be standardized for boys and girls 
separately or both sexes combined. These percentile scores can be treated as a continuous 
outcome in the statistical models. In addition, for risk associations of interest, the infants 
with scores of one SD and greater below the mean will be categorized as a group with 
lower levels of language development. 
 
The multivariable generalized linear models with identity link function with 
Gaussian (normal) distribution or log link function with Bernoulli (binomial) will be used 
to assess the associations between lactational exposure to PCBs, DDT, and DDE and 
infant development of cognitive skills and language at the 12 months of life. Effect 
measure modification (EMM) by race/ethnicity and infant gender will be assessed via 
stratification analysis of the full model. If the p-value of the homogeneity test is less than 
0.10, the interaction terms of main exposure and effect modifier will be included in the 
models. The models will also contain a priori confounders and risk factors based on 
substantive knowledge – race/ethnicity, maternal age, socioeconomic status, duration of 
breastfeeding, parity, maternal smoking, alcohol consumption, infant gender, and infant 
age. The effect estimates with 95% confidence intervals will be reported. All the 
statistical analyses will be conducted by PC-SAS computer program (version 9.1). 
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D.3 Specific Aim 3 – Estimate the Associations Between PCBs, DDT and DDE in 
Breast Milk and Infant Growth through the First 12 Months of Life. 
 
The initial descriptive analyses and defining exposure variables will be the same as 
the analyses describing in specific Aim 1. Infant serial growth measurements – weight 
and length – recorded on the babies’ growth card through the first 12 months of life will 
be the outcomes of interest for our second specific aim. The visit time for regular medical 
checkups are suggested at 2, 4, 6, 9, and 12 months of age, but the number and the time 
of visits could vary among infants. According to 2000 CDC growth charts 132, infants’ 
standardized sex-specific percentiles for weight-for-age, length-for-age and 
weight-for-length will be further determined. However, very-low-birth-weight infants, 
whose birth weight <1,500g, will be omitted, since they have different growth patterns 
and are excluded from the nationwide reference data. Infants who are ranked as <10th 
percentile will be categorized as having stunted growth. 
 
To assess the relationships of lactational exposure to PCBs, DDT and DDE and 
infant growth, we will use the generalized estimating equations (GEE), which handle 
repeated measurements of outcomes over time and unequal number and time of visits of 
study subjects 133,134. Residual plots will be used to assess the homoscedasticity 
assumption for generalized linear models. If the graphs show heteroscedasticity, mixed 
models will be used instead of GEE. Identity link function with Gaussian (normal) 
distribution will be used when weight and length are treated as continuous variables; log 
link function with Bernoulli (binomial) distribution will be used when the risk ratio of 
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high risk of slow growth are interested. The working correlation matrix will be defined as 
unstructured first to examine the correlation structure of repeated measurements. Infant’s 
age will be treated as a time-dependent predictor. A priori covariates contain 
race/ethnicity, socioeconomic status, maternal age at pregnancy, maternal smoking, 
alcohol consumption and drug use during pregnancy, maternal diabetes, maternal 
postpartum BMI, duration of breastfeeding, parity, infant gender, paternal weight and 
height, and in utero growth retardation. The interaction terms of chemical concentrations 
with infant age, chemical concentrations with infant gender, and chemical concentrations 
with in utero growth retardation will be considered. The covariates will be eliminated 
from the full model if they are not predictors of the outcome (p>0.10) and do not 
confound the main effect estimates of interest by 10% (10% change-in-estimate criterion) 
135. Test for the trend of the associations will be considered through analyses. The effect 
estimates with 95% confidence intervals will be reported. All the statistical analyses will 
be conducted by PC-SAS computer program (version 9.1). 
 
D.4 Statistical Power 
 
The expected size of the study population for having both exposure and outcome 
measurements is approximately 219 mother-child pairs. To simplify the calculations of 
statistical power, the statistical analyses for specific aim 2 and specific aim 3 are grouped 
in three situations – linear regression models, log-linear regression models and GEEs. All 
the hypothesis tests are two-sided and with type 1 error (α) equal to 0.05.  
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For simple linear regression models, for example, assessing the relationships 
between the concentrations of PCBs, DDT, and DDE in breast milk and the scores on the 
infant neurodevelopment tests, the statistical power is calculated by the nQuery Advisor® 
software given several assumed values (α=0.05, n=219): 
If the correlation coefficient (ρ) = 0.05, the power will be 11%. 
If the correlation coefficient (ρ) = 0.10, the power will be 31%. 
If the correlation coefficient (ρ) = 0.15, the power will be 60%. 
If the correlation coefficient (ρ) = 0.20, the power will be 85%. 
 
For log-linear regression models, for example, assessing the risk ratio of having 
deficits in neurodevelopment at the twelfth month between exposed and non-exposed 
groups, the statistical power is calculated by episheet.xls, developed by Ken Rothman, 
given several assumed values (α=0.05, n=219, unexposed/exposed ratio=3, 15% of 
unexposed group categorized as having low scores on the tests): 
If the risk ratio (RR) = 1.2, the power will be 8%. 
If the risk ratio (RR) = 1.5, the power will be 26%. 
If the risk ratio (RR) = 2.0, the power will be 68%. 
If the risk ratio (RR) = 3.0, the power will be 99%. 
 
To simplify the power calculations for GEEs, we have focused on calculating the 
sample size for testing the hypothesis that the infant growth rates of change through the 
first 12 months, as measured by weight, are the same for two equal-sized exposure groups. 
We assume: 1) the correlations (ρ) among repeated growth measurements are consistent 
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through the time period, i.e. exchangeable correlation matrix; 2) every child has an equal 
number (n) and time of visits, i.e. 5 visits at 2, 4, 6, 9, and 12 months of age. Given type I 
error (α) =0.05, power(1-β)=80%, and assumptive measurement variation (σ2)=100, we 
use the formula below to calculate that if the correlation between each measurement is 
0.2, we will need 79 subjects per exposed group to detect the difference in infant weight 
change rate of 0.5 kg/month. When the correlation between each measurement (ρ) 
increases and measurement variation (σ2) decreases, the sample size to detect the same 
effect will decrease. Since we may have at least a total of 200 subjects for this study aim, 
this study should be able to reach an acceptable statistical power. 
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Table 6. Characteristics of the participant women in this study, in the PIN 
Postpartum Study and in the PIN 3 Cohort. 
 OCs+FAs 
(n=175) 
Milk Samples 
(n=304) 
PIN Postpartum 
(n=688) 
PIN3 Cohort 
(n=2006) 
Characteristics No. % No. % No. % No. % 
Race         
White 152 87 262 86 526 76 1382 69 
Black 12 7 18 6 102 15 434 22 
Other 11 6 24 8 60 9 189 9 
Missing       1  
         
Age         
<25 18 10 32 11 132 19 479 24 
25-29 51 29 88 29 195 28 557 28 
30-34 76 43 130 43 250 36 657 33 
≥35 30 17 54 18 111 16 313 16 
         
Education         
< High school 4 2 7 2 36 5 166 8 
High school 6 3 10 3 82 12 328 16 
≥ College degree 165 94 287 94 570 83 1503 75 
Missing       9  
         
Parity         
0 95 54 160 53 334 49 901 45 
≥1 80 46 144 47 354 51 1098 55 
Missing       7  
         
Pre-pregnancy BMI         
<19.8 30 17 52 17 97 14 266 14 
19.8-26.0 111 63 189 62 371 54 930 49 
26.0-29.0 12 7 27 9 82 12 215 11 
>29.0 22 13 36 12 136 20 487 26 
Missing      2 108  
 
62
Table 7. List of chemicals of interest measured in breast milk samples and the 
median of lipid adjusted limit of detection (LOD) (ng/g lipid). 
Chemicals Name Median(LOD) 
PCBs 
mono-ortho-substituted PCBs 
PCB 28 2,4,4'-trichlorobiphenyl 2.50 
PCB 66 2,3',4,4'-tetrachlorobiphenyl 0.30 
PCB 74 2,4,4',5-tetrachlorobiphenyl 0.30 
PCB 105 2,3,3',4,4'-pentachlorobiphenyl 0.30 
PCB 118 2,3',4,4',5-pentachlorobiphenyl 0.30 
PCB 156 2,3,3',4,4',5-hexachlorobiphenyl 0.30 
PCB 157 2,3,3',4,4',5'-hexachlorobiphenyl 0.30 
PCB 167 2,3',4,4',5,5'-hexachlorobiphenyl 0.30 
PCB 189 2,3,3',4,4',5,5'-heptachlorobiphenyl 0.30 
di-ortho-substituted PCBs 
PCB 44 2,2',3,5'-tetrachlorobiphenyl 0.30 
PCB 49 2,2',4,5'-tetrachlorobiphenyl 0.30 
PCB 52 2,2',5,5'-tetrachlorobiphenyl 0.30 
PCB 87 2,2',3,4,5'-pentachlorobiphenyl 0.30 
PCB 99 2,2',4,4',5-pentachlorobiphenyl 0.30 
PCB 101 2,2',4,5,5'-pentachlorobiphenyl 0.30 
PCB 110 2,3,3',4',6-pentachlorobiphenyl 0.30 
PCB 128 2,2',3,3',4,4'-hexachlorobiphenyl 0.30 
PCB 138 2,2',3,4,4',5'-hexachlorobiphenyl 0.30 
PCB 146 2,2',3,4',5,5'-hexachlorobiphenyl 0.30 
PCB 153 2,2',4,4',5,5'-hexachlorobiphenyl 0.30 
PCB 158 2,3,3',4,4',6-hexachlorobiphenyl 0.30 
PCB 170 2,2',3,3',4,4',5-heptachlorobiphenyl 0.30 
PCB 172 2,2',3,3',4,5,5'-heptachlorobiphenyl 0.30 
PCB 180 2,2',3,4,4',5,5'-heptachlorobiphenyl 0.30 
PCB 194 2,2',3,3',4,4',5,5'-octachlorobiphenyl 0.30 
tri-ortho-substituted PCBs 
PCB 149 2,2',3,4',5',6-hexachlorobiphenyl 0.30 
PCB 151 2,2',3,5,5',6-hexachlorobiphenyl 0.30 
PCB 177 2,2',3,3',4',5,6-heptachlorobiphenyl 0.30 
PCB 178 2,2',3,3',5,5',6-heptachlorobiphenyl 0.30 
PCB 183 2,2',3,4,4',5',6-heptachlorobiphenyl 0.30 
PCB 187 2,2',3,4',5,5',6-heptachlorobiphenyl 0.30 
PCB 195 2,2',3,3',4,4',5,6-octachlorobiphenyl 0.30 
PCB 196 2,2',3,3',4,4',5',6-octachlorobiphenyl 0.30 
PCB 199 2,2',3,3',4,5,5',6'-octachlorobiphenyl 0.30 
PCB 203 2,2',3,4,4',5,5',6-octachlorobiphenyl 0.30 
PCB 206 2,2',3,3',4,4',5,5',6-nonachlorobiphenyl 0.30 
   
DDT and DDE 
p,p'-DDT 2,2-bis(4-chlorophenyl-1,1,1-trichloroethan 0.30 
o,p'-DDT 2-(4-chlorophenyl)-2-(2-chlorophenyl)- 1,1,1-trichloroethan 0.30 
p,p'-DDE 2,2-bis(4-chlorophenyl)-1,1-dichloroethene 0.30 
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Lactational PCBs, 
DDT, and DDE
? Infant growth
Confounders:
•Race/ethnicity
•Maternal age
•Socioeconomic status
•Maternal BMI
•Breast feeding/lactation time
•Parity
Risk factors:
•Maternal smoking
•Maternal alcohol consumption
•Drug use during pregnancy
•Maternal diabetes
•Paternal weight and height
•In utero growth retardation
•Infant gender
•Infant age at regular checkups
 
 
Figure 1. Conceptual diagram of potential covariates of the association between 
PCBs, DDT and DDE in breast milk and infant development and growth. An arrow 
indicates the causal effect.
Lactational PCBs, 
DDT, and DDE
? Infant development
Confounders:
•Race/ethnicity
•Maternal age
•Socioeconomic status
•Breast feeding/lactation time
•Parity
Risk factors:
•Maternal smoking
•Maternal alcohol consumption
•Drug use during pregnancy
•Infant gender
•Infant age at home visit
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CHAPTER IV. RESULTS 
 
A. Manuscript 1: Organochlorine Compounds and Fatty Acids in Breast Milk in 
Central North Carolina 2004-2006 
 
A.1 Introduction 
 
Polychlorinated biphenyls (PCB) and organochlorine pesticides, such as 
dichlorodiphenyltrichloroethane (DDT), hexachlorobenzene (HCB), chlordane, lindane 
and mirex, were widely used from the 1920s. When they were found to be widespread, 
toxic environmental contaminants with effects on ecosystems, wildlife and potentially 
human beings, they were banned for most usage in the United States. These 
organochlorine compounds (OCs) have long half-lives and are lipophilic, and thus they 
bioaccumulate in the environment through the food chain. Although most uses are 
restricted, people are still exposed to these chemicals and their metabolites through diet, 
most commonly by eating contaminated meat and seafood. Infants are exposed mainly 
through breast milk consumption. Infants are more vulnerable than adults to the potential 
adverse effects of these environmental pollutants. 
 
Despite the presence of environmental pollutants, breast feeding is still encouraged 
because it benefits infants. Among other things, breast milk contains long chain fatty 
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acids (FAs), which are used by the child to make central nervous system tissue. The 
concentrations of both fatty acids and organochlorines in breast milk are determined by 
maternal diet, and fish (or marine mammals) in particular can be relatively high in both. 
A study of Faroe Islanders who consumed fish and pilot whale showed that total PCBs 
(defined as two times of the summation of PCB138, 153 and 180) were positively 
correlated with the relative concentrations of eicosapentaenoic acid (EPA) (r=0.42) and 
docosahexaenoic acid (DHA) (r=0.24) in maternal serum at 34 gestational weeks and 
negatively correlated with arachidonic acid (AA) in cord serum (r=-0.32) 137. The Inuit 
cohort of pregnant women in 1995-2001 showed PCB153 was positively correlated with 
DHA (r=0.27) in cord blood 138. None of the previous studies examined the potential 
correlations between OCs and FAs in breast milk of populations exposed to background 
levels. 
 
Since most of the previous studies were conducted during the 1980s and 1990s, 
there are limited data published on the levels of OCs in breast milk of American women 
in the 21st century 7. The objectives of this paper are to report the levels of OCs and FAs 
in the breast milk of lactating women in central North Carolina from 2004 to 2006, to 
estimate the correlations within and between OCs and FAs, and to identify the factors 
determining the variability of the chemical concentrations. 
 
A.2 Methods 
 
Study Design and Population 
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The Pregnancy, Infection and Nutrition (PIN) Study is a cohort study that recruited 
pregnant women before 20 gestational weeks with a singleton birth who were receiving 
prenatal care at the University of North Carolina at Chapel Hill hospital from 2001 to 
2005. Mothers completed several self-administered questionnaires and two phone 
interviews during pregnancy and one brief questionnaire after delivery at the hospital to 
provide details about their health and lifestyle during pregnancy. After delivery, women 
were asked to continue participation as part of the PIN Postpartum Study. Participant 
mothers were interviewed in their homes around 3 months postpartum about their health 
and lifestyle and the health of their child. The Block Food Frequency Questionnaire was 
self-administered and used to assess maternal diet during the first 3 months postpartum. 
Between 2004-2006, participant women were also asked whether they were willing to 
have their child participate in the PIN Babies Study. Women who were still breastfeeding 
at the 3-month home visit were asked to provide a breast milk sample. 
 
A milk collection kit, containing three 1.5ml tubes, a plastic pipette, and the 
instructions, was sent before the scheduled visit. At around 10 o'clock in the morning of 
the scheduled visit day, participants were to follow the written instructions to pump both 
breasts, gently mix the milk extracted, and use the plastic pipette to transfer the milk into 
3 tubes and store them in the freezer until the interviewers arrived. Samples were then 
transported on ice to the -80 ºC storage freezers. The appropriate informed consent forms 
were signed at each stage of the study, and the participants were compensated for 
participation. The Institutional Review Board of University of North Carolina at Chapel 
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Hill approved all the study protocols of the PIN studies. 
 
Exposure Measurement 
 
Breast milk samples were analyzed for thirty-five PCB congeners, p,p’-DDT, 
o,p’-DDT, p,p’-DDE, HCB, β-hexachlorocyclohexane (HCH), γ-HCH, oxychlordane, 
trans-nonachlor and mirex according to the existing methodology at the Organic Analytic 
Toxicology Branch of the National Center for Environmental Health at the Centers for 
Disease Control and Prevention 122. The measurement of selected chemicals in breast 
milk samples was performed using gas chromatography/isotope dilution high-resolution 
mass spectrometry (GC/IDHRMS) using a MAT95 instrument (ThermoFinnigan MAT; 
Bremen, Germany). All milk samples were pasteurized prior to analysis to eliminate risk 
of pathogen exposure to the experimenter. Breast milk (1g) was added to cartridges 
containing Hydromarix (1g) (Varian Inc, Walnut Creek, CA). To the specimens were then 
added 13C-labeled internal standards. The specimens were then dried using pressurized 
nitrogen and the milk lipids eluted with dichloromethane (10mL), using the Rapid Trace 
Solid-phase Extraction Workstation (Caliper Life Sciences; Hopkinton, MA) for 
automation. The lipid concentration was gravimetrically determined by an analytical 
balance AX105 Delta Range (Mettler Toledo; Columbus, OH) with an accuracy of ±10-4 
g. The lipid extracts were then purified on a two layered column containing silica (top 
layer) and silica/sulfuric acid (bottom layer), using the Solid-phase Extraction 
Workstation for automation. The specimens were then evaporated to 10uL and fortified 
with recovery standards. Each analysis batch contained sixteen unknowns, two method 
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blanks and two quality control (QC) specimens. The specimens were then analyzed by 
GC-IDHRMS together with a 6-point calibration curve spanning the concentration range 
of 0.2-2000 µg/l. The between-assay coefficient of variation (CV) was normally less than 
10%. Only chemicals that were detected in more than 70% of the samples were reported 
in this paper. The concentrations were lipid adjusted. Total PCBs was calculated as the 
sum of the eighteen PCB congeners that were detectable in more than 70% samples: 
PCB66, PCB74, PCB99, PCB105, PCB118, PCB138_158, PCB146, PCB153, PCB156, 
PCB170, PCB177, PCB178, PCB180, PCB183, PCB187, PCB194, PCB196_203 and 
PCB199. The samples with concentrations lower than the limits of detection (LOD) were 
imputed to the median of the method LOD of each measurement divided by a square root 
of 2. 
 
For 175 milk samples collected in the first 18 months of the study, long chain 
polyunsaturated fatty acids were measured. The FAs extraction and assessment were 
performed by the Collaborative Studies Clinical Laboratory at the University of 
Minnesota Medical Center, Fairview (Minneapolis, MN). FAs were extracted from 0.5 ml 
of breast milk mixed with 0.5 ml of 0.9% saline. 0.1 mg of 17:0 standard 
(diheptadecanoyl phosphatidylcholine) was added to monitor efficacy of extraction. Milk 
total lipids were determined gravimetrically after extraction with a mixture of 
chloroform:methanol (2:1, v/v) 139. FA methyl esters from milk lipid extracts were 
prepared with 1.5 ml of 14% boron trifluoride in methanol at 80 ºC for 90 minutes, and 
then extracted with petroleum ether 140.The final product was dissolved in heptane and 
injected onto a capillary Varian CP7420 100m column. The extraction process was 
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conducted by a Hewlett Packard 5890 gas chromatograph equipped with a HP6890A 
autosampler as previously described 131. Programmed temperature started with 190 ºC for 
25 minutes and then 2ºC/min increments up to 240 ºC, and finally was held at 240 ºC for 
5 minutes.  Adequate separation of fatty acid methylesters was obtained over 50 minutes. 
Relative concentration of each FA was expressed as percent of total fat. Five ω-3 FAs and 
four ω-6 FAs in breast milk were identified: 18:3n-3 (alpha-linolenic acid, ALA), 20:3n-3, 
20:5n-3 (EPA), 22:5n-3 (docosapentaneoic acid), 22:6n-3 (DHA), 18:2n-6 (linolenic acid, 
LA), 18:3n-6 (gamma-LA), 20:2n-6, 20:3n-6 (dihomo-gamma-LA), and 20:4n-6 (AA). 
The ratio of ω-6 FAs to ω-3 FAs was calculated by the concentration of total ω-6 FAs 
divided by the concentration of total ω-3 FAs. 
 
Statistical Analysis 
 
Initial analyses describing the concentrations of OCs and FAs in breast milk were 
done via univariate analyses. The number of missing values and minimum, maximum, 
quartiles, and skewness of the concentration distributions were examined. Pearson 
correlation coefficients were used to estimate the linear correlations among OCs, among 
FAs and between OCs and FAs. 
 
Multivariable linear regression models were used to examine which characteristics 
of the mother were associated with the chemical concentrations in breast milk at 3 
months postpartum. The OC concentrations were right skewed and so were log 
transformed before analysis. The factors of interest included maternal age at the start of 
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pregnancy (years), parity (0 vs. ≥1), maternal race (nonwhite vs. white), maternal 
education (≤12 years, 13-15 years vs. ≥16 years), pre-pregnancy body mass index (BMI) 
(kg/m2), weight gain during pregnancy (kg), % body fat at 3 months postpartum, maternal 
smoking in the first three months postpartum (yes vs. no), income as a percentage of the 
poverty level during pregnancy (100%), and maternal postpartum diet in the first 3 
months estimated by daily grams of animal protein and the proportion of daily fish grams 
to animal protein grams. If maternal postpartum diet data were missing but maternal diet 
at pregnancy was available, then single imputation was used based on the equations 
constructed from the women who had diet information available at both durations.  
 
For the multivariable linear regression models of FAs, the factors of interest 
additionally included the natural log of OCs which were linearly correlated in order to 
examine the associations between OCs and FAs. 
 
Observations with missing values for OC concentrations and maternal 
characteristics were dropped from the models (5 missing poverty level during pregnancy, 
13 missing maternal diet, 1 missing PCBs, 1 missing p,p’-DDT, 29 missing HCB and 2 
missing oxychlordane). The statistical analyses were conducted by PC-SAS (version 9.1). 
 
A.3 Results 
 
A total of 585 infants without major birth defects were eligible to participate in the 
PIN Babies Study, and among them 496 infants participated at 3 months postpartum. 
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Three hundred and thirty-one women in the PIN Babies Study were still breast-feeding at 
the time of the three month postpartum visit and 306 (92%) were willing to provide a 
breast milk sample. There were only 2 of 306 milk samples unusable. 
 
The characteristics of the 304 participant women included in this study are listed in 
Table 10. They were mainly white, aged 25 years or older and had more than 12 years of 
education. More than half of the women had a normal pre-pregnancy BMI (19.8-26.0 
kg/m2). Most of the women (95%) did not smoke postpartum. One hundred and 
seventy-five out of 304 women had data on both OCs and FAs. The characteristics of this 
sub-group were not different from the larger study population. 
 
Table 11 presents lipid-adjusted concentrations of the OCs that were detected in 
more than 70% of breast milk samples. The dominant congener of PCBs was PCB153, 
followed by PCB138_158 and PCB180. The range of PCB153 concentration was from 
2.20 to 199.00 ng/g lipid with a median of 16.55 ng/g lipid, and for total PCBs the range 
was from 9.15 to 708.10 ng/g lipid with a median of 77.30 ng/g lipid. The correlation 
between PCB153 and total PCBs was high (r=0.98). P,p’-DDE was detected in all the 304 
samples and its concentration was much higher than p,p’-DDT. The range of p,p’-DDE 
was from 1.40 to 2140.00 ng/g lipid with a median of 120.50 ng/g lipid. The 
concentration of mirex compared to other organochlorine pesticides was much lower. 
Total PCBs in breast milk was positively correlated with other OCs except for β-HCH 
(table 12). P,p’-DDE were positively correlated with HCB and β-HCH but not other 
organochlorine pesticides. Generally the magnitude of the correlations was low to 
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moderate (Pearson correlation coefficient (r)<0.6), except that the chlordane-related 
compounds, oxychlordane and trans-nonachlor, were highly correlated (r=0.88, p<0.001). 
 
The 175 breast milk samples contained an average of 0.08% (standard deviation 
(SD)=0.05%) EPA, 0.20% (SD=0.14%) DHA and 0.50% (SD=0.10%) AA (table 13). The 
range of the ratio of ω-6 FAs to ω-3 FAs was from 5.6 to 22.8 with a median of 10.40. 
EPA and DHA were highly correlated (r=0.71, p<0.001), but AA was correlated with 
neither EPA (r=0.14, p>0.05) nor with DHA (r=0.10, p>0.05). Only weak correlations 
were found between OCs and ω-3 and ω-6 FAs in breast milk: between the natural log of 
total PCBs and DHA (r=0.15), between the natural log of PCBs and AA (r=0.20), and 
between the natural log of mirex and AA (r=0.28) (table 14). 
 
In the multivariable linear regression models for the natural log of OCs 
concentrations, we found primiparous women had higher OCs concentrations than 
multiparous women with a difference in natural log of concentrations from 0.22 for mirex 
to 0.61 for trans-Nonachlor (table 15). Because a monotonic association between 
maternal age and the natural log of OCs concentrations was observed, maternal age was 
treated as a continuous variable in the multivariate linear regression models. In our study, 
the natural log of OCs in breast milk increased 0.11 to 0.56 per 5-year increase in 
maternal age except for HCB. Non-white women compared to white women had higher 
concentrations of p,p’-DDT, p,p’-DDE and β-HCH, but had lower concentrations of 
trans-Nonachlor in breast milk. Women with education less than or equal to 12 years 
compared to women with education equal to or more than 16 years had higher 
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concentrations of p,p’-DDE, HCB, β-HCH and trans-nonachlor. Concentrations of PCBs, 
p,p’-DDE, HCB and β-HCH slightly increased with each 100% of poverty level increase. 
Pre-pregnancy BMI, weight gain during pregnancy, % body fat at 3 months postpartum 
and postpartum smoking were not associated with the concentrations of any OCs in 
breast milk, although Mirex concentration slightly decreased when % body fat at 3 
months postpartum increased. Maternal diet in the first 3 months postpartum was not 
associated with OCs concentrations in breast milk, except that β-HCH slightly increased 
as an increase in the proportion of daily fish intake to total daily animal protein intake 
(β=0.02, p=0.01), and the association between p,p’-DDT and proportion of fish intake 
was borderline (β=0.01, p=0.06). 
 
In the multivariable linear regression models for FAs concentrations, we found most 
of the factors of interest were not associated with FAs concentrations in breast milk, but 
an increase in proportion of daily fish intake was associated with EPA, DHA, total ω-3 
FAs and AA (table 16). Weight gain during pregnancy was positively associated with the 
concentration of AA in breast milk, but magnitude of the change was small. Women who 
smoked postpartum had higher DHA concentrations than non-smokers, but the 
confidence interval of the estimate was wide. The positive associations between total 
PCBs and DHA, PCBs and AA, and mirex and AA were still observed after controlling 
for other factors in the multivariate models, but the association between PCBs and DHA 
and between PCBs and AA did not achieve statistical significance. 
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A.4 Discussion 
 
This paper presents the contemporary concentrations of OCs and ω-3 and ω-6 FAs in 
breast milk at 3 months postpartum, which indicates the potential for infant exposure to 
these chemicals and fatty acids. ΣPCBs concentration in our study were relatively low 
when compared to PCBs concentrations published in the previous studies which 
examined the hazardous effects on children’s development 65,71,77,79,91,100. Longnecker et 
al compared PCB153 concentrations from different studies standardized to the same base. 
Across the studies, the range of PCB153 median concentrations were from 30 to 450 ng/g 
lipid in maternal serum 141. The median ratio of PCBs concentration in breast milk at 
birth to concentration in serum at pregnancy was suggested to be 1.34 in the Longnecker 
et al paper 141. The ratio of median concentration in milk at birth to concentration in milk 
at 3 months postpartum was 1.21 suggested from the findings of Rogan et al paper 100. 
According to these two values, the medium PCB153 concentration of our study 
population would approximate to 15 ng/g serum lipid (16.55 x 1.21 / 1.34 ~ 15), which is 
much lower than the lowest concentration (Massachusetts study 142, 1993-1998, 
median=30 ng/g lipid in serum) in the Longnecker paper 141. 
 
DDT and DDE concentrations were also lower in this study compared to others. The 
average concentration of p,p’-DDT in our study (mean= 6.25, SD= 7.60 ng/g lipid) was 
lower than the extrapolated DDT concentration obtained from the regression line 
suggested by Smith et al (DDT2005=exp(8.497 - 0.179 (2005-1975) = 22.81 ng/g in milk 
fat) 143. The p,p’-DDE concentration in a previous North Carolina study in 1978-1982 
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(median concentration in milk at 3 months=2.07 ppm, i.e. 2070 ng/g) was more than one 
order of magnitude of that observed in our study 100. 
 
The correlations among OCs observed in our study were low to moderate, and 
different from those of the Quebec Inuit population, where the correlations among OCs in 
breast milk were medium to high (r=0.45-0.95) 138. This difference may be due to 
different diet habits of the Inuit population who consumed mainly marine food and had 
higher chances of being exposed to OCs. In contrast, maternal fish consumption and daily 
animal protein intake in the first 3 months postpartum were generally not associated with 
the OCs concentrations in breast milk at 3 months postpartum in our study, which 
indicates that the OCs in this population were possibly accumulated throughout the 
lifetime rather than through short-term food consumption. 
 
Our study supports previous reports that maternal age and parity predict OCs 
concentrations in breast milk 7,144. The persistent and lipophilic nature of OCs contributes 
to the body’s accumulation with age and elimination by pregnancy and lactation. Since 
88% of 304 women in our study were exclusively or mostly breast-feeding in the first 3 
months, this study had little variability in duration of lactation thus we were unable to 
examine its association with OCs concentrations in breast milk. Racial differences of the 
concentrations was observed for p,p’-DDT, p,p’-DDE, β-HCH and trans-Nonachlor, 
although only 14% of our study was non-white women. Three factors – pre-pregnancy 
BMI, weight gain during pregnancy and % body fat at 3 months, which indicated the 
body weight status during pregnancy and after pregnancy, generally failed to predict OCs 
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concentration in breast milk at the third month postpartum. This finding was similar to 
other studies that found little or no correlation between organochlorine pesticides and 
BMI or body weight changes 7,144. Although relatively low maternal education was 
related to high concentrations of p,p’-DDE, HCB and β-HCH in this population, the 
concentrations of these chemicals were slightly decreased when the household was 
relatively poor during pregnancy. The paradoxical contradiction between these two 
variables, which were both used to be a proxy of socioeconomic status of the women, 
may be because these two variables represent socioeconomic status at two different time 
(long-term vs. at pregnancy) or because of the instable findings from the small sample 
size of education levels ≤ 12 years (n=17, 6%). 
 
AA, and EPA and DHA can be formed in the human body from desaturation and 
elongation of LA and ALA, respectively; they also can be obtained from dietary intake of 
animal tissues 145, which was supported by our findings that an increase in the proportion 
of daily fish intake to total animal protein intake was associated with AA, EPA and DHA 
measured in breast milk. Worldwide mean±SD concentration of DHA in breast milk was 
0.32±0.22% with range from 0.06% to 1.4%, and for AA, mean±SD concentration was 
0.47±0.13% with range from 0.24% to 1.0% 146. The breast milk of our study population, 
compared to worldwide average, contained similar amounts of AA (0.50±0.10%) but 
smaller amounts of DHA (0.20±0.14%). In the worldwide meta-analysis study, they also 
found positive but small correlation between DHA and AA in breast milk (r=0.25), which 
was not supported by our study. 
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Overall, no strong linear correlation was observed between the natural log of 
concentrations of OCs and concentrations of ω-3 and ω-6 FAs in breast milk. Without 
natural log transformation of OCs, PCBs and mirex were still positively but weakly 
correlated with AA (r=0.15, p<0.05 and r=0.25, p<0.001, respectively). After adjustments 
for other factors, a two-fold increase in concentrations of mirex increased AA levels by 
0.002 (% of total fat), and the positive association between PCBs and AA disappeared. 
Our results differed from the Faroe Island cohort study, which found a negative 
association between maternal serum PCBs concentration and umbilical cord serum AA 
concentration 137. The differences in the observed relationships between OCs and FAs 
between the studies may reflect different diet habits and variation in the specimen type. In 
vivo and in vitro studies have shown that PCBs can induce the release of AA 147-150. This 
may suggest a potential biomechanism responsible for the positive correlation between 
PCBs and AA. However, the biomechanism for the slight positive association between 
mirex and AA was not clear. It was also not clear whether OCs would influence the 
elongation and desaturation of FAs. 
 
This paper provides concentrations of OCs and FAs in breast milk of lactating 
women in Central North Carolina from 2004 to 2006, and supports the decline in the 
concentrations of OCs in the US population 5 and as seen in the Canadian population 
151,152. Since maternal age, maternal education level and maternal race were found to 
explain some variation in the concentrations of OCs in breast milk, the direct comparison 
of our study results to others should take into account that the population of this study 
was largely white lactating women greater than 25 years of age and with more than 12 
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years of education. Although infant lactational exposure to OCs has decreased, it remains 
unclear whether infant development is unaffected by these low background levels. The 
amounts of fatty acids in breast milk may influence the health and development of infants 
153-156. Having information on both OCs and FAs in the same population allows us to 
examine the correlations between environmental pollutants and nutrients in breast milk. 
Many studies only have information on one type of chemicals, beneficial or harmful, in 
breast milk. Our results helped to fill in this gap of knowledge and also provided 
additional information for the risk and benefit assessment of breast-feeding. 
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Table 10. Characteristics of participant women. * 
 Milk Samples 
(n=304) 
OCs+FAs † 
(n=175) 
Characteristics No. % No. % 
Race     
White 262 86.2 152 86.9 
Black 18 5.9 12 6.9 
Other 24 7.9 11 6.3 
     
Age (years)     
<25 32 10.5 18 10.3 
25-29 88 29.0 51 29.1 
30-34 130 42.8 76 43.4 
≥35 54 17.8 30 17.1 
Mean±SD 30.7±4.9 30.7±4.8 
     
Education (years)     
≤12 17 5.6 10 5.7 
13-15 37 12.2 20 11.4 
≥16 250 82.2 145 82.9 
     
Parity     
0 160 52.6 95 54.3 
≥1 144 47.4 80 45.7 
     
Pre-pregnancy BMI 
(kg/m2) 
    
<19.8 52 17.1 30 17.1 
19.8-26.0 189 62.2 111 63.4 
26.0-29.0 27 8.9 12 6.9 
>29.0 36 11.8 22 12.6 
     
Smoking postpartum     
Yes 14 4.6 9 5.1 
No 290 95.4 166 94.9 
     
Percent of 2001 poverty 
level during pregnancy 
    
Mean±SD 490±199 499±194 
Missing 5  2  
* Abbreviation: OCs, organochlorine compounds; FAs, fatty acids; BMI, body mass index (kg/m2); 
SD, standard deviation. 
† OCs+FAs represents the sub-group that has both OCs and FAs concentrations available. 
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Table 11. Lipid-adjusted chemical concentrations (ng/g lipid) in maternal breast 
milk at 3 months postpartum (n=304). 
Chemicals D (%) * Minimum 25th Median 75th Maximum
PCB66 264 (86.8) <LOD 0.55 1.00 1.40 7.00 
PCB74 301 (99.0) <LOD 3.35 5.00 6.90 24.70 
PCB99 301 (99.0) <LOD 2.60 4.00 5.80 33.30 
PCB105 280 (92.1) <LOD 0.90 1.40 2.00 11.70 
PCB118 303 (99.7) <LOD 4.10 5.95 9.35 52.60 
PCB138_158 303 (99.7) <LOD 9.70 15.15 24.10 144.00 
PCB146 293 (96.4) <LOD 1.10 1.90 3.10 11.90 
PCB153 304 (100.0) 2.20 10.50 16.55 26.60 199.00 
PCB156 274 (90.1) <LOD 1.20 2.15 3.65 19.70 
PCB170 300 (98.7) <LOD 2.40 3.5 5.95 54.50 
PCB177 215 (70.7) <LOD <LOD 0.60 1.00 8.90 
PCB178 218 (71.7) <LOD <LOD 0.60 1.20 10.40 
PCB180 303 (99.7) <LOD 5.15 8.20 13.75 128.00 
PCB183 253 (83.2) <LOD 0.60 1.10 1.60 16.20 
PCB187 289 (95.1) <LOD 1.70 2.90 4.70 55.30 
PCB194 257 (84.5) <LOD 0.70 1.20 2.10 10.40 
PCB196_203 265 (87.2) <LOD 0.80 1.40 2.10 15.90 
PCB199 260 (85.5) <LOD 0.65 1.30 2.00 9.50 
ΣPCBs † --  9.15 48.51 77.30 119.00 708.10 
p,p’-DDT 292 (96.1) <LOD 3.20 4.70 6.90 80.40 
p,p’-DDE 304 (100.0) 1.40 85.85 120.50 187.00 2140.00 
HCB 265 (87.2) <LOD 7.50 10.50 13.50 106.00 
β-HCH 290 (95.4) <LOD 3.00 4.60 6.90 1580.00 
Oxychlordane 293 (96.4) <LOD 10.10 14.35 22.70 59.00 
trans-Nonachlor 299 (98.4) <LOD 12.40 19.45 31.00 91.10 
Mirex 238 (78.3) <LOD 0.30 0.70 1.30 17.60 
* D (%), number and percent of samples with detectable concentrations. 
† ΣPCBs is the sum of the PCB congeners which are detectable in more than 70% samples, in 
which <LOD is treated as median(LOD) divided by a square root of 2. 
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Table 15. β coefficients and 95% confidence intervals of the factors of interest in 
multivariable linear regression models for the natural log of PCBs and 
organochlorine pesticides. * 
OCs Parameter β LCL UCL p-value
ΣPCBs Maternal age (per 5 years) 0.2639 0.1928 0.3351 <.0001
 Nulliparous (ref. multiparous) 0.3809 0.2509 0.5108 <.0001
 None-white (ref. white) -0.0586 -0.2437 0.1265 0.54
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.0583 -0.2463 0.3629 0.71
 13-15 years -0.0461 -0.2626 0.1704 0.68
 Pre-pregnancy BMI (kg/m2) -0.0018 -0.0205 0.0169 0.85
 Weight gain during pregnancy (kg) -0.0039 -0.0156 0.0078 0.51
 % body fat at 3 months -0.0060 -0.0166 0.0047 0.27
 Postpartum smoking (ref. non-smoking) 0.0780 -0.2116 0.3676 0.60
 Poverty level during pregnancy (per 100%) 
0.0524 0.0137 0.0911 0.01
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0013 -0.0049 0.0075 0.68
 Total animal protein daily intake (g) 0.0003 -0.0002 0.0008 0.26
    
p,p’-DDT Maternal age (per 5 years) 0.1519 0.0415 0.2623 0.01 
 Nulliparous (ref. multiparous) 0.4060 0.2047 0.6072 <.0001
 None-white (ref. white) 0.4525 0.1654 0.7397 0.002 
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.1022 -0.3709 0.5753 0.67 
 13-15 years 0.0242 -0.3121 0.3604 0.89 
 Pre-pregnancy BMI (kg/m2) 0.0196 -0.0094 0.0487 0.19 
 Weight gain during pregnancy (kg) -0.0121 -0.0302 0.0061 0.19 
 % body fat at 3 months -0.0040 -0.0206 0.0126 0.64 
 Postpartum smoking (ref. non-smoking) -0.3008 -0.7500 0.1485 0.19 
 Poverty level during pregnancy (per 100%) 
0.0243 -0.0362 0.0848 0.43 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0094 -0.0002 0.0190 0.06 
 Total animal protein daily intake (g) 0.0005 -0.0003 0.0013 0.21 
    
p,p’-DDE Maternal age (per 5 years) 0.1141 0.0293 0.1990 0.01 
 Nulliparous (ref. multiparous) 0.3008 0.1460 0.4556 0.0001 
 None-white (ref. white) 0.5700 0.3492 0.7908 <.0001
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.4675 0.1041 0.8309 0.01 
 13-15 years -0.0076 -0.2658 0.2506 0.95 
 Pre-pregnancy BMI (kg/m2) -0.0059 -0.0283 0.0164 0.60 
 Weight gain during pregnancy (kg) -0.0105 -0.0244 0.0034 0.14 
 % body fat at 3 months -0.0025 -0.0153 0.0102 0.70 
 Postpartum smoking (ref. non-smoking) -0.0820 -0.4276 0.2636 0.64 
 Poverty level during pregnancy (per 100%) 
0.0615 0.0153 0.1076 0.01 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0024 -0.0050 0.0098 0.52 
 Total animal protein daily intake (g) -0.0001 -0.0008 0.0005 0.69 
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HCB Maternal age (per 5 years) 0.0104 -0.0691 0.0899 0.80 
 Nulliparous (ref. multiparous) 0.3308 0.1830 0.4786 <.0001
 None-white (ref. white) -0.1790 -0.3879 0.0299 0.09 
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.3582 -0.0062 0.7227 0.05 
 13-15 years 0.0580 -0.1917 0.3076 0.65 
 Pre-pregnancy BMI (kg/m2) 0.0106 -0.0101 0.0313 0.32 
 Weight gain during pregnancy (kg) 0.0015 -0.0116 0.0147 0.82 
 % body fat at 3 months -0.0003 -0.0121 0.0116 0.96 
 Postpartum smoking (ref. non-smoking) -0.2069 -0.5373 0.1235 0.22 
 Poverty level during pregnancy (per 100%) 
0.0517 0.0069 0.0965 0.02 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0032 -0.0039 0.0102 0.38 
 Total animal protein daily intake (g) 0.0005 -0.0001 0.0011 0.12 
    
β-HCH Maternal age (per 5 years) 0.1518 0.0130 0.2906 0.03 
 Nulliparous (ref. multiparous) 0.5720 0.3187 0.8253 <.0001
 None-white (ref. white) 0.7992 0.4379 1.1606 <.0001
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.5838 -0.0109 1.1785 0.05 
 13-15 years 0.0764 -0.3462 0.4990 0.72 
 Pre-pregnancy BMI (kg/m2) -0.0096 -0.0461 0.0269 0.61 
 Weight gain during pregnancy (kg) -0.0105 -0.0333 0.0122 0.36 
 % body fat at 3 months -0.0009 -0.0217 0.0199 0.93 
 Postpartum smoking (ref. non-smoking) -0.2181 -0.7836 0.3474 0.45 
 Poverty level during pregnancy (per 100%) 
0.1351 0.0595 0.2107 0.001 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0153 0.0032 0.0275 0.01 
 Total animal protein daily intake (g) 0.0009 -0.0001 0.0019 0.09 
    
Oxychlordane Maternal age (per 5 years) 0.1478 0.0182 0.2775 0.03 
 Nulliparous (ref. multiparous) 0.5111 0.2743 0.7479 <.0001
 None-white (ref. white) -0.1418 -0.4795 0.1959 0.41 
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.0908 -0.4750 0.6565 0.75 
 13-15 years -0.0235 -0.4176 0.3706 0.91 
 Pre-pregnancy BMI (kg/m2) 0.0009 -0.0332 0.0350 0.96 
 Weight gain during pregnancy (kg) -0.0027 -0.0240 0.0185 0.80 
 % body fat at 3 months 0.0001 -0.0193 0.0196 0.99 
 Postpartum smoking (ref. non-smoking) 0.3130 -0.2146 0.8406 0.25 
 Poverty level during pregnancy (per 100%) 
0.0411 -0.0295 0.1117 0.25 
 Proportion of fish daily intake to total animal protein daily intake (%) 
-0.0004 -0.0117 0.0110 0.95 
 Total animal protein daily intake (g) 0.0001 -0.0009 0.0011 0.83 
    
trans-Nonachlor Maternal age (per 5 years) 0.2186 0.0982 0.3390 0.0004 
 Nulliparous (ref. multiparous) 0.6083 0.3887 0.8280 <.0001
 None-white (ref. white) -0.3418 -0.6551 -0.0284 0.03 
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 Maternal education (ref. ≥16 years)   
 ≤12 years 0.6495 0.1338 1.1651 0.01 
 13-15 years 0.1701 -0.1964 0.5365 0.36 
 Pre-pregnancy BMI (kg/m2) -0.0276 -0.0593 0.0041 0.09 
 Weight gain during pregnancy (kg) -0.0098 -0.0295 0.0100 0.33 
 % body fat at 3 months 0.0063 -0.0118 0.0244 0.49 
 Postpartum smoking (ref. non-smoking) 0.3399 -0.1505 0.8303 0.17 
 Poverty level during pregnancy (per 100%) 
0.0130 -0.0526 0.0785 0.70 
 Proportion of fish daily intake to total animal protein daily intake (%) 
-0.0036 -0.0141 0.0069 0.50 
 Total animal protein daily intake (g) 0.0006 -0.0003 0.0015 0.19 
    
Mirex Maternal age (per 5 years) 0.5639 0.4573 0.6705 <.0001
 Nulliparous (ref. multiparous) 0.2215 0.0270 0.4160 0.03 
 None-white (ref. white) 0.0534 -0.2240 0.3308 0.71 
 Maternal education (ref. ≥16 years)   
 ≤12 years 0.2396 -0.2169 0.6961 0.30 
 13-15 years 0.0229 -0.3015 0.3473 0.89 
 Pre-pregnancy BMI (kg/m2) -0.0058 -0.0339 0.0222 0.68 
 Weight gain during pregnancy (kg) -0.0079 -0.0253 0.0096 0.38 
 % body fat at 3 months -0.0186 -0.0346 -0.0026 0.02 
 Postpartum smoking (ref. non-smoking) 0.1714 -0.2628 0.6055 0.44 
 Poverty level during pregnancy (per 100%) 
-0.0307 -0.0887 0.0274 0.30 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0009 -0.0084 0.0102 0.85 
 Total animal protein daily intake (g) 0.0003 -0.0004 0.0011 0.40 
* Abbreviation: LCL, lower confidence limit; UCL, upper confidence limit; ref., reference group; BMI, 
body mass index. 
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Table 16. β coefficients and 95% confidence intervals of the factors of interest in 
multivariable linear regression models for ω-3 and ω-6 fatty acids. * 
FAs Parameter β LCL UCL p-value
EPA Maternal age (per 5 years) -0.0054 -0.0147 0.0039 0.26 
 Nulliparous (ref. multiparous) 0.0033 -0.0130 0.0196 0.69 
 None-white (ref. white) -0.0268 -0.0527 -0.0009 0.04 
 Maternal education (ref. ≥16 years)  
 ≤12 years -0.0305 -0.0711 0.0101 0.14 
 13-15 years -0.0078 -0.0347 0.0190 0.57 
 Pre-pregnancy BMI (kg/m2) 0.0011 -0.0012 0.0033 0.35 
 Weight gain during pregnancy (kg) -0.0007 -0.0021 0.0008 0.39 
 % body fat at 3 months -0.0004 -0.0016 0.0008 0.51 
 Postpartum smoking (ref. non-smoking) -0.0005 -0.0347 0.0338 0.98 
 Poverty level during pregnancy (per 100%) 
-0.0002 -0.0053 0.0048 0.93 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0009 0.0001 0.0017 0.02 
 Total animal protein daily intake (g) 0.0000 -0.0001 0.0000 0.34 
   
DHA Maternal age (per 5 years) -0.0105 -0.0380 0.0170 0.45 
 Nulliparous (ref. multiparous) 0.0008 -0.0439 0.0456 0.97 
 None-white (ref. white) -0.0286 -0.0964 0.0392 0.41 
 Maternal education (ref. ≥16 years)  
 ≤12 years -0.0598 -0.1665 0.0469 0.27 
 13-15 years -0.0221 -0.0923 0.0482 0.54 
 Pre-pregnancy BMI (kg/m2) -0.0012 -0.0070 0.0047 0.70 
 Weight gain during pregnancy (kg) 0.0003 -0.0036 0.0042 0.88 
 % body fat at 3 months -0.0012 -0.0043 0.0019 0.44 
 Postpartum smoking (ref. non-smoking) 0.0974 0.0080 0.1868 0.03 
 Poverty level during pregnancy (per 100%) 
-0.0001 -0.0135 0.0133 0.99 
 ln(ΣPCBs) 0.0283 -0.0124 0.0691 0.17 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0048 0.0028 0.0069 <.0001
 Total animal protein daily intake (g) 0.0000 -0.0001 0.0002 0.63 
   
Total ω-3 Maternal age (per 5 years) -0.0292 -0.1197 0.0614 0.53 
 Nulliparous (ref. multiparous) -0.0632 -0.2218 0.0954 0.43 
 None-white (ref. white) -0.0769 -0.3286 0.1748 0.55 
 Maternal education (ref. ≥16 years)  
 ≤12 years 0.0460 -0.3484 0.4403 0.82 
 13-15 years 0.0193 -0.2414 0.2800 0.88 
 Pre-pregnancy BMI (kg/m2) -0.0029 -0.0245 0.0188 0.80 
 Weight gain during pregnancy (kg) -0.0096 -0.0240 0.0048 0.19 
 % body fat at 3 months -0.0059 -0.0174 0.0055 0.31 
 Postpartum smoking (ref. non-smoking) -0.1780 -0.5108 0.1548 0.29 
 Poverty level during pregnancy (per 100%) 
0.0342 -0.0149 0.0833 0.17 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0141 0.0065 0.0217 0.0003 
 Total animal protein daily intake (g) -0.0003 -0.0011 0.0004 0.36 
   
AA Maternal age (per 5 years) -0.0098 -0.0313 0.0117 0.37 
 Nulliparous (ref. multiparous) 0.0064 -0.0262 0.0390 0.70 
 None-white (ref. white) 0.0046 -0.0448 0.0541 0.85 
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 Maternal education (ref. ≥16 years)  
 ≤12 years 0.0295 -0.0483 0.1073 0.46 
 13-15 years 0.0015 -0.0497 0.0527 0.95 
 Pre-pregnancy BMI (kg/m2) 0.0006 -0.0037 0.0048 0.80 
 Weight gain during pregnancy (kg) 0.0036 0.0008 0.0065 0.01 
 % body fat at 3 months -0.0011 -0.0034 0.0012 0.34 
 Postpartum smoking (ref. non-smoking) 0.0158 -0.0496 0.0812 0.64 
 Poverty level during pregnancy (per 100%) 
0.0003 -0.0096 0.0102 0.95 
 ln(ΣPCBs) 0.0230 -0.0086 0.0546 0.15 
 ln(Mirex) 0.0329 0.0116 0.0543 0.003 
 Proportion of fish daily intake to total animal protein daily intake (%) 
-0.0017 -0.0032 -0.0003 0.02 
 Total animal protein daily intake (g) 0.0000 -0.0001 0.0002 0.60 
   
Total ω-6 Maternal age (per 5 years) -0.0702 -0.6823 0.5418 0.82 
 Nulliparous (ref. multiparous) -0.7354 -1.8077 0.3369 0.18 
 None-white (ref. white) 0.8316 -0.8700 2.5331 0.34 
 Maternal education (ref. ≥16 years)  
 ≤12 years 1.4799 -1.1862 4.1459 0.28 
 13-15 years 1.0490 -0.7135 2.8116 0.24 
 Pre-pregnancy BMI (kg/m2) 0.0110 -0.1352 0.1572 0.88 
 Weight gain during pregnancy (kg) -0.0039 -0.1012 0.0933 0.94 
 % body fat at 3 months -0.0381 -0.1155 0.0393 0.33 
 Postpartum smoking (ref. non-smoking) -1.7835 -4.0333 0.4662 0.12 
 Poverty level during pregnancy (per 100%) 
0.0787 -0.2534 0.4107 0.64 
 Proportion of fish daily intake to total animal protein daily intake (%) 
0.0304 -0.0210 0.0817 0.25 
 Total animal protein daily intake (g) -0.0014 -0.0063 0.0034 0.56 
* Abbreviation: LCL, lower confidence limit; UCL, upper confidence limit; ref., reference group; BMI, 
body mass index. 
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B. Manuscript 2: Lactational Exposure to Polychlorinated Biphenyls, 
Dichlorodiphenyltrichloroethane, and Dichlorodiphenyldichloroethylene and 
Infant Neurodevelopment: An Analysis of the Pregnancy, Infections, and 
Nutrition Babies Study 
 
B.1 Introduction 
 
Polychlorinated biphenyls (PCBs) are mixtures of synthetic organic compounds that 
were widely used as insulators, coolants and lubricants in electrical transformers, 
capacitors and hydraulic equipment, and as plasticizers in plastic and rubber products. 
Production of PCBs for industrial and commercial applications in the United States 
started in 1929 157. Dichlorodiphenyltrichloroethane (DDT) was produced in the United 
States beginning in 1940. DDT was the first organochlorine pesticide in widespread use, 
and was used extensively as an insecticide in agriculture and mosquito control during the 
1950s and 1960s 158. The active ingredient in the commercial DDT sold as an insecticide 
was p,p’-DDT, accounting for 65-80% 4,159. Dichlorodiphenyldichloroethylene (DDE) is 
the most stable metabolite of DDT 160. 
 
PCBs and DDT are both halogenated compounds that were banned in the United 
States in 1977 and 1972, respectively, because they persist in the environment and 
bioaccumulate, adversely affecting the ecosystem and possibly human health 158. 
Although production and use of these two organic pollutants have been banned for 
decades, they can still be detected in the environment and in the blood and breast milk of 
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the US population 5-7. The main exposure route for humans is their diet, most commonly 
by eating contaminated meat, fish, and shellfish. For infants, the main exposure route is 
breast feeding. 
 
Infancy is a highly vulnerable period of exposure to these persistent environmental 
pollutants. Postnatally, synaptogenesis occurs rapidly over the first two years 161. Gilmore 
et al found that the neonate’s cortical gray matter of regions for visual and motor function 
grows rapidly in the first month, and total brain size increases 100% in the first year 162. 
Extremely rapid growth in specific areas may increase the vulnerability of the postnatal 
brain to environmental pollutants during the first year of life. Since brain maturation is 
not simultaneous in all areas, chemical exposures at different times may cause adverse 
effects on different developmental domains 21,22. 
 
Epidemiological studies have investigated the associations between exposure to 
PCBs, DDT and DDE and infant neurodevelopment for decades, but the findings have 
been conflicting and remain inconclusive. Most of the previous studies were conducted 
during the 1980s and 1990s and focused on infant prenatal exposure to PCBs and DDE 
through placental transfer from the mother. Little is known about the effects of infants’ 
lactational exposure to the low background levels of persistent organic pollutants in this 
century. Assessing these effects is also complicated by the co-existing beneficial 
attributes of breastfeeding, both social and nutritional. Long-chain polyunsaturated fatty 
acids are essential to fetal and neonatal brain development 8-10, yet the richest dietary 
sources of them for mothers, such as fish, may also be sources for the contaminant 
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chemicals. The potential for any harmful effects from persistent organic pollutants in 
breast milk to be modified by long-chain polyunsaturated fatty acids warrants 
consideration. Thus, this study was designed to examine associations between the 
exposure to environmental levels of PCBs, p,p’-DDT and p,p’-DDE through 
breast-feeding and infant neurodevelopment at 12 months of age in central North 
Carolina in 2004-2006. 
 
B.2 Methods 
 
Study Population 
 
Subjects were participants of the Pregnancy, Infection and Nutrition (PIN) Babies 
Study. The study follows children born to women who participated in the PIN3 and PIN 
Postpartum Studies 163. The PIN3 Study enrolled pregnant women from 2001 to 2005 
receiving prenatal care at the University of North Carolina Hospitals before 20 weeks 
gestation and the PIN Postpartum Study followed a subset of them through the first year 
postpartum. Mothers completed several self-administered questionnaires and two phone 
interviews during pregnancy and one brief questionnaire after hospital delivery at that 
provided details about their health and lifestyle during pregnancy. After delivery, women 
were invited to continue participation by allowing two in-home interviews at 3 and 12 
months postpartum. Details of these studies are available at the website: 
http://www.cpc.unc.edu/projects/pin/. 
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Beginning in January 2004, participants in the PIN Postpartum Study were invited to 
enroll their infants in the PIN Babies Study. This study added developmental assessment 
of the child at 3 and 12 months of age. All children were singletons, without major birth 
defects. The study protocols of the PIN, PIN Postpartum, and PIN Babies studies have 
been approved by the Institutional Review Board of the University of North Carolina at 
Chapel Hill. 
 
Exposure Measurement 
 
Participant women who were still breast-feeding at the time of the three-month 
postpartum home visit were asked to provide a breast milk sample; 88% of the total 304 
women who provided samples were exclusively or mostly breastfeeding at 3 months. A 
milk collection kit containing three 1.5ml tubes, a plastic pipette and instructions was sent 
before the scheduled visit. At around 10 o'clock in the morning of the scheduled visit day, 
participants were to follow the written instructions to pump both breasts, gently mix the 
milk extracted, and use the plastic pipette to transfer the milk into 3 tubes and store them 
in the freezer until the interviewers arrived. Samples were then transported on ice to the 
-80 ºC storage freezers. Breast milk was collected from women who participated between 
2004 and 2006. 
 
Breast milk samples were analyzed for p,p’-DDT, p,p’-DDE and thirty-five PCB 
congeners according to the existing methods at the Organic Analytic Toxicology Branch 
of the National Center for Environmental Health at the Centers for Disease Control and 
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Prevention 122. The measurement of selected chemicals in breast milk samples was 
performed using gas chromatography/isotope dilution high-resolution mass spectrometry 
(GC/IDHRMS) using a MAT95 instrument (ThermoFinnigan MAT; Bremen, Germany). 
The lipid concentration was gravimetrically determined by an analytical balance AX105 
Delta Range (Mettler Toledo; Columbus, OH) with an accuracy of ±10-4 g. Each analysis 
batch contained sixteen unknowns, two method blanks and two quality control specimens. 
The between-assay coefficient of variation was normally less than 10%. Concentrations 
reported here were all lipid adjusted. PCB153 and p,p’-DDE were detected in all 304 
samples, and p,p’-DDT was detected in 292 samples (96%). Total PCBs was calculated as 
the sum of eighteen detectable PCB congeners in more than 70% samples, that is PCB66, 
PCB74, PCB99, PCB105, PCB118, PCB138_158, PCB146, PCB153, PCB156, PCB170, 
PCB177, PCB178, PCB180, PCB183, PCB187, PCB194, PCB196_203 and PCB199. 
Concentrations lower than the limits of detection (LOD) were imputed to the median of 
the method LOD of each measurement divided by a square root of 2 164. 
 
In addition to the analyses for DDT, DDE and PCBs, long chain polyunsaturated 
fatty acids were measured in the first 175 of the 304 total breast milk samples. The fatty 
acid extraction and assessment was performed by the Collaborative Studies Clinical 
Laboratory at the University of Minnesota Medical Center, Fairview (Minneapolis, MN). 
Relative concentrations of docosahexaenoic acid (DHA) and arachidonic acid (AA) were 
expressed as percent of total fat. 
 
Lactational Exposure Determination 
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We quantified the duration of breast feeding in order to estimate the infant’s 
lactational exposure to PCBs, p,p’-DDT and p,p’-DDE through the first 12 months of life. 
Infant feeding status was reported during the maternal home interview at 3 and 12 months 
postpartum. Women were asked to recall their child’s feeding practices for each month, 
indicating the frequency that they breast fed, fed infant formula, and fed other types of 
food. Exclusively breast-feeding was defined as breast feeding with no other food or 
liquid; mostly breast-feeding was defined as breast feeding and feeding of other 
supplements equal to or less than one time per day; and breast-feeding with supplements 
was defined as breast feeding with feeding any other liquids or solids >1 time per day. 
The number of months representing each type of feeding was summed and used in a 
Lactational Exposure Metric (LEM). 
 
The LEM was developed to represent the infant’s exposure to each chemical in the 
first 12 months as follows: 
LEM = C × (D1+D2) + ½ × C × D3, 
in which C denotes chemical concentration in breast milk at the third month postpartum 
(ng/g lipid), D1 is duration of exclusively breast-feeding (months), D2 is duration of 
mostly breast-feeding (months), and D3 is duration of breast-feeding with other 
supplements (months). The unit of this estimate is concentration-months, i.e. ng/g-months. 
Using this metric, breast milk concentration for each chemical was assumed to be 
constant through the lactation period, and breast milk consumption was assumed to be 
decreased by half during the period when breast milk was supplemented with formula, 
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other liquids or solids. 
 
Developmental Assessment 
 
Infant cognition was measured at twelve months by the Mullen Scales of Early 
Learning: AGS Edition (Mullen, 1995). The Mullen was administered in the home by 
trained study staff members. This standardized assessment instrument was designed to 
evaluate cognitive and motor functioning of children from birth to 68 months of age in 
five domains of development – receptive language, expressive language, visual reception, 
fine motor, and gross motor 165. 
 
Raw scores for each of the five scales are used to derive T scores that take into 
account the infant’s age. Mullen T scores have a mean of 50 and a standard deviation (SD) 
of 10. The T scores of receptive language, expressive language, fine motor and visual 
reception scales are added together to form the Cognitive T Score Sum, which is used to 
derive the Early Learning Composite standardized score (mean=100, SD=15). This 
composite score provides an overall estimate of the infant’s developmental level. 
Standardized scores below one standard deviation below the mean (i.e. <40 for T scores 
on the five individual scales and scores <85 for the Early Learning Composite) are 
categorized as below average for the corresponding scale or overall index. 
 
Infant language comprehension and production were also measured at 12 months via 
parental report, using the Short Form: Level I (for infants) of the MacArthur-Bates 
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Communicative Development Inventories (CDI) (Fenson, Pethic, Renda, Cox, Dale & 
Reznick 2000; see also http://www.sci.sdsu.edu/cdi/cdiwelcome.htm). The Infant Short 
Form (for 8- to 18-month-olds) was used to reduce self-administration time and increase 
the response rate; its scores are highly correlated with the original 396-word full form 
(r=0.97) 128,129. The instrument prompts parents to endorse whether their child 
“understands” or both “understands and says” 89 specific words. The raw score for 
vocabulary comprehension is the sum of the words the child “understands” and 
“understands and says”. The raw score for infant vocabulary production is the number of 
words endorsed as “understands and says”. At the 12-month postpartum home visit, 
mothers were asked to complete the form and return it in a self-addressed stamped 
envelope. Infants’ raw scores for vocabulary comprehension were dichotomized as below 
the 15th percentile (below average), comparable to the cutpoints used for the Mullen, vs. 
scores at or above the 15th percentile (average and above average). Production scores 
were generally low, as would be expected at this age, and did not have sufficient 
variability to warrant analysis. 
 
Statistical Analysis 
 
All the analyses were conducted using PC-SAS (version 9.1). The associations 
between lactational exposure to PCBs, p,p’-DDT and p,p’-DDE and the T scores for each 
of the Mullen scales were estimated using multivariable linear regression models. LEM 
of PCB153, PCBs, p,p’-DDT and p,p’-DDE were natural log transformed and modeled 
separately. Robust regression with Least Trimmed Squares estimation for multiple linear 
  
101
regression models was used to examine the influence by the outliers of chemical 
concentrations on beta coefficients 166. 
 
Multivariable logistic regression models were used to estimate the associations 
between each chemical and the odds of scoring below average on the Mullen scales and 
below the 15th percentile scores for vocabulary comprehension of the CDI. LEM of 
PCB153, PCBs, p,p’-DDT and p,p’-DDE were natural log transformed and modeled 
separately. 
 
To control the positive confounding effects from breast feeding, the residuals from 
the models of breastfeeding and Mullen scores were first calculated using simple linear 
regression, and then were included in the multiple linear regression models as dependent 
variables to estimate the effects of the LEM. Because we were unable to pre-adjust the 
confounding effects from breast feeding for logistic regression models, total months of 
breast feeding was included in the models as a continuous variable. 
 
Other covariates that were associated with both lactational exposure to PCBs, 
p,p’-DDT and p,p’-DDE and infant neurodevelopment, but were not an effect of either 
exposure or outcome, were evaluated as potential confounders. These covariates included 
maternal age at the start of pregnancy (years), parity (0 vs. ≥1), maternal race (nonwhite 
vs. white), maternal education (≤12 years, 13-15 years vs. ≥16 years), income as a 
percentage of the poverty level during pregnancy (100%), and infant gender (male vs. 
female). Mother-child pairs missing values for variables in the model were excluded 
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because only 6% were missing any data and missingness did not appear to be related to 
exposure or outcome status. 
 
The potential for infant gender to modify the measured effects was assessed via 
interaction terms between gender and the natural log of LEM of PCBs, p,p’-DDT and 
p,p’-DDE in the multiple logistic regression models. The potential for the fatty acids in 
breast milk to modify the measured effects was assessed by dichotomizing the relative 
concentrations of DHA and AA as <25th percentile vs. ≥25th percentile and creating 
interaction terms between the natural logs of LEM of PCBs, p,p’-DDT and p,p’-DDE and 
DHA and AA. The interaction terms were added in the multiple logistic regression 
models and assessed by the likelihood ratio test. If interaction was indicated (p<0.1), we 
calculated stratum-specific odds ratios, 95% confidence intervals, and confidence limit 
ratios, i.e. upper confidence limit divided by lower confidence limit. Because of the 
smaller sample size of mother-child pairs with known fatty acids concentrations (n=175), 
the covariates included in the multiple logistic regression models were reduced to major 
factors, which were total months of breast-feeding, maternal age at the start of pregnancy, 
and infant gender. 
 
B.3 Results 
 
Three hundred and four participants provided samples of breast milk at three months 
postpartum (mean±SD = 3.5±0.6 months). Two hundred and sixty-four of the 304 women 
continued their participation at the 12-month postpartum home visit and provided 
  
103
complete infant feeding information. Among these 264 women, 231 consented to allow 
their child to be evaluated by the Mullen and 218 women returned the parent report Short 
Form of the CDI. The study sample included more male than female infants, and most 
participant women were white, aged 25 years or older and had more than 12 years of 
education (Table 1). Most of the women breast fed for 6 months or longer, and were not 
smoking in the 12 months postpartum. 
 
In this study population, female infants had higher scores than male infants on the 
receptive language, expressive language, and fine motor scales of the Mullen and on the 
Early Learning Composite. Infants who were breast fed longer than 9 months compared 
to 9 months or less had higher scores on expressive language, fine motor and the Early 
Learning Composite scales. Non-white infants and infants whose mothers had 12 or 
fewer years of education had higher scores on the gross motor scale. 
 
In the multivariable linear regression models, a two-fold increase in the LEM of 
PCB153, total PCBs, p,p’-DDT and p,p’-DDE did not change any of the Mullen Scale T 
Scores or the Early Learning Composite standardized score by more than 2 points (Table 
2). All confidence intervals included zero, indicating no difference. Zero to 0.9% outliers 
were identified in the robust regression models, but none affected the effect estimates. 
 
In the multivariable logistic regression models, a two-fold increase in LEM of 
PCB153 tended to increase the odds of scoring below average on the receptive language 
scale (OR=1.3, 95%CI=0.8, 2.0), though the association is not statistically significant 
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(Table 3). A two-fold increase in LEM of p,p’-DDT and p,p’-DDE increased the odds of 
scoring below average on the gross motor scale (DDT: OR=1.4, 95%CI=0.9, 2.0; DDE: 
OR=1.4, 95%CI=0.9, 2.2), the fine motor scale (DDT: OR=1.4, 95%CI=1.0, 2.0; DDE: 
OR=1.3, 95%CI=0.9, 2.1), and the Early Learning Composite score (DDT: OR=1.4, 
95%CI=0.9, 2.2; DDE: OR=1.4, 95%CI=0.8, 2.2), although all confidence intervals 
included 1. 
 
Using the norms appropriate for gender and age, 19% of the 218 infants scored 
below the 15th percentile for word comprehension. The infants who were breast fed 
longer than 9 months were less likely to score below the 15th percentile for 
comprehension. None of other factors showed an association with comprehension. After 
adjusting for duration of breast feeding and other covariates in the multivariable logistic 
regression models, two-fold increases in LEMs of PCB153, total PCBs, p,p’-DDT and 
p,p’-DDE were not associated with CDI scores (Table 4). 
 
Infant gender did not modify the observed effects in most models (p-values of the 
interaction terms ≥0.1). However, male infants who had a two-fold increase in LEM of 
p,p’-DDE were more likely to score below average on the gross motor scale (adjusted 
OR=1.9, 95%CI=1.1, 3.3); this association was not observed among female infants 
(adjusted OR=0.7, 95%CI=0.3, 1.5) (p-value of the likelihood ratio test=0.02). 
 
The 25th percentile of DHA and AA concentrations were 0.12% and 0.43% of total 
fat, respectively. The effects of exposure to PCB153, PCBs, p,p’-DDT and p,p’-DDE 
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were generally similar above and below the 25th percentile of each fatty acid, although 
the effects of DDE on the odds of scoring below average on the Mullen fine motor scale 
was higher when DHA level was <25th percentile (OR=1.9, 95%CI=0.8, 4.8) compared 
to the level ≥25th percentile (OR=0.7, 95%CI=0.4, 1.4). Because data were sparse, the 
stratum-specific estimates were unstable; consequently, this study was unable to confirm 
or interpret potential differential effects. 
 
B.4 Discussion 
 
In this study, lactational exposures to PCBs, p,p’-DDT and p,p’-DDE were generally 
not associated with infant neurodevelopment at age of 12 months, as assessed by the 
Mullen and the Short Form of the CDI. However, we found that lactational exposure to 
p,p’-DDE through the first 12 months was associated with scoring below average on the 
gross motor scale among males but not females. The neurological toxic effects of DDE 
on male infants in these data were not precise; however, as a known antiandrogen, 
p,p’-DDE can inhibit the biologic effects of androgens, which might differentially affect 
the development of males. The effect of DDE on the gross motor modified by infant 
gender hasn’t been reported before. Our results suggest that the potential for this 
interaction should be examined in other large datasets with available data. 
 
Most prior epidemiological studies used the Bayley Scales of Infant Development 
(BSID) which included only two scales (mental and psychomotor). We used the Mullen 
to assess neurodevelopment because the five subscales may help distinguish among finer 
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domains of development. The Mullen Early Learning Composite score has been found to 
be highly correlated with the mental development index (MDI) of the BSID (r=0.70), and 
the Mullen gross motor score has also been found to be highly correlated with the 
psychomotor development index (PDI) of the BSID (r=0.76) 165, which may provide the 
basis for comparisons of our study results with those of previous studies. However, it is 
important to note that both the Mullen and the Bayley Scales are limited in the ability to 
detect subtle physiological deficits of the brain and nervous system which might be 
identified with more sensitive clinical assessments. 
 
In a study of Mexican farm-workers' children in California, 1999-2000, prenatal 
p,p’-DDE was found to be associated with infant PDI at 6 months but not at a later age 85. 
A study of a cohort of 92 mother-child pairs in Spain found that an increase in cord blood 
DDE levels was associated with decrements in MDI and PDI, and was also associated 
with lower scores on the personal-social scale, locomotor scale and performance scale 
assessed by the Griffiths Mental Development Scales at 13 months 66. In a cohort study in 
Mexico, 2001-2005, they only found an association between maternal DDE serum level 
in the first trimester of pregnancy and a reduction in infant PDI throughout the first year 
167. However, neither study investigated postnatal exposure or reported effect measure 
modification by infant gender. Three other studies did not observe associations between 
DDE and infant neurodevelopment 61,62,70. 
 
Prenatal exposure to PCBs was associated with lower scores on the PDI at 6 to 24 
months in a North Carolina cohort between 1978-1982 61,62. A Dutch study (1990-1992) 
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reported delays in motor development at 3 months, but not at older ages, for prenatal 
exposure 63. In addition, in the Dutch cohort, infants with postnatal exposure to PCBs 
scored lower on the PDI at 7 months, after controlling for lactational periods 63. In 
contrast to these two studies, the Collaborative Perinatal Project cohort (in the US), and 
cohorts in Germany, Spain and Japan did not find any associations between infant motor 
development and either prenatal PCBs 64-67 or postnatal PCBs 65. None of the studies 
found associations using the BSID mental development index 61-64,66,67, although the 
German study found that PCBs in breast milk related to a decrease in infant MDI 65,68. 
The Michigan cohort 69 and the Oswego cohort 70, both of which used the Fagan Test of 
Infant Intelligence to assess infant cognition, found a deficit in infant novelty preference 
associated with prenatal PCBs exposure. 
 
This study differed from other studies focused on infants’ lactational exposure to 
PCBs, p,p’-DDT and p,p’-DDE by the method of exposure assignment. Rather than using 
only the chemical concentration at the time of measurement, we used the LEM to 
estimate each infant’s total exposure to PCBs, p,p’-DDT and p,p’-DDE through breast 
feeding during the first year of life. This metric accounted for both the chemical 
concentration in breast milk and the duration of breast feeding. According to the Hooper 
et al study 102, PCB153 concentration in breast milk decreased 4% over the first 6 months 
of breast feeding; after 6 months the change in PCB153 concentration did not change 
more than 1% per month. Among 83 women in our study who had concentrations 
available in both 3-month and 12-month breast milk samples, there was no statistical 
difference in the percentage change of the concentrations of PCB153, PCBs, p,p’-DDT 
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and p,p’-DDE. These findings support our assumption of a relatively constant 
concentration throughout the lactation period of interest here. Additionally, under the 
assumptions that infants in the same feeding status group consume similar breast milk 
volume and that the each mother’s milk had similar fat composition, the LEM should be 
highly correlated with the absolute value of the accumulated dose of the chemicals 
throughout the first 12 months of life. The LEM is therefore appropriate for estimating 
the relative effects of chemical exposure. 
 
In contrast to the potential detrimental effects of these persistent organic pollutants 
in breast milk, breastfeeding could also convey beneficial effects through enhanced 
nutrition or through social enrichment. Our study observed that infants who were breast 
fed longer scored higher than infants breast fed for a shorter period on the expressive 
language and fine motor scales and the Early Learning Composite of the Mullen; this 
finding of a beneficial effect of breast feeding on infant cognitive development is in 
agreement with that found in previous studies 104. Because most of the women in this 
study did breast feed for 6 months or longer, to further diminish this confounding effect 
by long-term breast feeding, we carefully controlled for breast feeding and the potential 
confounding effects from long-term breast feeding are reduced in the analyses. 
 
Beneficial fatty acids and possibly harmful environmental pollutants unavoidably 
coexist in breast milk, mainly from maternal dietary sources. It is difficult to know how 
the beneficial and harmful constituents of breast milk interact to affect development. 
While we evaluated the interaction between the pollutants PCBs, DDT and DDE, and 
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fatty acids DHA and AA in breast milk on infant neurodevelopment, only one interaction 
term appeared statistically significant at an a priori significant level of 0.1 in the multiple 
logistic regression models. However, the sample size of this study was too small to 
provide precise effect estimates. Other studies of larger sample sizes are needed to 
examine these relationships. 
 
Animal studies have shown that different degrees of chlorination of PCB congeners 
may cause different neurochemical effects 40, but based on the number of chlorine 
substitutions in the ortho positions (2, 2', 6, and 6'), our study did not find an association 
between lactational exposure to different ortho-chlorinated PCBs groupings with any 
measurements of infant neurodevelopment. 
 
The Mullen scores at 12 months in this study were calculated without the 
conventional age adjustment for prematurity (infants born earlier than 37 gestational 
weeks) that is common in clinical practice. In this sample, conventional age adjustment 
led to artificially-elevated T scores for the 18 preterm infants. These scores were 
significantly higher than those of the 200 full term infants on the visual reception and fine 
motor scales and the Early Learning Composite, after controlling for infant gender, parity, 
maternal race, maternal age, maternal education, poverty level, and duration of breast 
feeding. Therefore, we determined that it was better to use actual chronological age in 
calculating the Mullen scores. The norming sample for the CDI Short Form had excluded 
babies born at 34 weeks or younger. We conducted a sensitivity analysis by excluding the 
3 babies in our sample who were born at 34 weeks and 1 baby at 33 weeks from the 
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models, and the results were not changed. Therefore, we retained those infants in our 
analyses. 
 
One of the study limitations is that we were unable to distinguish the effects of 
lactational exposure to PCBs, p,p’-DDT and p,p’-DDE from the effects of prenatal 
exposure. PCBs and DDE concentration in breast milk have been shown to be highly 
correlated with the concentrations in cord plasma 100,101, so infants exposed to high 
chemical concentrations postnatally in breast milk were also likely to be exposed to high 
chemical concentrations prenatally. The other limitation is that most of our study 
population breast fed 6 months or longer, so we had limited sample size to differentiate 
the effects of short-term high-concentration exposure to PCBs, DDT and DDE from the 
effects of long-term low-concentration exposure. 
 
Overall, our study did not find lactational exposure to PCBs, DDT and DDE to be 
associated with infant neurodevelopment at 12 months. This may be attributed to the 
combination of low chemical concentrations in breast milk and the beneficial effects of 
the long duration of breastfeeding in this study population. Larger studies are needed to 
assess the potential for gender to modify the association between lactational exposure to 
p,p’-DDE and infant gross motor development, and to assess the potential effect measure 
modification on the associations between environmental pollutants in breast milk and 
infant neurodevelopment by the concentrations of beneficial long chain polyunsaturated 
fatty acids in breast milk. This study contributes to the knowledge of potential effects of 
accumulated exposure to low levels of PCBs, DDT and DDE through lactation in the first 
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year of life on infant neurodevelopment, taking into account interactions with fatty acids. 
 
B.5 Acknowledgement 
 
We acknowledge Dr. Andreas Sjödin and the Organic Analytic Toxicology Branch of 
the NCEH, CDC for assays of PCBs, DDT and DDE. We also acknowledge support from 
NIEHS P30ES10126. Dr. Rogan's work on this project was supported by the Intramural 
Research Program, NIEHS, NIH. 
  
112
Table 17. Characteristics of participant mothers who provided breast milk at 3 
months in the PIN Babies study and the mother-child pairs included in this study. * 
 Milk Samples 
(n=304) 
Mullen Subgroup
(n=231) 
CDI Subgroup 
(n=218) 
Participant characteristics No. % No. % No. % 
Maternal chracteristics       
Race       
White 262 86 204 88 194 89 
Black 18 6 12 5 9 4 
Other 24 8 15 7 15 7 
       
Age (years)       
<25 32 11 24 10 20 9 
25-29 88 29 63 27 61 28 
30-34 130 43 99 43 94 43 
≥35 54 18 45 20 43 20 
Mean±SD 31±5 31±5 31±5 
       
Education (years)       
≤12 17 6 11 5 10 5 
13-15 37 12 26 11 23 11 
≥16 250 82 194 84 185 85 
Mean±SD 17±2 17±2 17±2 
       
Parity       
0 160 53 118 51 113 52 
≥1 144 47 113 49 105 48 
       
Percent of 2001 poverty level 
during pregnancy 
      
Mean±SD 490±199 493±197 513±190 
Missing 5  4  4  
       
Postpartum smoking       
Yes 13 5 9 4 10 5 
No 251 95 222 96 208 95 
Missing 40  0  0  
       
Median (range) of chemical 
concentrations in breast milk 
(ng/g lipid) ‡ 
      
PCB153 17 (2-199) 18 (2-199) 17 (2-199)
ΣPCBs † 77 (9-708) 79 (12-708) 79 (12-708)
p,p’-DDT 5 (<LOD-80) 5 (<LOD-80) 5 (<LOD-80)
p,p’-DDE 121 (1-2140) 117 (15-2140) 117 (15-2140)
 
Infant characteristics 
Median (range) of LEM 
(ng/g lipid - months) ‡ 
      
PCB153 119 (12-1194) 118 (12-1194) 119 (12-1194)
ΣPCBs † 546 (64-4249) 550 (64-4249) 549 (64-4249)
p,p’-DDT 33 (1-523) 33 (1-523) 33 (1-523)
p,p’-DDE 871 (134-19260) 867 (134-19260) 864 (134-19260)
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Duration of breast feeding 
(months) 
      
0-<6 11 4 10 4 11 5 
6-9 66 25 60 26 54 25 
>9-12 187 71 161 70 153 70 
Missing 40  0  0  
Mean±SD 10±2 10±2 10±2 
       
Gender       
Male 163 54 122 53 120 55 
Female 141 46 109 47 98 45 
       
Preterm birth       
Yes 22 7 18 8 18 8 
No 282 93 213 92 200 92 
       
Age at developmental 
assessment (months) 
      
Mean±SD  12±1 13±1 
       
Mullen Scales of Early 
Learning (Mean±SD) ‡ 
      
Receptive Language  46±8  
Expressive Language  54±9  
Visual Reception  51±11  
Gross Motor  50±12  
Fine Motor  51±11  
Composite Standard Score  101±14  
       
MacArthur CDI       
Words comprehended       
Mean±SD   29±20 
Comprehension       
<15th     42 19 
15th-85th     149 68 
>85th     27 12 
* Abbreviation: CDI, the MacArthur Communicative Development Inventories; SD, standard 
deviation; <LOD, lower than detection limit; PCB, polychlorinated biphenyls; DDT, 
dichlorodiphenyltrichloroethane; DDE, dichlorodiphenyldichloroethylene; LEM, Lactational 
Exposure Metric. 
† ΣPCBs is the sum of the concentrations of PCB66, PCB74, PCB99, PCB105, PCB118, 
PCB138_158, PCB146, PCB153, PCB156, PCB170, PCB177, PCB178, PCB180, PCB183, 
PCB187, PCB194, PCB196_203 and PCB199, in which <LOD is treated as median(LOD) divided 
by a square root of 2. 
‡ There was 1 subject missing ΣPCBs concentration and the LEM of ΣPCBs and 1 subject missing 
p,p’-DDT concentration and the LEM of p,p’-DDT. An additonal 40 subjects in the milk sample 
group were missing LEM because of missing duration of breast feeding through 12 months. These 
Mullen scores were missing: 2 for receptive language, 2 for expressive language, 6 for visual 
reception, 7 for fine motor, 2 for gross motor, and 8 for the Early Learning Composite. 
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Table 20. Adjusted odds ratio for the infant Short Form of the MacArthur 
Communicative Development Inventories associated with a two-fold increase in 
lactational exposure metrics. *, † 
 Comprehension <15th percentile 
 OR 95% CI 
PCB153 1.0 0.7, 1.6 
ΣPCBs 1.0 0.6, 1.6 
p,p’-DDT 1.0 0.8, 1.4 
p,p’-DDE 1.0 0.7, 1.5 
* Abbreviation: OR, odds ratio; CI, confidence interval; PCB, polychlorinated biphenyls; DDT, 
dichlorodiphenyltrichloroethane; DDE, dichlorodiphenyldichloroethylene. 
† Adjusted for duration of breast feeding (months), maternal age at the start of pregnancy (years), 
parity (0 vs. ≥1), maternal race (nonwhite vs. white), maternal education (≤12 years, 13-15 years 
vs. ≥16 years), poverty level during pregnancy and infant gender (male vs. female). 
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C. Manuscript 3: Lactational Exposure to Polychlorinated Biphenyls, 
Dichlorodiphenyltrichloroethane, and Dichlorodiphenyldichloroethylene and 
Infant Growth: An Analysis of the Pregnancy, Infections, and Nutrition Babies 
Study 
 
C.1 Introduction 
 
The first 12 months of life is a period of dramatic change in babies’ physical growth. 
Infants gain weight at a rate of about 680 g per month during the first 5 to 6 months 24. 
Weight triples by the end of the first year, and body length increases by approximately 
50% 24. Growth in infancy has been related to long-term outcomes such as children’s 
cognition, pubertal development, adult obesity, chronic diseases, and workplace success 
25-32. Infant growth retardation can be due to intrauterine growth inhibition, early 
childhood diseases, malnutrition, or disruption of hormone systems, potentially caused by 
environmental pollutants. 
 
Polychlorinated biphenyls (PCBs), dichlorodiphenyltrichloroethane (DDT) and its 
most stable metabolite, p,p’-dichlorodiphenyldichloroethylene (p,p’-DDE), are persistent 
organic compounds in the environment, which have been recognized as endocrine 
disruptors 168. In vivo and in vitro studies have shown that PCBs may alter dopamine, 
estrogen and thyroid effects 33,35,38,41. DDT has been suspected to have estrogenic effects, 
and p,p’-DDE is known as an antiandrogen which inhibits the biologic effects of 
androgens 42-46. The potential for these compounds to interfere with the endocrine system 
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could adversely affect infant development and growth. 
 
The main route of exposure to PCBs, DDT and DDE for infants is through breast 
feeding. As the duration of lactation increases, the infant’s accumulated dose of these 
long half-life chemicals increases. Exclusive breastfeeding up to 6 months postpartum is 
recommended by the World Health Organization (WHO) because breast milk provides 
essential nutrients that an infant needs for growth and development 169. Assessing the 
adverse effects of chemical exposure through breastfeeding is thus complicated by the 
co-existing beneficial attributes. 
 
Breast-fed infants compared to formula-fed infants generally gain less weight in the 
first twelve months without much difference in length 170,171. Breast feeding duration 
could affect the infant’s growth curve as well as the accumulated lactational exposure. We 
estimated the relationships between lactational exposure to PCBs, DDT and DDE and 
infant growth in the first 12 months using two methods. We first restricted our study to 
the infants who were breast fed for 6 months or longer to make breast feeding duration in 
the first 6 months uniform across the sample. This allowed us to assess the effects of 
chemical exposure on growth in the first 6 months independently from effects of 
breastfeeding. We also examined exposure to the accumulated chemicals over the first 12 
months of life, incorporating duration of breastfeeding into an exposure metric. 
 
C.2 Methods 
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Study Population 
 
The Pregnancy, Infection and Nutrition (PIN) Babies Study from January 2004 to 
the end of 2006 followed the infants of the PIN and PIN Postpartum Study participants. 
These studies enrolled pregnant women receiving prenatal care at the University of North 
Carolina Hospitals before 20 weeks gestation and followed them through the first year 
postpartum. Mothers completed several self-administered questionnaires and two phone 
interviews during pregnancy, one brief questionnaire after delivery at hospital, and two 
in-home interviews at 3 and 12 months postpartum to provide details about their health 
and lifestyle during and after pregnancy. Infants in the PIN Postpartum and PIN Babies 
studies were singletons without major birth defects. Details of these studies are available 
at the website: http://www.cpc.unc.edu/projects/pin/. The study protocols of the PIN, PIN 
Postpartum, and PIN Babies studies have been approved by the Institutional Review 
Board of the University of North Carolina at Chapel Hill. 
 
Three hundred and four of the participant women in the PIN Postpartum Study were 
still lactating at 3 months postpartum and willing to provide a valid breast milk sample 
for the postpartum in-home interview. They followed the written instructions to pump 
both breasts at around 10 o'clock in the morning of the scheduled interview. They gently 
mixed the milk extracted, used the plastic pipette to transfer the milk into three 1.5ml 
tubes, and stored the milk in the freezer until the interviewers arrived. Samples were then 
transported on ice to the -80 ºC storage freezers. 
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Two hundred and sixty-four women continued participation in the postpartum 
12-month in-home interview. Infant feeding status for each preceding month was reported 
at these two home interviews. Two hundred and fifty-three women were accordingly 
identified as breast feeding for 6 months or longer in the first year. 
 
Growth Measurement 
 
Mothers were provided with an infant growth card to take to their child’s 12 month 
pediatric well-child visit. The children’s medical care providers completed the growth 
card by recording the infant’s weight and length at each routine clinical visit from birth 
through 12 months. The schedule for visits recommended by the American Academy of 
Pediatrics is at 1, 2, 4, 6, 9, and 12 months of age, but actual dates of visits were recorded 
because the frequency and times of visits varied among infants. The growth card was then 
collected at the 12-month postpartum home visit. 
 
The weights and lengths of infants were compared to the nationally representative 
data, the 2000 Centers for Disease Control and Prevention (CDC) growth charts, to 
determine their age- and gender-standardized z-scores of weights and lengths and their 
age- and gender-specific percentiles of weights, lengths and weight-for-length 132. Growth 
measurements were considered as biologically implausible if the z-scores were in the 
fixed exclusion range suggested by the World Health Organization 172. Infants who were 
less than the 5th percentile of length-for-age were classified as having stunted growth. 
Underweight was the infant’s percentile of weight-for-length less than the 5th percentile, 
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and overweight was the infant’s percentile of weight-for-length equal to or greater than 
the 95th percentile. The 2000 CDC growth charts were based on a mix of both breast-fed 
and formula-fed infants, in which only 33% was breast-fed for 3 months or longer. It is 
likely that the weight of the 206 infants in this sample, in general, will be on the “light” 
side on the 2000 charts because the entire sample breast fed for 6 months or longer. 
 
Exposure Measurement 
 
Breast milk samples were analyzed for p,p’-DDT, p,p’-DDE and thirty-five PCB 
congeners according to the existing methodology at the Organic Analytic Toxicology 
Branch of the National Center for Environmental Health at the CDC 122. The 
measurement of selected chemicals in breast milk samples was performed using gas 
chromatography/isotope dilution high-resolution mass spectrometry (GC/IDHRMS) 
using a MAT95 instrument (ThermoFinnigan MAT; Bremen, Germany). The lipid 
concentration was gravimetrically determined by an analytical balance AX105 Delta 
Range (Mettler Toledo; Columbus, OH) with an accuracy of ±10-4 g. Each analysis batch 
contained sixteen unknowns, two method blanks and two quality control specimens. The 
between-assay coefficient of variation was normally less than 10%. Concentrations 
reported here were all lipid adjusted. PCB153 and p,p’-DDE were detected in all 304 
samples, and p,p’-DDT was detected in 292 samples (96%). Total PCBs was calculated as 
the sum of eighteen detectable PCB congeners in more than 70% samples, that is PCB66, 
PCB74, PCB99, PCB105, PCB118, PCB138_158, PCB146, PCB153, PCB156, PCB170, 
PCB177, PCB178, PCB180, PCB183, PCB187, PCB194, PCB196_203 and PCB199. 
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Concentrations lower than the limits of detection (LOD) were imputed to the median of 
the method LOD of each measurement divided by a square root of 2 164. 
 
Lactational Exposure Metric 
 
We quantified the duration of breast feeding in order to estimate the infant’s the 
lactational exposure to PCBs, p,p’-DDT and p,p’-DDE through the first 12 months of life. 
At the 3- and 12-month interviews, women were asked to recall their child’s feeding 
practices for each of the preceding months, indicating the frequency that they breast fed, 
fed infant formula, and fed other types of food. For each month, feeding status was 
classified. Exclusively breast-feeding was defined as breast feeding with no other food or 
liquid; mostly breast-feeding was defined as breast feeding with feeding of other 
supplements equal to or less than one time per day; and breast-feeding with supplements 
was defined as breast feeding with feeding any other liquids or solids >1 time per day. 
The number of months representing each type of feeding was summed and used in a 
Lactational Exposure Metric (LEM). 
 
The LEM was developed as follows to represent the infant’s cumulative exposure to 
each chemical at 12 months: 
LEM = C × (D1+D2) + ½ × C × D3, 
in which C denotes chemical concentration in breast milk (ng/g lipid), D1 is duration of 
exclusively breast-feeding (months), D2 is duration of mostly breast-feeding (months), 
and D3 is duration of breast-feeding with other supplements (months). The unit of this 
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estimate is concentration-months, i.e. ng/g-months. Using this metric, breast milk 
concentration for each chemical was assumed to be constant through the lactation period, 
and breast milk consumption was assumed to be decreased by half during the period 
when breastmilk was supplemented with formula, other liquids or solids. 
 
Statistical Analysis 
 
To estimate the relationships between lactational exposure to PCBs, DDT and DDE 
and infant growth in the first 12 month, two statistical analyses were conducted using 
PC-SAS (version 9.1). In the first analysis, linear mixed effects models (SAS PROC 
MIXED) were used to assess the relationships between PCB153, PCBs, DDT and DDE 
concentration in breast milk and longitudinal infant weight (grams) and length 
(centimeters) measurements in the first 6 months 173. This analysis was restricted to 
infants who were breast fed for 6 months or longer, in order to distinguish the effects of 
the chemicals from effects of the duration of breast feeding. The concentrations of 
PCB153, total PCBs, DDT and DDE in breast milk at 3 months postpartum were 
included in the separate mixed models as time-independent variables. Infant age at the 
pediatric well-child visits was a time dependent variable, and centered at 90 days. A 
linear term, a quadratic term and a cubic term of infant age at the visit were included in 
the model to allow a curvilinear growth pattern. Models also included a random intercept 
and a random slope for infant age to allow infants to have their own growth patterns. The 
interaction terms between infant age and gender, between infant age and preterm status, 
between infant age and maternal race, and between infant gender and the concentrations 
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of chemicals were added in the models and assessed by likelihood ratio tests using 
maximum likelihood. The a priori α-level for interaction tests was 0.1. Influence statistics 
were assessed to examine how observations impacted the effect estimators 174. The 
parameters in the final models were estimated using restricted maximum likelihood. 
Other covariates in the final model were potential confounders and the important factors 
of the outcomes: infant gender (male vs. female), preterm birth (yes vs. no), birth weight 
(grams), maternal race (nonwhite vs. white), education (<16 years vs. ≥16 years), income 
as a percentage of the poverty level during pregnancy (100%), parity (0 vs. ≥1), and 
maternal pre-pregnancy body mass index (kg/m2). 
 
In the second analysis, multivariable linear regression models were used to assess 
the relationships between lactational exposure to PCB153, PCBs, DDT and DDE through 
12 months, which was estimated by LEM, and the z-scores of infant weight and length at 
12 months. Infants who had a growth measurement in the interval 12±1.5 months were 
included in this analysis. If there were multiple measurements within the range, we used 
the one measured at the age closest to 12 months. To control the confounding effects from 
breast feeding, the residuals were first calculated separately from the models of 
breastfeeding and z-scores of weight and z-scores of length using simple linear regression, 
and then were included in the multiple linear regression models as dependent variables to 
estimate the effects of the LEM. Other covariates included in the linear regression models 
were z-score of birth weight, preterm birth (yes vs. no), maternal race (nonwhite vs. 
white), education (<16 years vs. ≥16 years), income as a percentage of the poverty level 
during pregnancy (100%), parity (0 vs. ≥1) and maternal pre-pregnancy body mass index 
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(kg/m2). Gender and LEM interaction was included in the models and assessed by the 
likelihood ratio test (a priori α-level=0.10). Robust regression with Least Trimmed 
Squares (LTS) estimation for multiple linear regression models was used to examine the 
influence by the outliers of chemical concentrations on beta coefficients 166. 
 
C.3 Results 
 
Among 253 women who breast fed for 6 months or longer, 206 women returned the 
growth card. The study population was primarily white women with 16 or more years of 
education who were about 30 years of age at the start of pregnancy (table 21). 
Comparison of the 206 mother-child pairs in the growth card subgroup with the original 
304 participants showed that those who breast fed for 6 months or longer and also 
participated in the follow-up studies were more highly educated and more likely to be 
white women. However, this subgroup had similar distributions of chemical 
concentrations and LEMs to those of the original population. In the subgroup of 206 
mother-child pairs, one infant had no records of clinical visits in the first 6 months and 
was not included in the mixed models; 8 infants had no clinical visits around 12 months 
and were not included in the linear regression models. 
 
Children averaged 3.7 (range 1 to 7) well-child visits in the first 6 months. A total of 
750 visits for 205 infants were included in the analysis. After controlling for other 
covariates in the mixed models, no difference were observed in growth curves of infant 
weight and length through 6 months as an increase of 10 ng/g-lipid in the concentrations 
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of PCB153, total PCBs, DDT and DDE (table 22). Although the p-values for the 
parameter estimates of PCB153 and total PCBs in the models for body weight were at 
borderline (p=0.06), these borderline effects disappeared when excluding chemical 
concentration outliers (>mean+3 standard deviation (SD)). Several chemical 
concentration outliers also appeared to be influential on other parameter estimates. 
However, excluding these outliers (2 for analysis of PCB153, 1 for total PCBs, and 4 for 
DDT and DDE) only changed the effect estimates by 2.8 to 48.6 grams on weight and by 
0.06 centimeters or less on length, and the confidence intervals of the associations 
became wider and still remained inclusive of zero. 
 
The interaction terms between infant age and gender, infant age and preterm status, 
and infant age and maternal race contributed to the fit of the models, which indicated the 
growth curves of weight in the first 6 months varied by gender, preterm status and 
maternal race; however, in the models of lengths, the growth curves did not vary by 
maternal race. The likelihood ratio tests for the interaction between the chemical 
concentrations and gender were greater than 0.1, so the effects of chemicals were not 
modified by infant gender. 
 
At twelve months, the mean weight of 198 infants who had medical visits at 12 
months was 9570 grams (standard deviation (SD)=1126) and the mean z-score of weight 
was -0.50 (SD=1.03). The mean length was 75.7 centimeters (SD=2.7) and the mean 
z-score of length was 0.17 (SD=0.88). Twenty-one of 198 infants (10.6%) were classified 
as underweight, 9 infants (4.6%) were overweight, and 4 infants (2.0%) were stunted 
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using the 2000 CDC growth charts. As the duration of breast feeding increased by a 
month, the z-scores of weight at 12 months decreased by 0.13 (p<0.001) and the z-score 
of length at 12 months decreased by 0.06 (p=0.04). Table 23 shows that after covariate 
adjustment, no differences in z-scores of weight or length were observed with increases in 
LEM of PCB153, PCBs, DDT and DDE. No gender modification was observed on the 
effect measurements of LEM. Robust regression identified 1 to 2 outliers (0.5 to 1 %) in 
the multivariable linear regression models, but none changed the effect estimates. 
 
C.4 Discussion 
 
Our results suggest that among infants breast fed for 6 months or longer there was 
no difference in weight and length through the first 6 months as PCBs, DDT and DDE 
concentration in breast milk increased. No difference was observed in weight and length 
at 12 months when comparing the accumulated lactational exposure through 12 months 
after controlling for their total duration of breast feeding. No sex-specific association was 
observed. 
 
The associations between PCBs, DDT and DDE and children’s growth have not 
been consistent throughout the literature, and nor has the effect modification of gender. 
Inconsistent results may be due to different exposure periods assessed (prenatal, 
lactational or childhood), different chemical concentrations in the different study 
populations and different mixtures of environmental chemicals across studies, or 
inadequate confounding control for duration of breast feeding. Our study measured 
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chemical concentrations in breast milk at 3 months postpartum to examine the effects of 
infants’ lactational exposure. Our study population was exposed to low background levels 
reflected by the relatively lower chemical concentrations compared to other previous 
studies. Because breast feeding itself can affect growth patterns, we restricted the 
analyses to those breast fed for 6 months or longer. This restriction should have 
minimized the potential for confounding by the duration of breast feeding per se. 
 
Despite different methods of exposure estimation and different time windows of 
outcome measurements, this study supported previous findings of no associations 
between children’s growth and postnatal exposure to PCBs 90,95,98. Our results contrast 
those from the Faroe Islands cohort study, which suggested that an increase in lactational 
exposure, estimated by the product terms of chemical concentrations and the duration of 
exclusive breast feeding, decreased body height and weight at 18 months 91. As for 
prenatal exposure to PCBs in previous studies, children with higher prenatal PCBs were 
reported to be shorter from birth to 3 months of age in a formula-fed group in the Dutch 
cohort 90, but was associated with greater height among 5-year-old girls in the California 
study 92. A negative association with body weight was observed only among girls in the 
small subset of the Collaborative Perinatal Project (CPP) cohort in New York 93 and in a 
Michigan cohort of polybrominated biphenyl accident victims 94. This negative 
association was found without gender differentiation among 4-year-old children in the 
Michigan fish consumption cohort 95, and from birth to 3 months in a formula-fed group 
in the Dutch cohort 90. However, there were two other studies that reported no difference 
was observed in children’s growth when prenatal exposure to PCBs increased 97,111. 
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No prior studies have investigated lactational exposure to DDT and DDE in relation 
to infant growth. In several studies regarding prenatal exposure to DDT and DDE, no 
difference was observed in children’s growth 93,111,113. However, the CPP cohort found a 
negative association between prenatal p,p’-DDE and children’s height at 1, 4, and 7 years 
97. This negative association was also found only among girls in the German study by 
using the concentrations detected in child’s blood at 8 years old to index perinatal 
exposure 98.  
 
Compared to the use of a single chemical concentration at the time of measurement, 
the lactational exposure metrics used in this study can more accurately reflect an infant’s 
accumulated lactational exposure through the first 12 months. According to the Hooper et 
al study 102, PCB153 concentration in breast milk decreased 4% over the first 6 months of 
breast feeding; after 6 months the change in PCB153 concentration did not change more 
than 1% per month. These findings support our assumption of a relatively constant 
concentration throughout the lactation period of interest. Additionally, under the two 
assumptions that infants in the same feeding status group consumed similar amounts of 
breast milk and that the mothers had similar fat composition in their breast milk, the LEM 
should be highly correlated with the absolute value of the accumulated dose of the 
chemicals. The LEM is therefore appropriate for estimating the relative effects of 
chemical exposure. 
 
For the investigation on the growth trajectory in the first 6 months, we used the 
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concentration of chemicals in breast milk by itself in the mixed models. This 
measurement should be highly correlated with the accumulated exposure through the first 
6 months, because all the infants in this study were at least breast fed for 6 months and 
90% of the infants were exclusively and mostly breast fed for 4 months or longer. This 
selection criterion provided comparability among the infants, and also provided an 
unambiguous measure of the chemical effect independent of the duration of breast 
feeding. We also used the LEM at each pediatric well-child visit as a time-dependent 
variable in the mixed models, and the findings confirmed the results of no association. 
 
The logarithmic transformation of the concentrations of PCB153, total PCBs, DDT 
and DDE was considered for the general linear mixed models, but it did not substantially 
improve the normality of residuals or reduce leverage points. We decided to use a linear 
term of the concentrations in the models for simplicity and ease of interpretation. 
 
The babies’ growth cards provided a low cost collection of serial growth 
measurements recorded from the pediatric medical record to construct each infant’s 
growth pattern. Although it was not feasible to standardize the measurement procedures 
and equipment used in the physical examination at the various pediatric clinics, there is 
no reason to suspect that any potential measurement error was associated with infants’ 
true growth or lactational exposure to chemicals. 
 
Several limitations of this study should be noted. This study population was 
primarily well educated white mothers, which may constrain the generalization of the 
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findings if heterogeneous effects by race and socioeconomic status were believed to be 
true. There were no direct measurements of prenatal exposure to PCBs, DDT and DDE in 
this study, thus the effects of lactational exposure could not be differentiated from the 
effects of prenatal exposure. However, we adjusted for infant birth weight in the mixed 
models and adjusted the z-scores of birth weight in the multiple linear regression models 
to control for the potential adverse effects of prenatal exposure on intrauterine growth.  
 
Women have been encouraged to breast feed for at least 6 months by the WHO and 
the American Academy of Pediatrics. Although longer durations of breast feeding may 
involve increased exposure to potentially hazardous chemicals, our study indicates that 
breast feeding for 6 months or longer, with lactational exposure to PCBs, DDT and DDE 
in the ranges of low background level concentrations studied here, results in no negative 
influence on infant growth in the first 12 months. 
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Table 21. Characteristics and chemical concentrations in breast milk of participant 
mothers who provided breast milk at 3 months in the PIN Babies study and 
characteristics and chemical concentrations of the mother-child pairs included in 
this study. * 
 Milk Samples 
(n=304) 
Growth Card Subgroup 
(n=206) 
 No. % No. % 
Maternal characteristics     
Race     
White 262 86 185 90 
Non-white 42 14 21 10 
     
Education (years)     
<16 54 18 28 14 
≥16 250 82 178 86 
     
Parity     
0 160 53 106 52 
≥1 144 47 100 48 
     
Age (years)     
Mean±SD 31±5 31±5 
     
Percent of 2001 poverty level during 
pregnancy (%) 
    
Mean±SD 490±199 508±188 
Missing 5  4  
     
Pre-pregnancy body mass index 
(kg/m2) 
    
Mean±SD 23.8±4.9 23.5±4.8 
     
Median (range) of chemical 
concentrations in breast milk 
(ng/g lipid) ‡ 
    
PCB153 17 (2-199) 18 (2-199) 
ΣPCBs † 77 (9-708) 81 (12-708) 
p,p’-DDT 5 (<LOD-80) 5 (<LOD-36) 
p,p’-DDE 121 (1-2140) 114 (15-2140) 
     
Infant characteristics     
Baby gender     
Male 163 54 109 53 
Female 141 46 97 47 
     
Preterm birth     
Yes 22 7 15 7 
No 282 93 191 93 
     
Birth weight (g)     
Mean±SD 3426±729 3358±468 
     
Duration of breast feeding (months)     
Mean±SD 10±2 11±2 
Missing 40  0  
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Months of exclusive breastfeeding     
Mean±SD 4±2 5±2 
Missing 40  0  
     
Median (range) of LEM at 12 
months (ng/g lipid - months) ‡ 
    
PCB153 119 (12-1194) 126 (19-1194) 
ΣPCBs † 546 (64-4249) 574 (100-4249) 
p,p’-DDT 33 (1-523) 35 (1-326) 
p,p’-DDE 871 (134-19260) 887 (134-19260) 
* Abbreviation: SD, standard deviation; <LOD, lower than detection limit; PCB, polychlorinated 
biphenyls; DDT, dichlorodiphenyltrichloroethane; DDE, dichlorodiphenyldichloroethylene. 
† ΣPCBs is the sum of the concentrations of PCB66, PCB74, PCB99, PCB105, PCB118, 
PCB138_158, PCB146, PCB153, PCB156, PCB170, PCB177, PCB178, PCB180, PCB183, 
PCB187, PCB194, PCB196_203 and PCB199, in which <LOD is treated as median(LOD) divided 
by a square root of 2. 
‡ There were 1 subject missing ΣPCBs concentration and the LEM of ΣPCBs and 1 subject 
missing p,p’-DDT concentration and the LEM of p,p’-DDT. Additonal 40 subjects in the milk sample 
group missed LEM because of missing duration of breast feeding through 12 months. 
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Table 22. Fixed effect estimates of a 10 ng/g lipid increase in the concentrations 
of PCB153, PCBs, DDT and DDE in breast milk at 3 months postpartum on infant 
weight and length in the first 6 months. * 
Chemical concentration Weight (g) Length (cm) 
(per 10 ng/g lipid) β † 95% CI β † 95% CI 
PCB153 -22.8 -46.1, 0.6 -0.04 -0.18, 0.10 
ΣPCBs -6.1 -12.5, 0.3 -0.02 -0.05, 0.02 
p,p’-DDT 21.0 -89.7, 131.6 0.24 -0.39, 0.88 
p,p’-DDE 0.6 -1.7, 2.8 0.01 -0.005, 0.02 
* Abbreviation: PCB, polychlorinated biphenyls; DDT, dichlorodiphenyltrichloroethane; DDE, 
dichlorodiphenyldichloroethylene; CI, confidence interval. 
† Adjusted for infant gender (male vs. female), preterm birth (yes vs. no), birth weight (grams), 
maternal race (nonwhite vs. white), education (<16 years vs. ≥16 years), income as a percentage 
of the poverty level during pregnancy (100%), parity (0 vs. ≥1), and maternal pre-pregnancy body 
mass index (kg/m2). 
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Table 23. Mean difference in age- and gender-standardized weight and length 
(z-scores) at 12 months per 10 ng/g-month increase in lactational exposure 
metrics of PCB153, PCBs, DDT and DDE. * 
LEM Weight Length 
(per 10 ng/g-month) β † 95% CI β † 95% CI 
PCB153 0.00 -0.01, 0.01 0.00 -0.01, 0.01 
ΣPCBs 0.00 -0.003, 0.003 0.00 -0.002, 0.003 
p,p’-DDT -0.01 -0.04, 0.03 -0.002 -0.03, 0.03 
p,p’-DDE 0.00 -0.0002, 0.001 0.0004 -0.0002, 0.001 
* Abbreviation: PCB, polychlorinated biphenyls; DDT, dichlorodiphenyltrichloroethane; DDE, 
dichlorodiphenyldichloroethylene; CI, confidence interval. 
† Adjusted for z-score of birth weight, preterm birth (yes vs. no), maternal race (nonwhite vs. white), 
education (<16 years vs. ≥16 years), income as a percentage of the poverty level during 
pregnancy (100%), parity (0 vs. ≥1) and maternal pre-pregnancy body mass index (kg/m2) 
 
 CHAPTER V. DISCUSSION 
 
A. Summary of Findings 
 
The Pregnancy, Infection and Nutrition (PIN) Babies Study from January 2004 to 
the end of 2006 followed up the infants of the participant women of the PIN and PIN 
Postpartum Studies. Three hundred and four of the participant women in the PIN Babies 
Study were still lactating at 3 months postpartum and willing to provide a valid breast 
milk sample. The range of PCB153 concentration in breast milk of this study population 
was 2.2–199.0 ng/g lipid (median: 16.6 ng/g lipid); for total PCBs the range was 
9.2–708.1 ng/g lipid (median: 77.3 ng/g lipid); for p,p’-DDT the range was <LOD–80.4 
ng/g lipid (median: 4.7 ng/g lipid); and for p,p’-DDE the range was 1.4-2140.0 ng/g lipid 
(median: 120.50 ng/g lipid). Compared to other previous studies which examined the 
potential hazardous effects on children’s development 141, PCB153 median concentration 
in this study was the lowest. Compared to p,p’-DDE concentration in a previous North 
Carolina study in 1978-1982 (median concentration in milk at 3 months=2.07 ppm, i.e. 
2070 ng/g) 100 this study DDE concentration was very much lower. 
 
The correlation between the concentrations of PCBs and DDE in breast milk at 3 
months postpartum was low (r=0.21). PCBs was observed to be positively correlated with 
the concentrations of DHA (r=0.15) and AA (r=0.20) in breast milk at 3 months 
  
137
postpartum, but the associations disappeared when adjusted for other covariates. No 
correlations were observed between the concentrations of p,p’-DDT and p,p’-DDE and 
the concentrations of DHA, EPA and AA in breast milk. 
 
Findings of this dissertation do not suggest adverse effects of lactational exposure to 
PCBs, DDT and DDE on infant neurodevelopment at 12 months, although lactational 
exposure to p,p’-DDE through the first 12 months appeared associated with scoring 
below average on the gross motor scale among males but not females. The interaction 
between PCB153 and EPA in the model of scoring below average on the visual reception 
scale, and the interaction between p,p’-DDE and DHA in the model of scoring below 
average on the fine motor scale appeared statistically significant at an a priori significant 
level of 0.1 in the multiple logistic regression models. However, the sample size of this 
study was too small to provide precise effect estimates. Other studies of larger sample 
sizes are needed to examine these relationships. 
 
Findings of the linear mixed effects models among the infants who were breast fed 
for 6 months or longer suggested no difference in infants’ growth patterns in the first 6 
months when concentrations of PCBs, DDT and DDE in breast milk increased. 
Cumulative lactational exposure to PCBs, DDT and DDE through 12 months was not 
associated with infant weight and length at 12 months after pre-adjustment for the 
duration of breast feeding. No sex-specific association was observed. 
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B. Strengths and Limitations 
 
B.1 Strengths 
 
One of the main strengths of this dissertation is an appropriate estimation of 
lactational exposure of infants by using LEM. This metric, accounting for both the 
chemical concentration in breast milk and the duration of breast feeding, reflected an 
infant’s accumulated lactational exposure through the first 12 months of life better than 
the use of a single chemical concentration at the time of measurement. Because infant 
feeding status and frequencies of breast feeding, feeding infant formula and feeding other 
type of food at each month were reported at the maternal home interview at 3 and 12 
months postpartum, the durations of exclusively breast-feeding, mostly breast-feeding 
and breast-feeding with supplements were able to be accordingly defined. This exposure 
measurement is also better than using indirect exposure surrogates such as the amounts of 
maternal fish consumption and the duration of lactation only.  
 
Assessing the adverse effects of chemical exposure through breastfeeding is 
complicated by the co-existing beneficial attributes of breastfeeding. This study 
adequately controlled this confounding effect by pre-adjusting the duration of breast 
feeding in the separate linear regression models or by sample selection of infants so they 
had a uniform duration of breast feeding in the study period. 
 
This dissertation has direct measurements of environmental pollutants – PCBs, DDT 
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and DDE and nutrients – LC-PUFAs in breast milk, so the correlations between PCBs, 
DDT, DDE and LC-PUFAs in breast milk could be examined and the modification by 
LC-PUFAs on the effects of lactational exposure to PCBs, DDT and DDE on infant 
neurodevelopment could be assessed. 
 
The Mullen Scales of Early Learning has not been used in previous related papers. 
This developmental assessment, compared to the commonly used Bayley Scales, may 
help distinguish effects on more refined domains of development. The administration 
time for evaluating an infant at 12 months old is about 30 minutes, which is feasible to be 
conducted at a home interview. The Mullen Early Learning Composite score has been 
found to be highly correlated with the mental development index of the Bayley Scales 
(r=0.70), and the Mullen gross motor score has also been found to be highly correlated 
with the psychomotor development index of the Bayley Scales (r=0.76) 165, which may 
provide the basis for comparisons of study results. The parent-report approach of the 
infant Short Form of the MacArthur-Bates Communicative Development Inventories 
requires no child cooperation and therefore can be used to evaluate the language 
development of the infant who is often unwilling to interact with strangers or cooperate 
during testing. Meadows et al have reported that mothers can consistently report their 
infants' communicative acts 130, supporting the use of a self-administered instrument in 
research studies. 
 
Infant growth through age 12 months is measured regularly at the pediatric 
well-child visits. The babies’ growth cards provided a cost-effective collection of these 
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serial growth measurements to construct each infant’s growth pattern. Although it was not 
feasible to standardize the measurement procedures and equipment used in the physical 
examination at the various pediatric clinics, there is no reason to suspect that any 
potential measurement error was associated with infants’ true growth or lactational 
exposure to chemicals. 
 
All pre-, peri-, and post-natal covariates in the PIN studies were collected 
prospectively, so recall of the relative information is likely accurate. Because of the 
availability and accuracy of the covariate information, this dissertation can properly 
control potential confounders. However, as in any observational study, residual 
confounding effects may still exist. 
 
B.2 Limitations 
 
The main study limitation is that we were unable to distinguish the effects of 
lactational exposure to PCBs, p,p’-DDT and p,p’-DDE from the effects of prenatal 
exposure. PCBs and DDE concentration in breast milk have been shown to be highly 
correlated with the concentrations in cord plasma 100,101, so infants exposed to high 
chemical concentrations postnatally in breast milk were also likely to be exposed to high 
chemical concentrations prenatally. 
 
Another limitation is that most of our study population breast fed more than 6 
months, so we had limited variability in duration of breast feeding and also limited 
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sample size to differentiate the effects of short-term high-concentration exposure to PCBs, 
DDT and DDE from the effects of long-term low-concentration exposure when using 
LEM (concentrations-months) as an index of lactational exposure for analysis. 
 
Although the sample size of lactating mother-child pairs in this dissertation is larger 
than in some of the previous studies, this study still has limited power to detect a small 
magnitude of the association. Because only 175 mothers had measurements for the 
concentrations of LC-PUFAs in breast milk and only 14 of 304 participants were 
non-white women, the stratification analyses by LC-PUFAs and maternal race was 
limited. 
 
Finally, this study population was primarily well educated white mothers who had 
their pregnancy at around 30 years old, which may constrain the generalization of the 
findings in this dissertation if heterogeneous effects by maternal race, age and 
socioeconomic status were believed to be true. 
 
C. Conclusions 
 
Women have been encouraged to breast feed for at least 6 months by the WHO and 
the American Academy of Pediatrics. Although longer durations of breast feeding may 
involve increased exposure to potentially hazardous chemicals, our study indicates that 
lactational exposure to PCBs, DDT and DDE was generally not found to be associated 
with infant neurodevelopment at 12 months, and breast feeding for 6 months or longer, 
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with lactational exposure to PCBs, DDT and DDE in the ranges of concentrations studied 
here, results in no negative influence on infant growth in the first 12 months. 
 
Because previous studies had higher chemical exposure and some of the studies 
investigated populations who consumed large amounts of fish or seafood, this dissertation, 
in which the study population was lactating women and their infants in Central North 
Carolina in 2004-2006, who were generally exposed to low background levels of 
chemicals, is informative for future risk assessment of infants exposed to low background 
levels of PCBs, DDT and DDE through lactation. 
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